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The	   continuous	   release	   of	   micropollutants	   into	   receiving	   waters	   due	   to	  
insufficient	   elimination	   from	  wastewater	   treatment	  plants	   (WWTP)	   raises	   global	  
concerns	   regarding	   their	   potential	   risks	   to	   the	   environment	   and	   human	   health.	  
Most	  treatment	  plants	  employ	  biological	  systems	  to	  degrade	  organic	  matter	  due	  
to	  economic	  and	  environmental	   advantages	  but	   they	  are	  not	  designed	   to	   select	  
microbial	   consortia	   that	   possess	   the	   necessary	   enzymes	   to	   remove	  
micropollutants.	   Therefore,	   it	   is	   important	   to	   characterise	   the	   microbial	  
populations	   in	   treatment	   systems	   in	   order	   to	   optimise	   the	   elimination	   of	   these	  
compounds	   from	  WWTP.	   This	  work	   characterises	   the	   performance,	  metabolism	  
and	   identity	   of	   the	  microbial	   populations	   involved	   in	   the	   degradation	   of	   target	  
micropollutants,	  namely	  two	  pharmaceutical	  compounds	  and	  a	  heavy	  metal.	  
	  
The	   main	   factors	   influencing	   the	   performance	   of	   activated	   sludge	   during	   the	  
degradation	   of	   ibuprofen	   and	   ketoprofen	   are	   described	   in	   this	   study	   using	  
mathematical	  models.	   The	  model	   accurately	   predicted	   the	   degradation	   of	   both	  
compounds,	   which	   was	   found	   to	   be	   a	   function	   of	   biomass	   composition	   and	  
substrate	   loading	   rate.	   From	   one	   of	   the	   characterised	   activated	   sludge,	   12	  
microorganisms	  were	   isolated	   that	  were	   possibly	   involved	   in	   the	   ibuprofen	   and	  
ketoprofen	   biodegradation.	   One	   of	   the	   isolates	   was	   characterised	   via	   another	  
model,	   where	   ibuprofen	   degradation	   performance	   was	   dependent	   on	   both	  
biomass	   growth	   and	   initial	   substrate	   concentration.	   This	   isolate	   with	   unique	  
ix
phenotypical	   and	  molecular	   characteristics	   has	   been	   classified	   as	   a	   new	   species	  
(Patulibacter	   medicamentivorans).	   Furthermore,	   the	   metabolic	   aspects	   of	  
ibuprofen	   degradation	   by	   Patulibacter	   medicamentivorans	   were	   investigated	  
through	  quantitative	  proteomics	  using	  a	  metabolic	   labelling	   strategy.	  The	  whole	  
genome	   of	   this	   microorganism	   was	   sequenced	   to	   provide	   a	   species-­‐specific	  
protein	   platform	   for	   optimal	   protein	   identification.	   Several	   proteins	   were	  
identified	  that	  are	  possibly	  involved	  in	  the	  degradation	  of	  ibuprofen	  and	  that	  will	  
enable	   further	   studies	   aiming	   at	   characterising	   the	   mechanisms	   of	   microbial	  
community	   development	   and	   dynamics	   in	   engineered	   systems.	   An	   example	   of	  
such	   an	   application	   was	   conducted	   in	   this	   thesis	   to	   assess	   the	   evolution	   of	  
mercury	   reducing	   microbial	   communities	   developed	   under	   different	   operating	  
conditions.	   The	   genetic	   (16S	   rRNA	   gene)	   and	   functional	   (merA	   gene)	  
characteristics	   of	   the	   mercury-­‐reducing	   cultures	   enriched	   with	   different	   carbon	  
sources	  (glucose,	  ethanol	  or	  acetate)	  were	  investigated.	  The	  choice	  of	  the	  carbon	  
source	   was	   shown	   to	   have	   profound	   effects	   on	   both	   the	   phylogenetic	  
development	  of	  microbial	  cultures	  and	  mercury	  reducing	  performance.	  	  
	  
This	   thesis	   represents	   a	   step	   towards	   a	   better	   understanding	   of	   the	   microbial	  
communities	   involved	   in	   the	   degradation	   of	   important	   micropollutants.	   This	  
knowledge	   can	   be	   applied	   in	   the	   future	   for	   improved	   design	   and	   operation	   of	  
















A	  emissão	  constante	  de	  micropoluentes	  em	  meios	  aquáticos,	  devido	  à	  eliminação	  
ineficiente	  destes	  compostos	  nas	  estações	  de	  tratamento	  de	  água	  residual	  (ETAR),	  
tem	   suscitado	   preocupações	   a	   nível	   mundial	   a	   respeito	   de	   riscos	   adversos	  
potenciais	  para	  o	  meio	  ambiente	  e	  saúde	  humana.	  	  
	  
A	  maioria	  das	  ETARs,	  utilizam	  processos	  biológicos	  para	   remover	  contaminantes	  
orgânicos	   da	   água	   residual	   por	   serem	   processos	   vantajosos	   em	   termos	  
económicos	  e	  ambientais.	  No	  entanto,	  estes	  sistemas	  não	  estão	  projectados	  para	  
seleccionar	   consórcios	   microbianos	   que	   possuam	   as	   enzimas	   necessárias	   para	  
remover	   micropoluentes,	   levando	   à	   eliminação	   ineficiente	   destes	   compostos.	  
Perante	  este	  fato,	  torna-­‐se	  importante	  caracterizar	  as	  populações	  microbianas	  em	  
sistemas	   de	   tratamento,	   a	   fim	   de	   optimizar	   a	   eliminação	   destes	   compostos	   nas	  
ETARs.	   O	   trabalho	   apresentado	   nesta	   tese	   caracteriza	   o	   desempenho,	   o	  
metabolismo	   e	   a	   identidade	   das	   populações	   microbianas	   envolvidas	   na	  
degradação	  de	  dois	  compostos	  farmacêuticos	  (ibuprofeno	  e	  cetoprofeno)	  e	  de	  um	  
metal	  pesado	  (mercúrio).	  
	  
Os	  principais	  factores	  que	  influenciam	  o	  desempenho	  de	  lamas	  activadas	  durante	  
a	   degradação	   do	   ibuprofeno	   e	   do	   cetoprofeno	   foram	   descritos	   neste	   estudo	  
através	  de	  modelação	  matemática.	  O	  modelo	  matemático,	  previu	  com	  precisão	  a	  
degradação	  de	  ambos	  os	  compostos,	  em	  função	  da	  composição	  de	  biomassa	  e	  de	  
concentração	   inicial	   de	   substrato.	   Doze	   microrganismos,	   potencialmente	  
envolvidos	   na	   biodegradação	   do	   ibuprofeno	   e	   cetoprofeno,	   foram	   isolados	   de	  
uma	  das	   lamas	  activadas	  previamente	  caracterizada	  pelo	  modelo	  matemático.	  A	  
degradação	   de	   ibuprofeno	   por	   um	   dos	   isolados	   foi	   descrita	   por	   outro	   modelo	  
xi
matemático,	  em	  função	  do	  crescimento	  de	  biomassa	  e	  da	  concentração	  inicial	  de	  
substrato.	   Este	   isolado,	   com	   características	   fenotípicas	   e	  moleculares	   exclusivas	  
foi	   classificado	   como	   uma	   espécie	   nova,	   Patulibacter	   medicamentivorans.	  
Adicionalmente,	   os	   aspectos	   metabólicos	   de	   degradação	   do	   ibuprofeno	   por	  
Patulibacter	  medicamentivorans,	  foram	  investigados	  por	  proteómica	  quantitativa	  
usando	  uma	  estratégia	  de	  marcação	  metabólica.	  O	  genoma	  deste	  microrganismo	  
foi	   sequenciado	   e	   usado	   como	   uma	   plataforma	   de	   identificação	   proteica	  
específica	   para	   as	   proteínas	   desta	   espécie.	   Várias	   proteínas	   foram	   induzidas	   na	  
presença	  de	  ibuprofeno,	  que	  provavelmente	  estarão	  envolvidas	  na	  biodegradação	  
deste	   composto.	   A	   identificação	   destas	   proteínas	   permitirá	   elucidar	   os	  
mecanismos	   de	   degradação,	   e	   seguir	   a	   actividade	   e	   a	   dinâmica	   de	  
desenvolvimento	   das	   comunidades	   microbianas	   em	   bioreactores.	   Um	   exemplo	  	  
desta	  aplicação	  foi	  realizada	  nesta	  tese	  para	  avaliar	  a	  evolução	  das	  comunidades	  
microbianas	   reductoras	  de	  mercúrio,	   desenvolvidas	   sob	  diferentes	   condições	  de	  
operação.	  As	  características	  genéticas	   (gene	  rRNA	  16S)	  e	   funcionais	   (gene	  merA)	  
de	  culturas	  reductoras	  de	  mercúrio	  enriquecidas	  na	  presença	  de	  diferentes	  fontes	  
de	  carbono	  (glicose,	  etanol	  ou	  acetato)	  foram	  investigadas.	  A	  escolha	  da	  fonte	  de	  
carbono	  demonstrou	  afectar	  a	  selecção	  e	  a	  filogenética	  das	  culturas	  microbianas,	  
bem	  como	  a	  sua	  capacidade	  de	  redução	  do	  mercúrio.	  
	  
Esta	   tese	   representa	   um	   avanço	   no	   sentido	   de	   uma	   melhor	   compreensão	   das	  
comunidades	   microbianas	   envolvidas	   na	   degradação	   de	   importantes	  
micropoluentes.	  No	  futuro,	  este	  conhecimento	  pode	  ser	  aplicado	  na	  concepção	  e	  
operação	   de	   sistemas	   de	   tratamento	   de	   águas	   residuais,	   com	   o	   objectivo	   de	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"The	  Silent	  Highway	  -­‐	  Man".	  This	  cartoon	  comments	  on	  the	  polluted	  condition	  
of	  the	  Thames	  river.	  Death	  is	  here	  associated	  with	  pollution	  and	  disease.	  Punch,	  
10	  July	  1858.	  
	  
The	   industrial	  progress	  had	  a	  profound	  positive	  effect	  on	  the	  social,	  economic	  
and	   cultural	   conditions	   of	   our	   times	   but	   it	   has	   also	   been	   associated	  with	   the	  
generation	   and	   release	   into	   the	   environment	   of	   large	   amounts	   of	   toxic	  
compounds,	  causing	  the	  widespread	  contamination	  of	  land	  and	  water.	  	  
	  
The	  presence	  of	  toxic	  compounds	  in	  water	  has	  raised	  concerns	  among	  drinking-­‐
water	   regulators,	   governments,	   water	   suppliers	   and	   the	   public	   in	   general,	  
regarding	   their	   potential	   risks	   to	   the	   environment	   and	   to	   human	   health.	   The	  
protection	   of	   water	   resources	   has	   become	   one	   of	   the	   most	   important	  







1.1	  Micropollutants	  in	  water	  	  
	  
The	   term	   “micropollutant”	   refers	   to	   an	   environmental	   toxic	   compound	   at	  
concentrations	   below	   the	   milligram	   per	   liter	   (mg	   L-­‐1)	   (Murray	   et	   al.,	   2010).	  
Micropollutants	   are	   comprised	   not	   only	   by	   metals	   and	   metalloids	   such	   as	  
mercury,	   cadmium	   or	   arsenic,	   but	   also	   by	   organic	   contaminants	   such	   as	  
pharmaceuticals,	   biocides	   and	   personal	   care	   products.	   Some	   of	   which	   have	  
been	  classified	  as	  priority	  pollutants	  due	  to	  possible	  mutagenic,	  carcinogenic	  or	  
toxic	  effects	  (Kolpin	  et	  al.,	  2002).	  A	  list	  of	  33	  priority	  micropollutants	  has	  been	  
established	  by	  the	  European	  Union	  Water	  Framework	  Directive	  to	  regulate	  the	  
levels	  of	   these	   compounds	   in	  environmental	  discharges	  and	   in	  drinking	  water	  
(European	   Commission,	   2008,	   Murray	   et	   al.,	   2010).	   With	   the	   advances	   in	  
analytical	   techniques,	   new	   contaminants	   are	   being	   detected	   that	   can	   have	  
adverse	   effects	   to	   human	   health	   or	   environment.	   These	   so	   called	   “emerging	  
contaminants”	  are	  strong	  candidates	  for	  future	  regulation	  (Murray	  et	  al.,	  2010).	  
Furthermore,	   potential	   synergistic	   or	   antagonistic	   toxic	   effects	   might	   occur	  
from	  mixtures	  of	  compounds	  or	  metabolites	  (Kolpin	  et	  al.,	  2002).	  
	  
The	   routes	   by	   which	  micropollutants	   enter	   the	   environment	   are	   diverse	   and	  
closely	   related	   to	   the	   final	   target/function	   for	   which	   they	   are	   produced.	   The	  
major	   point	   source	   is	   wastewater	   from	   industrial,	   domestic	   and	   agricultural	  
activities.	  A	  variety	  of	  monitoring	  campaigns	  showed	  that	  micropollutants	  occur	  
up	  to	  the	  μg	  L-­‐1	   level	   in	  wastewater	  treatment	  plant	   (WWTP)	  effluents	  due	  to	  
the	  ineffectiveness	  of	  the	  existing	  treatment	  systems	  (Heberer,	  2002;	  Murray	  et	  
al.,	  2010;	  Reemtsma	  et	  al.,	  2006;	  Salgado	  et	  al.,	  2010).	  	  
	  
A	  study	  on	  23	  European	  countries	  detected	  the	  presence	  of	  organic	  persistent	  





perfluorinated	   acids,	   benzotriazoles,	   hormones,	   alkylphenolics,	   caffeine,	  
diethyltoluamide	   and	   triclosan,	   at	   concentrations	   of	   ng	   L-­‐1	   (Loos	   et	   al.,	   2010)	  
suggesting	  that	  the	  when	  left	  untreated,	  these	  compounds	  can	  achieve	  aquifers	  
used	   for	   drinking	   water	   supply.	   While	   most	   emerging	   contaminants	   are	  
detected	  at	  ng	  L-­‐1	  concentrations	   in	  surface	  waters,	  research	  surveys	  detected	  
some	   of	   them	   up	   to	   the	   μg	   L-­‐1	   range	   (Kolpin	   et	   al.,	   2002;	   Loos	   et	   al.,	   2009;	  
Murray	   et	   al.,	   2010;	   Pal	   et	   al.,	   2010).	   Toxicological	   studies	   often	   show	   acute	  
effects	  at	  mg	  L-­‐1	  concentrations,	  but	  sublethal	  effects	  have	  also	  been	  reported	  
below	  the	  μg	  L-­‐1	  level.	  For	  example,	  133	  mg	  L-­‐1	  of	  ibuprofen	  showed	  a	  lethality	  
of	  50	  %	  in	  the	  population	  of	  Daphnia	  magna	  (Han	  et	  al.,	  2006)	  but	  also	  chronic	  
exposure	   of	   ibuprofen	   concentrations	   below	   100	   μg	   L-­‐1,	   interfered	   in	   the	  
ovulation	  of	  Japanese	  medaka	  (Oryzias	  latipes)	  (Flippin	  et	  al.,	  2007).	  	  
	  
1.2	  Micropollutants	  in	  wastewater	  treatment	  plants	  
	  
Conventional	   biological	   municipal	   WWTPs	   are	   designed	   to	   remove	   organic	  
carbon,	   nitrogen	   and	   phosphorus	   loads	   from	   domestic	   and	   industrial	  
wastewater	   streams,	  as	  well	   as	   to	   reduce	   the	  concentration	  of	  pathogens.	  To	  
date,	  the	  design	  of	  WWTPs	  does	  not	  focus	  on	  the	  removal	  of	  micropollutants.	  
The	   removal	   of	   these	   compounds	   from	  wastewater	   is	   possible,	   and	  has	   been	  
reported	  in	  numerous	  studies	  as	  being	  affected	  by	  the	  specific	  properties	  of	  the	  
individual	   compounds	   (e.g.	  biodegradability,	   sorption	  behaviour,	   volatility),	  by	  
the	  technological	  and	  operational	  characteristics	  of	  the	  treatment	  system	  (e.g.	  
temperature,	  redox	  potential,	  sludge	  and	  hydraulic	  retention	  time),	  and	  by	  the	  
microbial	   community	   (e.g.	   biomass	   activity	   and	   nitrification	   potential)	   (Hamid	  
and	   Eskicioglu,	   2012;	   Helbling	   et	   al.,	   2012;	   Kummerer,	   2009;	   Onesios	   et	   al.,	  
2009).	   Furthermore,	   biodegradation	   was	   shown	   to	   be	   the	   predominant	  





which	  reflect	  the	  compound´s	  hydrophobicity	  and	  thus	  its	  adsorption	  potential)	  
are	  primarily	  removed	  in	  wastewater	  treatment	  systems	  (Carballa	  et	  al.,	  2004;	  
Hamid	  and	  Eskicioglu,	  2012;	  Quintana	  et	  al.,	  2005;	  Salgado	  et	  al.,	  2012).	  	  
	  
Pharmaceutical	   active	   compounds	   (PhACs),	   in	   the	   form	   of	   the	   parent	  
compound	   or	   active	   metabolite,	   are	   the	   most	   studied	   group	   of	   emerging	  
contaminants	   (Richardson,	   2009).	   Tons	   of	   PhACs	   are	   annually	   produced	  
worldwide	  to	  be	  administrated	  to	  humans	  and	  animals	  (Santos	  et	  al.,	  2010).	  In	  
Germany	  a	   total	   of	   6000	   -­‐	   7000	   tons	  of	  potentially	   adverse	  active	   substances	  
are	   produced	   every	   year	   (Kummerer,	   2009).	   Generally,	   their	   production	   is	  
intended	  to	  have	  a	  particular	  physiological	  effect	   in	   living	  beings	  and	  to	   resist	  
inactivation	   before	   administration.	   Thus,	   leading	   to	   biocumulative	   and	   toxic	  
effects	   in	   aquatic	   and	   terrestrial	   ecosystems	   (Santos	   et	   al.,	   2010).	   	   PhACs	   are	  
internally	   or	   externally	   administrated	   to	   humans	   and	   animals	   and	   excreted	  
primarily	   via	   feces	   and	   urine.	   After	   excretion	   the	   parent	   compound	   and	   the	  
originated	   metabolites	   enter	   the	   sanitary	   sewer	   systems,	   which	   are	   directly	  
connected,	  to	  the	  municipal	  WWTPs	  (Santos	  et	  al.,	  2010).	  	  	  
	  
Commonly,	  PhACs	  feature	  low	  biodegradability	  and	  high	  polarity,	  which	  affects	  
their	   removal	   by	   conventional	  wastewater	   treatments	   and	   therefore	   leads	   to	  
their	   continuous	   discharge	   into	   the	   receiving	   water	   bodies	   (Ternes	   and	   Joss,	  
2006).	  Wide	  dissemination	  at	  low	  concentrations	  in	  the	  range	  of	  the	  ng	  L-­‐1	  up	  to	  
the	  μg	  L-­‐1	  in	  the	  aquatic	  environment	  is	  evident	  today	  (Kummerer	  et	  al.,	  2009).	  
The	  presence	  of	  pharmaceuticals	  in	  the	  River	  Rhine	  in	  Germany	  was	  monitored	  
for	  10	  years	   (1997-­‐2006)	   indicating	  no	  major	  decrease	  on	   the	  concentrations.	  
Furthermore,	   the	   loading	   rates	   exceeded	   one	   ton	   per	   year	   at	   the	   most	  
downstream	  site	   suggesting	   the	   inefficient	   removal	  of	   these	  compounds	   from	  





In	   a	   Portuguese	   survey,	   Salgado	   (2010)	   analysed	   the	   presence	   of	   65	  
pharmaceutical	   and	   personal	   care	   products	   in	   5	   WWTPs	   and	   confirmed	   the	  
detection	  of	  such	  compounds	  up	  to	  the	  11.5	  μg	  L-­‐1	  in	  the	  influent	  and	  0.9	  μg	  L-­‐1	  
in	  the	  effluent.	  Non-­‐steroidal	  anti-­‐inflammatory	  drugs	  (NSAIDs)	  were	  frequently	  
detected	   and	   were	   found	   to	   be	   the	   most	   abundant	   group	   of	   PhACs.	   Non-­‐
steroidal	   drugs	   are	   over-­‐the-­‐counter	   drugs	   usually	   administrated	   to	   alleviate	  
pain.	  
	  
Besides	  the	  Portuguese	  study,	  NSAIDs	  such	  as	  diclofenac,	  ibuprofen,	  ketoprofen	  
and	  naproxen	  have	  been	  detected	  in	   influent	  wastewaters	  and	  surface	  waters	  
of	  numerous	  other	  geographical	  points	  (Murray	  et	  al.,	  2010;	  Loos	  et	  al.,	  2009;	  
Loos	  et	  al.,	  2010;	  Pal	  et	  al.,	  2010).	  In	  particular,	  ibuprofen	  and	  ketoprofen	  were	  
two	   of	   the	   most	   recurrent	   and	   abundant	   NSAIDs	   in	   WWTPs	   influents	   and	  
effluents	  worldwide	  (Murray	  et	  al.,	  2010;	  Onesios	  et	  al.,	  2009;	  Pal	  et	  al.,	  2010;	  
Salgado	  et	  al.,	  2010;	  Santos	  et	  al.,	  2010),	  and	  therefore	  they	  were	  selected	  as	  
target	  compounds	  in	  this	  study.	  
	  
Several	   studies	   have	   reported	   the	   detection	   of	   ibuprofen	   (α-­‐Methyl-­‐4-­‐(2-­‐
methylpropyl)-­‐benzeneacetic	  acid)	  up	  to	  106	  μg	  L-­‐1	  and	  44	  μg	  L-­‐1	  in	  raw	  sewage	  
and	   treated	   effluent	   wastewater,	   respectively,	   and	   up	   to	   5	   μg	   L-­‐1	   in	   surface	  
waters.	  Similarly,	  several	  studies	  have	  reported	  the	  detection	  of	  ketoprofen	  (3-­‐
Benzoyl-­‐α-­‐methyl-­‐benzeneacetic	  acid)	  up	  to	  104	  μg	  L-­‐1	  in	  raw	  influents	  and	  0.1	  
μg	   L-­‐1	   in	   surface	  waters	   (Murray	   et	   al.,	   2010;	   Pal	   et	   al.,	   2010;	   Salgado	   et	   al.,	  
2010;	  Santos	  et	  al.,	  2010).	  Low	  concentrations	  of	   ibuprofen	  (ng	  L-­‐1)	  showed	  to	  
affect	   the	   growth	   and	   reproduction	   of	   aquatic	   species	   and	   to	   have	   genotoxic	  
effects	   for	   fish.	   (Flippin	   et	   al.,	   2007;	   Han	   et	   al.,	   2010;	   Hayashi	   et	   al.,	   2008;	  
Ragugnetti	   et	   al.,	   2011).	   So	   far,	   the	   toxic	   effects	   of	   low	   concentrations	   of	  





has	   been	   reported	   by	   several	   studies,	   while	   contribution	   of	   sorption	   and	  
volatilisation	   seemed	   to	   be	   negligible	   (Joss	   et	   al.,	   2006;	   Salgado	   et	   al.,	   2012;	  
Ternes	   et	   al.,	   2004).	   Reported	   removal	   efficiencies	   vary	   greatly,	   with	  
eliminations	  of	  anywhere	  between	  0	  %	  and	  100	  %,	   likely	  due	   to	   the	  different	  
influent	   concentrations	   and	   operating	   parameters	   of	   the	   different	   studies	  
(Murray	  et	  al.,	  2010;	  Pal	  et	  al.,	  2010;	  Salgado	  et	  al.,	  2012;	  Santos	  et	  al.,	  2010).	  
	  
Mercury	   is	   the	   most	   toxic	   and	   frequently	   detected	   heavy	   metal	   in	   industrial	  
wastewaters(Wagner-­‐Dobler	   et	   al.,	   2000).	   Mercury	   pollution	   arises	   from	  
anthropogenic	  sources	  such	  as	   the	  chlor-­‐alkali	   industry,	  coal	  burning	  and	  gold	  
mining	  and	  naturally	   from	  volcanoes	  (Jaysankar	  et	  al.,	  2007).	  Once	  discharged	  
into	   the	  environment,	  mercury	   tends	   to	  accumulate	   in	   the	  aquatic	  media	  and	  
soils,	  where	  it	  can	  contaminate	  drinking	  water	  aquifers.	  Furthermore,	  it	  is	  taken	  
up	  by	  aquatic	  organisms	  and	  enters	  the	  food	  chain.	  Mercury	  poisoning	  results	  
in	  severe	  chronic	  disease	  or	  death.	  Therefore,	  the	  maximum	  allowable	  mercury	  
level	  in	  industrial	  wastewater	  effluents	  is	  50	  μg	  Hg	  L-­‐1.	  The	  biological	  reduction	  
of	   mercury	   is	   an	   efficient	   process	   that	   has	   been	   applied	   in	   wastewater	  
treatment	  systems	  (Chang	  and	  Law,	  1998;	  Wagner-­‐Dobler	  et	  al.,	  2000,	  Wagner-­‐
Dobler,	  2003).	  	  
	  
1.3	  Biological	  removal	  of	  micropollutants	  in	  wastewater	  treatment	  plants	  
	  
Biological	   degradation	   can	   transform	   organic	   molecules	   to	   CO2	   and	   H2O	  
(mineralisation)	   or	   to	   one	   or	   more	   organic	   compounds	   (transformation).	   In	  
both	   cases,	   compounds	   can	   serve	   as	   primary	   substrate	   of	   carbon	   and	   energy	  
source	  (catabolism)	  or	  as	  secondary	  substrate	  coincidentally	  transformed	  in	  the	  
presence	  of	  a	  primary	  growth	  substrate	  (co-­‐metabolism)	  (Onesios	  et	  al.,	  2009).	  





which	   type	   of	   transformation	   occurred.	   Therefore,	   in	   this	   study	   the	   term	  
degradation	   is	   used	   in	   a	   general	   way	   meaning	   all	   the	   possible	   degradation	  
processes.	  	  
	  
Microbial	  degradation	  seems	  to	  be	  the	  predominant	  mechanism	  for	  elimination	  
of	  polar	  acidic	  pharmaceuticals	  in	  WWTPs	  (Quintana	  et	  al.,	  2005;	  Salgado	  et	  al.,	  
2012).	   Previous	   lab-­‐scale	   studies	   found	   that	   activated	   sludge	   can	   partially	   or	  
completely	  eliminate	  such	  compounds	  in	  aerobic	  and	  anaerobic	  conditions.	  As	  
an	  example,	  testes	  conducted	  by	  Quintana	  et	  al.	  (2005)	  showed	  that	  ibuprofen	  
and	   naproxen	   were	   fully	   mineralised	   by	   activated	   sludge,	   although	   these	  
authors	   only	   observed	   degradation	   in	   the	   presence	   of	   lactose	   as	   additional	  
carbon	   source.	   In	   the	   same	   study,	   activated	   sludge	   when	   incubated	   with	  
ketoprofen	  as	  the	  sole	  carbon	  source	  produced	  stable	  metabolites.	  	  	  
	  
Generally,	   degradation	   rates	   are	   difficult	   to	   predict	   and	   can	   be	   affected	   by	  
different	   variables	   such	   as	   hydraulic	   retention	   time,	   sludge	   age	   and	  
environmental	   conditions,	   and	   has	   been	   mostly	   determined	   experimentally	  
(Daughton	  and	  Ternes,	  1999).	  	  
	  
Modelling	   and	   simulating	   the	   degradation	   performance	   of	  micropollutants	   by	  
activated	   sludge	   is	   required	   to	   improve	   process	   optimisation,	   design	   and	  
control	  of	  the	  existing	  treatment	  systems	  or	  by	  identifying	  additional	  treatment	  
stages.	  
	  
The	   activated	   sludge	   models	   (ASMs)	   are	   the	   most	   commonly	   implement	  
mechanistic	  models	  to	  describe	  the	  biochemical	  transformations	  of	  soluble	  and	  
particulate	  compounds	   in	  activated	  sludge.	  Recently,	  ASMs	  models	  have	  been	  





(Plósz	  et	  al.,	  2010;	  Plósz	  et	  al.,	  2011).	  Joss	  et	  al.	  (2006)	  modelled	  the	  kinetics	  of	  
degradation	   of	   35	   PhACs	   by	   activated	   sludge	   using	   a	   pseudo	   first-­‐order	  
equation.	  The	  information	  obtained	  was	  used	  to	  classify	  the	  biodegradability	  of	  
the	   35	   studied	   PhACs	   according	   to	   the	   obtained	   degradation	   constants,	  
classified	   in	   three	  biodegradation	   levels	   (Joss	  et	  al.,	  2006).	  However,	   reported	  
degradations	   constants	   vary	   greatly	   among	   different	   studies,	   which	   were	  
carried	   out	   with	   different	   environmental	   conditions,	   and	   specific	   microbial	  
populations.	  	  
	  
Other	   studies	   have	   associated	   the	   degradation	   of	   micropollutants	   to	   the	  
presence	  of	  another	  primary	  substrate	  used	  as	  carbon	  and	  energy	  source	  (Egli,	  
2010).	   For	   example,	   the	   degradation	   of	   nitrilotriacetic	   acid	   by	   Chelatobacter	  
heintzii,	   where	   a	   higher	   glucose	   fraction	   led	   to	   faster	   nitrilotriacetic	   acid	  
reduction	  (Bally	  and	  Egli,	  1996).	  Oehmen	  et	  al.	  (2012)	  also	  observed	  this	  effect	  
using	  a	  mixed	  culture	  degrading	   the	  herbicide	  propanil,	  where	   faster	  propanil	  
degradation	  was	  observed	  with	  propionate	  addition.	  Nevertheless,	  competition	  
or	   inhibition	   of	   micropollutant	   degradation	   due	   to	   the	   presence	   of	   readily	  
growth	  substrates	  is	  also	  possible	  (Plósz	  et	  al.,	  2010).	  
	  
Prior	   to	   the	   degradation	   of	   many	   compounds,	   a	   period	   of	   adaptation	   (lag	  
phase)	   occurs.	   This	   period	   of	   adaptation	   has	   been	   associated	   with	   the	  
acclimatisation	  to	  new	  conditions,	  enzyme	  synthesis,	  increase	  in	  the	  number	  of	  
degrading	   microorganisms	   and	   inhibition	   (Alexander,	   1999).	   Chong	   (2009)	  
proposed	   a	   model	   to	   describe	   the	   degradation	   of	   a	   micropollutant	   that	   is	  
dependent	  on	  the	  growth	  of	  the	  micropollutant	  degrading	  biomass.	  This	  author	  
associated	   the	   observed	   lag-­‐phase	   to	   the	   acclimation	   of	   the	   biomass	   to	   the	  






When	   subjected	   to	   the	   appropriate	   operating	   conditions,	   microbial	  
communities	   have	   the	   potential	   to	   acclimatise	   by	   microbial	   selection	   or	  
development	  of	  catabolic	  ways	  to	  degrade	  micropollutants,	  due	  to	  their	  natural	  
genetic	  flexibility	  (Rieger	  et	  al.,	  2002).	  The	  acclimatisation	  of	  microorganisms	  to	  
a	  pollutant	  requires	  time	  and	  the	  presence	  of	  the	  adequate	  bacterial	  enzymes	  
for	   degradation	   of	   that	   compound	   (Matsumura,	   1989;	   Spain	   et	   al.,	   1980).	  
González	   et	   al.	   (2006)	   demonstrated	   that	   the	   acclimatisation	   of	   microbial	  
populations	   improved	  the	  degradation	  rate	  of	  diclofenac	  and	  selected	  priority	  
acidic	  pesticides.	  	  
	  
Generally,	  the	  adaptations	  of	  microbial	  communities	  to	  the	  target	  contaminant	  
are	  observed	  with	  an	  increase	  of	  the	  population	  that	  tolerates	  or	  degrade	  the	  
compound.	   The	   acquisition	   of	   the	   degradation	   capacity	   can	   be	   the	   result	   of	  
mutations	   such	   as	   nucleotide	   changes	   or	   DNA	   rearrangements.	   Genetic	  
information	   located	   in	   mobile	   genetic	   elements	   can	   be	   transferred	   to	   other	  
community	   members	   through	   horizontal	   gene	   transfer.	   Eventually	   the	  
community	  members	  that	  are	  best	  adapted	  to	  resisting	  or	  degrading	  the	  target	  
compound	  get	  selected	  and	  their	  number	  increases	  in	  the	  microbial	  community	  
(Top	   and	   Springaely,	   2003).	   This	  microbial	   genetic	   flexibility	   is	   evident	   in	   the	  
mercury	  reduction	  mechanism	  that	  relies	  on	  the	  mer	  operon,	  specifically	  in	  the	  
merA	   gene,	  which	   encodes	   for	   the	  mercuric	   reductase	   or	  MerA	   enzyme.	   The	  
mer	  operon	  can	  be	  present	  in	  both	  the	  chromosomal	  DNA	  and	  mobile	  genetic	  
elements,	  such	  as	  transposons	  and	  plasmids.	  This	  suggests	  that	  horizontal	  gene	  
transfer	  may	  play	  an	  important	  role	  in	  the	  adaptation	  of	  a	  microbial	  community	  
to	  mercury	  contamination	  (Osborn	  et	  al.,	  1997).	  	  
	  
However,	   other	  microorganisms	   that	   are	   not	   responsible	   for	   the	   degradation	  





degrading	  it.	  As	  an	  example,	  the	  growth	  of	  a	  Bacillus,	  involved	  in	  floc	  formation,	  
enhanced	   the	  growth	  of	  other	   two	   strains	   that	  were	   capable	  of	   growing	  with	  
nonylphenol	  polyethoxylate	   surfactants	   as	   the	   sole	   carbon	  and	  energy	   source	  
(Di	  Gioia	  et	  al.,	  2004).	  
	  
Furthermore,	   in	   situations	   where	   the	   degrading	   biomass	   is	   present,	   the	  
necessary	   genes	   that	   encode	   for	   the	   degrading	   enzymes	  might	   require	   to	   be	  
induced	   (Alexander,	   1999).	   Environmental	   concentrations	   entering	   WWTPs	  
might	   be	   too	   low	   to	   induce	   the	   expression	   of	   the	   appropriate	   enzymes	   for	  
degradation	   of	   these	   compounds,	   but	   high	   concentrations	   can	   be	   toxic	   or	  
inhibit	  microbial	  propagation	  and	  metabolism	  (Daughton	  and	  Ternes,	  1999).	  	  
	  
Despite	   the	   abundant	   literature	   on	   biodegradation	   of	   micropollutants	   in	  
WWTPs	   related	   to	   occurrence	   and	   fate,	   and	   the	   parameters	   affecting	  
elimination,	  very	  little	  is	  known	  about	  the	  governing	  microorganisms.	  A	  general	  
interest	  is	  growing	  in	  research	  groups	  worldwide	  in	  characterising	  the	  microbial	  
communities	   and	   their	   responses	   to	   micropollutants,	   to	   isolate	   degrading	  
microorganisms	  and	  to	  identify	  the	  genes	  related	  to	  the	  degradation	  processes.	  	  
	  
1.4	  Micropollutant	  degrading	  microorganisms	  
	  
The	  identification	  of	  the	  microorganisms	  involved	  in	  the	  degradation	  of	  specific	  
contaminants	  enables	   the	  monitoring	  of	   their	  presence	   in	  activated	  sludge,	   in	  
order	   to	   potentially	   predict	   the	   performance	   of	   the	   system	   as	   well	   as	   to	  
optimise	  operational	  parameters	  that	  better	  suit	  communities	  of	  interest.	  	  
	  
In	   the	  past,	   the	  discovery	  of	  Brocadia	  anammoxidans	   as	  being	  able	   to	  oxidise	  





contribution	   to	   research	   on	   nitrogen	   elimination	   in	   WWTPs	   (Strous	   et	   al.,	  
1999).	   Nowadays,	   promising	   results	   in	   studies	   addressing	   micropollutant	  
degrading	   microorganisms	   have	   started	   to	   appear.	   For	   example,	   Roh	   et	   al.	  
(2009)	   examined	   the	   biodegradation	   potential	   of	   triclosan,	   bisphenol	   A,	   and	  
ibuprofen	  by	  Nitrosomonas	  europaea	  and	  mixed	  ammonia-­‐oxidizing	  bacteria	  in	  
nitrifying	   activated	   sludge.	   Authors	   observed	   that	   microorganisms	   degraded	  
triclosan	   and	   bisphenol	   A.	   On	   the	   other	   hand,	   ibuprofen	   was	   more	   likely	  
degraded	   by	   the	   heterotrophic	   microorganisms	   in	   activated	   sludge.	   In	   a	  
different	   study,	   Kraigher	   et	   al.	   (2008)	   showed	   a	   shift	   in	   the	   microbial	  
communities	  present	  in	  activated	  sludge	  due	  to	  the	  exposure	  of	  5-­‐500	  μg	  L-­‐1	  of	  
diclofenac,	   ibuprofen,	   ketoprofen	   and	   naproxen.	   Additionally,	   these	   authors	  
also	   observed	   the	   growth	   inhibition	   of	   bacteria	   from	   the	   genus	   Nitrospira,	  
correlating	   it	   with	   the	   decrease	   in	   the	   efficiency	   of	   NSAIDs	   removal	   in	  
wastewater	  treatment	  systems.	  	  
	  
When	   studying	   micropollutant	   degrading	   communities	   two	   fundamental	  
questions	  arise:	   (1)	  who	  are	   the	  degrading	  microorganisms?	   (2)	  how	  do	  these	  
microorganisms	  degrade	  micropollutants?	  	  
	  
1.4.1	  Assessing	  the	  diversity	  of	  micropollutant	  degrading	  microorganisms	  
	  
The	   detailed	   analysis	   of	   the	   microbial	   diversity	   can	   be	   addressed	   using	   two	  
broad	  approaches:	  culture-­‐dependent	  studies	  and	  culture-­‐independent	  studies.	  	  
	  
Culture-­‐dependent	   methods	   are	   based	   on	   the	   cultivability	   of	   the	  
microorganisms	   on	   selective	   media.	   Cultivation	   is	   an	   important	   tool	   for	   the	  
detection	  of	  degrading	  microorganisms,	  especially	  when	  genes	  of	  the	  degraders	  





based	  methods.	   Isolation	   and	   cultivation	   in	   an	   agar	   medium	   only	   allows	   the	  
characterisation	   of	   microorganisms	   capable	   of	   growing	   in	   the	   selected	  
experimental	   growth	   conditions.	   This	   is	   even	   more	   evident	   in	   complex	  
biological	   systems	  where	   only	   <	   1	  %	  of	   bacterial	   species	   are	   currently	   known	  
and	   cultivable.	  Moreover	   only	   5	   –	   10	   %	   of	   the	   total	   number	   assumed	   to	   be	  
present	  in	  water	  and	  wastewater	  treatment	  plants	  can	  be	  identified	  by	  classical	  
microbiological	   methods	   (Kummerer,	   2004).	   Despite	   that,	   studying	   cultured	  
isolates	  enables	  the	  straightforward	  characterisation	  of	  their	  functions	  and	  the	  
evaluation	   of	   their	   biotechnological	   potential	   (Cardenas	   and	   Tiedje,	   2008).	  
Relevant	  microorganisms	  have	  great	  potential	  for	  preparing	  starter	  cultures	  to	  
be	  used	  in	  bioaugmentation	  purposes.	  Moreover,	  cultured	  isolates	  can	  be	  used	  
in	   studies	   concerning	   the	   kinetics	   and	   process	   optimisation	   of	  micropollutant	  
degradation	  in	  biological	  treatment	  systems.	  
	  
The	   study	  of	  microbial	   communities	   sometimes	   results	   in	   the	   identification	  of	  
new	   species	   with	   specific	   characteristics	   regarding	   the	   degradation	   of	  
micropollutants.	   	   The	   identification	   a	   new	   species	   relies	   in	   a	   polyphasic	  
approach	  where	  both	  phenotypic	  and	  genotypic	  methods	  are	  necessary	  for	  an	  
appropriate	  bacterial	  classification	  (Uilenberg	  and	  Goff,	  2006).	  	  
	  
To	  overcome	  the	  limitations	  of	  traditional	  microbiological	  methods	  a	  variety	  of	  
molecular	  methods	  independent	  of	  cultivation	  have	  been	  developed	  based	  on	  
the	  small	  subunit	  of	  ribosomal	  ribonucleic	  acid	  (16S	  rRNA	  gene	  for	  prokaryotes	  
and	  18S	  rRNA	  gene	  for	  eukaryotes).	  The	  16S	  rRNA	  gene	  has	  on	  average	  a	  length	  
of	   1,500	   nucleotides.	   This	   sequence	   is	   characterised	   by	   its	   universal	  
distribution,	  high	  conservation,	  as	  well	  as	  differentiation	  at	  species	  level.	  These	  
characteristics	  make	  rRNA	  genes	  useful	  for	  comparative	  analysis.	  Furthermore,	  





microorganisms	   at	   genus	   or	   species	   level	   (Cardenas	   and	   Tiedje,	   2008).	   The	  
application	   of	   16S	   rRNA	   gene	   based	   methods	   in	   studying	   the	   microbial	  
communities	  dynamics,	  development	  and	  function	  will	  be	  further	  addressed	  in	  
the	  introduction.	  	  
	  
1.4.2	  Assessing	  the	  mechanisms	  of	  microbial	  degradation	  of	  micropollutants	  
	  
Laboratory	   degradation	   experiments	   may	   be	   used	   to	   test	   the	   ability	   of	  
microorganisms	  to	  degrade	  a	  target	  micropollutant	  by	  monitoring	  the	  decrease	  
of	   the	   parent	   compound	   concentration	   or	   an	   increase	   of	   metabolite	  
concentrations,	   relative	   to	   microbially	   inhibited	   controls,	   under	   controlled	  
conditions	   that	   mimic	   the	   real	   conditions	   (e.g.	   temperature,	   oxygen	  
concentration,	  pH	  etc.).	  	  
	  
So	  far,	  the	  majority	  of	  the	  studies	  on	  the	  mechanisms	  of	  microbial	  degradation	  
of	  pollutants	  primarily	  relied	  on	  the	  detection	  and	  identification	  of	  degradation	  
intermediates	   (Onesios	   et	   al.,	   2009;	   Quintana	   et	   al.,	   2005;	   Radjenovic	   et	   al.,	  
2008).	   A	   complementary	   approach	   is	   to	   study	   the	   enzymatic	   mechanisms	   of	  
microbial	  degradation	  by	  identifying	  key	  enzymes	  involved	  in	  the	  process,	  using	  
proteomic	  techniques.	  	  
	  
Quantitative	   proteomics	   has	   proven	   to	   be	   a	   valuable	   tool	   for	   analysing	   the	  
physiological	   response	   of	   microorganisms	   in	   the	   presence	   of	   specific	  
compounds	   or	   under	   the	   influence	   of	   different	   physico-­‐chemical	   parameters	  
(Kim	  et	  al.,	  2009;	  Kim	  et	  al.,	  2007).	  When	  grown	  in	  the	  presence	  of	  the	  target	  
compound,	  microorganisms	   induce	   the	  expression	  of	  enzymes	   involved	   in	   the	  
degrading	  metabolic	   pathway(s).	   These	   induced	   proteins	   can	   be	   identified	   by	  





of	   the	   micropollutant,	   which	   give	   direct	   measurement	   of	   protein	   expression	  
levels	   (Kim	  et	   al.,	   2007;	   Kim	  et	   al.,	   2009).	   In	  quantitative	  proteomics	   typically	  
cells	  are	  primarily	   lysated	  and	  fractionated,	  and	  separated	   in	  one-­‐dimensional	  
gel	  electrophoresis.	  After	  separation,	  proteins	  are	  enzymatically	  degraded	  into	  
peptides	  and	   separated	  by	   liquid	   chromatography	   (LC).	  Peptides	  are	  detected	  
by	   tandem	  mass	   spectrometry	   (MS/MS)	   and	   identified	   based	   on	  MS	   spectra	  
using	   bioinformatics	   tools,	   therefore	   resulting	   on	   the	   identification	   of	   the	  
proteins	   (Aebersold	   and	   Mann,	   2003).	   Furthermore,	   the	   whole	   genome	   of	  
model	  microorganisms	  can	  be	  sequenced	  to	  provide	  a	  species-­‐specific	  protein	  
identification	   platform,	   which	   improves	   the	   quality	   of	   protein	   identification	  
(Lacerda	  and	  Reardon,	  2009).	  
	  
Proteomics	   has	   been	   successfully	   applied	   for	   studying	   the	   biodegradation	   of	  
aromatic	   hydrocarbons	   such	   as	   benzoate,	   aniline,	   and	   phenol	   by	   several	  
microorganisms,	   e.g.	   Acinetobacter	   (Giuffrida	   et	   al.,	   2001;	   Park	   et	   al.,	   2006;	  
Pessione	  et	  al.,	  2003)	  and	  Pseudomonas	  strains	  (Loh	  and	  Cao	  2008),	  as	  well	  as	  
several	   mycobacterial	   (Kim	   et	   al.,	   2004;	   Liang	   et	   al.,	   2006)	   and	   rhodococcal	  
species	   (Navarro-­‐Llorens	  et	  al.,	  2005;	  Patrauchan	  et	  al.,	  2005;	  Tomas-­‐Gallardo	  
et	  al.,	  2006).	  
	  
The	  identification	  of	  key	  enzymes	  involved	  in	  biodegradation	  can	  help	  discover	  
microbial	  degradation	  pathways	  and	  suggest	  candidate	  biomarkers	  to	  monitor	  
micropollutant	   degradation.	   Additionally,	   the	   identity	   of	   the	   micropollutant	  
degrading	  microorganisms	  and	  the	  corresponding	  degrading	  genes	  can	  be	  used	  
in	   studies	   to	   monitor	   the	   degradation	   potential	   and	   microbial	   communities	  
development	   under	   specific	   environments.	   This	   approach	   is	   of	   great	   use	   in	  
biotechnological	   studies	   aiming	   the	   enrichment	   of	   degrading	   microbial	  





bioremediation	  and	  bioaugmentation	  processes	   (Eyers	  et	  al.,	  2004;	  Widada	  et	  
al.,	  2002).	  	  
	  
1.4.3	  Characterising	  micropollutant	  degrading	  microbial	  communities	  	  
	  
A	   fundamental	   understanding	   of	   the	   microbial	   community	   structure	   and	  
stability,	   as	   well	   as	   its	   response	   to	   different	   pollutants	   in	   the	   wastewater,	   is	  
necessary	  for	  efficient	  and	  stable	  WWTP	  operation.	  The	  variations	  in	  microbial	  
community	   structure	   throughout	   time	   can	   be	   monitored	   using	   molecular	  
techniques	   such	   as	   denaturing	   gradient	   gel	   electrophoresis	   (DGGE)	   and	  
fluorescence	  in	  situ	  hybridisation	  (FISH).	  Moreover,	  under	  varying	  experimental	  
conditions	  it	  is	  important	  not	  only	  to	  know	  the	  phylogenetic	  changes	  but	  also	  to	  
determine	   the	   functional	   changes.	   Quantitative	   polymerase	   chain	   reaction	  
(qPCR)	   targeting	   functional	   genes	   that	   encode	   enzymes	   in	   key	   metabolic	   or	  
catabolic	  pathways	  enables	  to	  assess	  changes	  in	  microbial	  functions.	  	  
	  
1.4.3.1	  Denaturing	  gradient	  gel	  electrophoresis	  
	  
DGGE	   is	   the	   method	   of	   choice	   to	   demonstrate	   an	   effect	   on	   microbial	  
communities	  or	  differences	  between	  microbial	  communities.	  It	  is	  based	  on	  the	  
electrophoretic	   mobility	   of	   denatured	   DNA-­‐fragments	   of	   the	   same	   size,	   with	  
different	   nucleic	   acid	   sequences,	   in	   a	   denaturing	   gradient	   polyacrylamide	   gel	  
containing	   a	   linear	   gradient	   DNA	   denaturant	  made	  with	   urea	   and	   formamide	  
(Muyzer,	  1995).	  Each	  gel	  is	  composed	  of	  DNA	  band	  patterns	  that	  directly	  reflect	  
the	  genetic	  biodiversity	  of	  the	  sample.	  The	  relative	  intensity	  of	  each	  band	  and	  
its	   number	   roughly	   corresponds	   to	   the	   abundance	   of	   dominant	   species	   (Sanz	  
and	   Kochling,	   2007).	   For	   determining	   the	   phylogenetic	   identities	   from	  DGGE,	  





technique	   to	   monitor	   the	   enrichment	   of	   microbial	   cultures.	   For	   example,	  
LaPara	   et	   al.	   (2002)	   used	   DGGE	   to	   characterise	   the	   stability	   of	   the	   bacterial	  
community	  structures	  treating	  pharmaceutical	  wastewater,	  and	  concluded	  that	  
the	   microbial	   community	   was	   able	   to	   adapt	   to	   perturbations	   in	   the	   influent	  
wastewater	  characteristics.	  More	  recently,	  Carvalho	  et	  al.	  (2010)	  employed	  16S	  
rRNA	   gene-­‐targeted	  DGGE	   to	   investigate	   the	  microbial	   ecology	   of	   a	   propanil-­‐
degrading	  enrichment	  carried	  out	   in	  a	  sequencing	  batch	  reactor	  and	  operated	  
with	  different	  feeding	  strategies.	  	  
	  
1.4.3.2	  Fluorescence	  in	  situ	  hybridisation	  
	  
FISH	  is	  a	  technique	  that	  allows	  the	  qualitative	  and	  quantitative	  investigation	  of	  
the	   composition	   of	   bacterial	   communities	   through	   the	   use	   of	   rRNA-­‐targeting	  
fluorescent	   probes.	   These	   probes	   consist	   of	   a	   short	   sequence	   of	   16-­‐20	  
nucleotides	   conjugated	   to	   a	   fluorescent	   dye	   on	   the	   5’	   end	   that	   enable	   the	  
detection/identification	  of	  microorganisms	  (Sanz	  and	  Kochling,	  2007).	  A	  variety	  
of	   molecular	   probes	   targeting	   rRNA	   genes	   have	   been	   reported	   at	   various	  
taxonomic	  levels	  (Amann	  et	  al.,	  1995).	  In	  FISH,	  cells	  are	  fixed	  and	  permeabilised	  
to	  enable	  the	  penetration	  of	  the	  probes	  inside	  the	  cell	  and	  to	  protect	  the	  RNA	  
from	  degradation.	  Hybridisation	  of	  the	  probe	  to	  the	  target	  rRNA	  gene	  is	  carried	  
out	   in	   stringent	   conditions	   adjusted	   by	   varying	   either	   the	   formamide	  
concentration	  or	  the	  hybridisation	  temperature.	  Labelled	  cells	  can	  be	  visualised	  
by	   fluorescence	  microscopy	   (Moter	   and	  Gobel,	   2000).	  Multiple	   group-­‐specific	  
oligonucleotide	  probes	  targeting	  different	  microbial	  taxa	  can	  be	  used	  in	  a	  FISH	  
experiment	   for	   simultaneous	   phylogenetic	   classification	   and	   quantification	   of	  
active	  microbial	   populations.	   FISH	   is	   a	   valuable	   tool	   for	   the	   identification	   and	  
quantification	   of	   microbial	   populations.	   This	   technique	   has	   been	   extensively	  





processes	   in	   wastewater	   treatment	   plants	   (Amann	   et	   al.,	   2001;	   Wagner	   and	  
Loy,	   2002).	   For	   example	   in	   the	   detection	   and	   quantification	   of	   Candidatus	  
Accumulibacter	  phosphatis,	   the	  polyphosphate-­‐accumulating	  organism,	   in	   full-­‐
scale	  systems	  (Crocetti	  et	  al.,	  2000).	  	  
	  
Recent	   studies	  demonstrated	   the	  use	  of	  FISH	   to	  characterise	   the	  variations	   in	  
microbial	   communities	   in	   the	   presence	   of	   micropollutants.	   Haseborg	   and	  
Frimmel	   (2007)	   employed	   FISH	   to	   evaluate	   the	   impact	   of	   clofibric	   acid	   and	  
ibuprofen	  on	  the	  nitrifying	  bacterial	  population	  in	  fixed	  bed	  biofilm	  reactors.	  In	  
a	  different	  study,	  Serrano	  et	  al.	  (2011)	  used	  FISH	  to	  follow	  the	  evolution	  of	  the	  
microbial	   populations	   present	   in	   a	   membrane	   bioreactor	   operating	   in	   a	  
sequential	  mode	  for	  the	  simultaneous	  removal	  of	  nutrients	  and	  pharmaceutical	  
compounds	  from	  synthetic	  urban	  wastewater.	  	  
	  
However,	  FISH	   is	  an	  exclusively	   taxonomic	   technique	  that	  does	  not	   reveal	   the	  
function	  or	  metabolic	  features	  of	  the	  microorganisms,	  although	  in	  some	  cases	  
these	   characteristics	   can	   be	   deduce	   from	   comparison	   with	   other	  
phylogenetically-­‐related	   bacteria	   (Sanz	   and	   Kochling,	   2007),	   or	   investigated	  
through	  combination	  of	  FISH	  with	  e.g.	  microautoradiography	  (MAR).	  	  
	  
1.4.3.3	  Quantitative	  polymerase	  chain	  reaction	  
	  
Quantitative	  PCR	  (qPCR)	  has	  been	  used	  in	  microbial	  ecology	  studies	  to	  measure	  
the	   abundance	   and	   expression	   of	   taxonomic	   and	   functional	   gene	   markers	  
related	   to	   the	   removal	   of	   micropollutants	   (Bustin	   et	   al.,	   2005;	   Smith	   and	  
Osborn,	  2009).	  Quantitative-­‐PCR	  works	   in	   the	   same	  way	  of	  an	  end-­‐point	  PCR,	  
i.e.	   multiple	   amplification	   cycles	   in	   which	   the	   DNA	   is	   initially	   denatured	   and	  





complementary	  strand	  from	  each	  annealed	  primer,	  resulting	  in	  an	  exponential	  
increase	   in	   amplicon	   numbers.	   In	   qPCR,	   oligonucleotide-­‐intercalating	  
fluorescent	  dyes	  such	  as	  SYBR	  Green	  or	  fluorescent	  probes	  (TaqMan)	  are	  used	  
to	  detect	  the	  increase	  in	  amplicon	  numbers.	  Software	  records	  in	  ‘real-­‐time’	  the	  
increase	   of	   amplicons	   concentration	   during	   the	   early	   exponential	   phase	   of	  
amplification,	   enabling	   the	   quantification	   of	   gene	   numbers	   when	   these	   are	  
proportional	  to	  the	  starting	  template	  concentration	  (Bustin	  et	  al.,	  2005;	  Smith	  
and	  Osborn,	  2009).	  
	  
As	  qPCR	  is	  a	  sensitive	  and	  specific	  method	  to	  detect	  changes	  in	  the	  abundance	  
of	   target	   functional	   genes,	   it	   can	   be	   applied	   to	   investigate	   the	   effects	   of	  
experimental	  parameters	  on	  the	  numbers	  of	  the	  target	  gene	  and	  subsequently	  
on	  the	  process	  that	  these	  genes	  encode	  for.	  Several	  functional	  genes	  encoding	  
key	  reactions	  in	  biodegradation	  pathways	  of	  environmental	  pollutants,	  such	  as	  
herbicides,	   aromatic	   hydrocarbons,	   halogenated	   and	   chlorinated	   compounds,	  
have	  been	  targeted	  by	  qPCR	  analysis	  (Smith	  and	  Osborn,	  2009).	  	  
	  
Aims	  and	  layout	  
	  
Wastewater	   treatment	   plants	   (WWTPs)	   are	   one	   of	   the	   main	   routes	   for	   the	  
introduction	  of	  micropollutants	   into	  the	  environment	  but	  can	  also	  represent	  a	  
major	   treatment	   opportunity	   for	   preventing	   significant	   environmental	  
exposure.	  	  
	  
Most	  conventional	  treatment	  plants	  use	  biological	  systems	  to	  degrade	  organic	  
matter	   due	   to	   their	   economical	   and	   environmental	   advantages.	   However,	  
knowledge	   on	   the	   microbiology	   and	   biodegradation	   pathways	   involved	   in	  






A	  variety	  of	  biochemical	  and	  molecular	  methods	  can	  be	  applied	   to	   reveal	   the	  
microbial	   community	   structure	   and	   dynamics	   over	   time	   in	   response	   to	   the	  
presence	   of	   specific	   micropollutants.	   These	   approaches	   allow	   linking	  
micropollutants	  degradation	  performance	  with	   the	  microbial	   community.	   This	  
knowledge	  facilitates	  the	  optimisation	  of	  the	  process	  operation	  conditions	  that	  
enable	  the	  acclimatisation	  of	  microbial	  populations	  for	  micropollutants	  removal	  
in	  WWTPs.	  
	  
The	  main	  objective	  of	  the	  work	  presented	  in	  this	  thesis	  was	  to	  characterise	  the	  
microbial	  populations	   involved	  in	  the	  removal	  of	  micropollutants	   in	  water	  and	  
wastewater	   treatment	   systems,	   focusing	   essentially	   in	   understanding	   and	  
predicting	  the	  main	  factors	  influencing	  the	  microbial	  degradation	  of	  important	  
emerging	   pollutants,	   in	   identifying	   and	   characterising	   key	   microorganisms	  
involved	   in	   the	   degradation	   process,	   as	   well	   as	   the	  metabolic	   aspects	   of	   the	  
degradation.	   Finally,	   the	   potential	   application	   of	   the	   knowledge	   of	   such	  
characterisation	   is	   explored	   in	   monitoring	   the	   acclimatisation	   of	   microbial	  
communities	   for	   the	   degradation	   of	   a	   target	  micropollutant,	  where	  microbial	  
community	  structure	  and	  dynamics	  were	  linked	  with	  degradation	  performance.	  	  
	  
The	   ultimate	   goal	   of	   this	   thesis	   is	   to	   provide	   a	   step	   forward	   towards	  
understanding	   and	   improving	   the	  microbial	   degradation	   of	  micropollutants	   in	  
WWTP.	  
	  
This	  thesis	  is	  divided	  into	  six	  chapters.	  
	  
• Chapter	   one	   consists	   of	   a	   general	   introduction	   on	   the	   challenges	   of	  





is	  given	  to	  the	  biological	  degradation	  of	  micropollutants,	  particularly	  on	  
the	   importance	   of	   addressing	   the	   microbial	   population	   dynamics,	  
structure	  and	  function	  during	  the	  degradation	  process.	  
	  
• In	   Chapter	   two,	   the	   biodegradation	   of	   two	   NSAIDs	   (ibuprofen	   and	  
ketoprofen)	  by	  activated	  sludge	  and	  a	  pure	  culture	  was	  described	  using	  
mathematical	   models.	   Mathematical	   models	   can	   help	   to	   understand	  
and	   predict	   the	   main	   factors	   influencing	   the	   biodegradation	   of	  
micropollutants	  and	  are	  essential	   for	  process	  optimisation,	  design	  and	  
control	   of	   wastewater	   treatment	   systems.	   The	   effects	   of	   substrate	  
loading	  rate	  and	  mixtures	  of	  compounds	  on	  the	  microbial	  degradation	  
performance	   of	   ibuprofen	   and	   ketoprofen	   were	   characterised	   using	  
three	   different	   activated	   sludges.	   Since	   the	   micropollutant	   degrading	  
biomass	   constitutes	   only	   a	   small	   fraction	   of	   activated	   sludge,	   more	  
specific	   investigation	   of	   the	   performance	   and	   growth	   of	   these	  
organisms	   required	   the	   use	   of	   pure	   cultures.	   Several	   ibuprofen	   and	  
ketoprofen	   degrading	   microorganisms	   were	   obtained	   from	   isolation	  
and	   cultivation	   in	   an	   agar	   medium.	   One	   isolate	   was	   further	  
characterised	   in	   terms	   of	   ibuprofen	   degradation	   kinetics	   using	   an	  
additional	  mathematical	  model.	  	  
	  
• Chapter	   three	   presents	   the	   unique	   phenotypic	   and	   genotypic	  
characteristics	  of	  the	  ibuprofen	  degrading	  isolate,	  previously	  kinetically	  
characterised	   for	   ibuprofen	   degradation,	   which	   enabled	   its	  
classification	  as	  a	  new	  species,	  Patulibacter	  medicamentivorans.	  	  
	  
• In	   Chapter	   four	   the	   metabolism	   of	   ibuprofen	   degradation	   by	  





describes	   the	   proteomic	   analysis	   of	   Patulibacter	   medicamentivorans,	  
with	   and	   without	   exposure	   to	   ibuprofen,	   carried	   out	   by	   in	   vivo	  
metabolic	   labelling.	   Furthermore,	   the	   whole	   genome	   of	   this	  
microorganism	   was	   sequenced	   and	   employed	   to	   provide	   a	   species-­‐
specific	  protein	  identification	  platform,	  for	  improved	  quality	  of	  protein	  
identification.	  
	  
• The	   identification	   of	   key	   enzymes	   involved	   in	   biodegradation	   can	  
suggest	   candidate	   biomarkers	   to	  monitor	  micropollutant	   degradation.	  
The	   knowledge	   of	   the	   genes	   encoding	   for	   micropollutant	   degrading	  
enzymes,	   as	  well	   as	   the	   identity	  of	  degrading	  microorganisms,	   can	  be	  
applied	   in	   studies	   to	  monitor	   the	  degradation	  potential	   and	  microbial	  
communities	   development	   in	   engineered	   systems.	   Chapter	   five	  
explores	   the	   potential	   application	   of	   such	   knowledge.	   The	   taxonomic	  
(16S	  rRNA	  gene)	  and	  functional	  (merA	  gene)	  characteristics	  of	  mercury-­‐
reducing	   cultures	   enriched	   with	   different	   carbon	   sources	   (glucose,	  
ethanol	  or	  acetate)	  were	  investigated	  aiming	  at	  understanding	  the	  long	  
term	  effect	  of	   the	  carbon	  substrate	   (that	  can	  be	  supplemented	  to	  the	  
system)	  on	   the	  microbial	   structure	  and	   function.	   The	  dynamics	  of	   the	  
microbial	  cultures	  during	  the	  enrichment	  period	  were	  monitored	  using	  
complementary	   molecular	   techniques	   such	   as	   DGGE	   and	   FISH.	  
Additionally,	   functional	   changes	   were	   determined	   through	   the	  
abundance	  of	  the	  merA	  gene	  using	  qPCR,	  which	  were	  then	  related	  with	  
mercury	  removal	  efficiency.	  
	  
• To	   finalise,	   Chapter	   six,	   encloses	   a	   general	   discussion	   of	   all	   the	  
conclusions	   from	   the	   other	   chapters	   and	   presents	   perspective	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A	   model	   describing	   ibuprofen	   and	   ketoprofen	   biodegradation	   by	   activated	  
sludge	   from	   three	   different	   wastewater	   treatment	   plants	   (WWTPs)	   was	  
developed	   in	   this	   study.	  This	  model	   successfully	  described	   the	  biodegradation	  
profiles	   observed	   at	   two	   different	   initial	   concentrations	   of	   each	   compound,	  
where	   a	   lag-­‐phase	   was	   observed	   prior	   to	   the	   biodegradation	   of	   each	  
compound.	   Twelve	   ibuprofen	   and	   ketoprofen	   degrading	   isolates	   were	  
identified	   in	   this	   study	   from	   the	   WWTP	   sludge	   showing	   the	   best	   removal	  
performance.	   One	   of	   these	   isolates	   was	   characterised	   via	   another	   model,	  
where	   biodegradation	  was	   dependent	   on	   biomass	   growth	   rate	   as	  well	   as	   the	  
ibuprofen	   concentration.	   The	   fact	   that	   different	   models	   were	   needed	   to	  
describe	   the	   biodegradation	   by	   activated	   sludge	   and	   a	   pure	   culture	   suggests	  
that	   the	   biodegradation	   of	   non-­‐steroidal	   anti-­‐inflammatory	   drugs	   (NSAIDs)	  
depends	   on	   the	   microbial	   community,	   thus	   pharmaceutical	   biodegradation	  
models	   may	   require	   adaptation	   depending	   upon	   the	   system.	   This	   study	  







The	   presence	   of	   pharmaceutically	   active	   compounds	   (PhACs)	   in	   wastewater	  
treatment	  plants	   (WWTPs)	   as	  well	   as	   in	   natural	  matrices	   (soil,	   sediments	   and	  
water)	   has	   been	   an	   issue	   of	   concern	   in	   recent	   years.	   PhACs	   are	   known	   to	  
possess	   potentially	   harmful	   effects	   to	   the	   environment	   and	   public	   health	  
(mutagenic,	   carcinogenic,	   endocrine	   disruptor)	   (Heberer,	   2002;	   Kolpin	   et	   al.,	  
2002).	  PhACs	  have	  been	  detected	  in	  concentrations	  up	  to	  µg	  L-­‐1	  in	  influents	  and	  
effluents	  of	  WWTP	  worldwide	  and	  in	  surface	  waters	  (Heberer,	  2002;	  Kolpin	  et	  
al.,	   2002;	   Murray	   et	   al.,	   2010;	   Pal	   et	   al.,	   2010;	   Salgado	   et	   al.,	   2010).	   The	  
elimination	  of	  such	  compounds	  from	  wastewater	  treatment	  is	  possible,	  and	  has	  
been	   reported	   in	   numerous	   studies,	   through	   the	   action	   of	   different	   removal	  
mechanisms	   such	   as	   sorption,	   biodegradation	   and	   abiotic	   degradation	   (e.g.	  
Salgado	   et	   al.,	   2012).	   Biodegradation	   was	   shown	   to	   be	   the	   predominant	  
mechanism	   by	   which	   polar	   acidic	   pharmaceuticals	   are	   primarily	   removed	   in	  
wastewater	  treatment	  systems	  (Quintana	  et	  al.,	  2005;	  Salgado	  et	  al.,	  2012).	  
	  
Ibuprofen	   and	   ketoprofen	   are	   two	   common	   non-­‐steroidal	   anti-­‐inflammatory	  
drugs	  (NSAIDs)	  that	  are	  among	  the	  most	  abundantly	  detected	  (in	  the	  ng	  L-­‐1	  to	  
µg	   L-­‐1	   range)	   in	   WWTP	   influents	   and	   effluents,	   as	   shown	   by	   various	   surveys	  
carried	  out	  all	  over	   the	  world	   (Marco-­‐Urrea	  et	  al.,	  2010;	  Onesios	  et	  al.,	  2009;	  
Salgado	  et	  al.,	  2010;	  Zwiener	  et	  al.,	  2002).	  	  
	  
Ibuprofen	   was	   detected	   up	   to	   106	   µg	   L-­‐1	   and	   44	   µg	   L-­‐1	   in	   raw	   sewage	   and	  
treated	  effluent	  wastewater,	  respectively,	  and	  up	  to	  5	  µg	  L-­‐1	   in	  surface	  waters	  
(Murray	  et	  al.,	  2010;	  Pal	  et	  al.,	  2010;	  Salgado	  et	  al.,	  2010;	  Santos	  et	  al.,	  2010).	  
At	   concentrations	   of	   ng	   L-­‐1	   ibuprofen	   was	   shown	   to	   affect	   the	   growth	   and	  





2010;	   Hayashi	   et	   al.,	   2008;	   Pomati	   et	   al.,	   2004;	   Ragugnetti	   et	   al.,	   2011).	   The	  
range	   of	   detection	   of	   ketoprofen	   in	   wastewater	   and	   freshwaters	   is	   lower	   as	  
compared	  to	  ibuprofen,	  with	  detections	  of	  up	  to	  104	  µg	  L-­‐1	  in	  raw	  influents	  and	  
0.1	  µg	  L-­‐1	  in	  surface	  waters	  (Murray	  et	  al.,	  2010;	  Pal	  et	  al.,	  2010;	  Salgado	  et	  al.,	  
2011;	   Santos	   et	   al.,	   2010).	   The	   toxic	   effects	   that	   such	   concentrations	   might	  
pose	  to	  the	  aquatic	  environment	  are	  still	  unknown.	  	  
	  
Biodegradation	   of	   the	   two	   compounds	   in	   WWTPs	   have	   been	   reported	   by	  
several	  studies,	  which	  differ	  in	  removal	  efficiencies	  due	  to	  the	  varying	  influent	  
concentrations	  and	  operating	  factors,	  with	  eliminations	  of	  anywhere	  between	  0	  
%	  to	  100	  %	  	  (Daughton	  and	  Ternes,	  1999;	  Murray	  et	  al.,	  2010;	  Pal	  et	  al.,	  2010;	  
Salgado	  et	  al.,	  2012;	  Santos	  et	  al.,	  2010).	  Biodegradation	  models	  are	  still	  in	  their	  
infancy,	  and	  are	  needed	  to	  evaluate,	  understand	  and	  predict	   the	  main	  factors	  
influencing	  the	  biodegradation	  of	  PhACs	  in	  WWTPs.	  Developing	  an	  appropriate	  
mathematical	  model	  to	  describe	  NSAID	  biodegradation	  by	  activated	  sludge	  was	  
indeed	  an	  objective	  of	  this	  study.	  Further,	  previous	  studies	  have	  not	  examined	  
the	  biodegradation	  of	  a	  mixture	  of	  NSAIDs	  (or	  other	  PhACs),	  and	  the	  synergistic	  
effects	   that	   the	  presence	  of	  one	  compound	  can	  have	  on	  another.	   It	   is	   known	  
that	  mixtures	  of	  compounds	  can	  affect	  microbial	  degradation	  due	  to	  inhibition	  
by	  either	  competition	  or	  toxicity	  (Reardon	  et	  al.,	  2002),	  and	  therefore	  this	  was	  
evaluated	  in	  this	  work.	  
	  
Some	   PhAC	   biodegradation	   models	   are	   derived	   from	   first-­‐order	   kinetic	  
expressions,	  as	  proposed	  by	  Joss	  et	  al.	   (2006).	   In	  general,	  the	  most	  commonly	  
used	  activated	  sludge	  models	  (ASMs)	  employ	  Monod-­‐based	  kinetic	  expressions	  
(Hauduc	   et	   al.,	   2012).	   Previous	   studies	   incorporating	   PhAC	   degradation	   into	  
ASMs	  have	  usually	  employed	  one	  of	  these	  two	  approaches	  (Collado	  et	  al.,	  2012;	  





to	  describe	  the	  degradation	  of	  a	  xenobiotic,	  which	  is	  dependent	  on	  the	  growth	  
of	  xenobiotic-­‐degrading	  biomass.	  Chong	  (2009)	  proposed	  that	  degradation	  was	  
a	  process	  dependent	  upon	  the	  acclimation	  of	  biomass,	  affecting	  the	  growth	  of	  
the	  degrading	  fraction.	  Such	  a	  hypothesis	  is	  very	  difficult	  to	  test	  with	  activated	  
sludge,	   which	   contains	   a	   wide	   diversity	   of	   organisms,	   where	   the	   PhAC	  
degraders	  likely	  represent	  only	  a	  minor	  fraction	  (Chong,	  2009;	  Majewsky	  et	  al.,	  
2011).	   We	   investigated	   this	   hypothesis	   by	   using	   a	   pure	   culture	   to	   study	   the	  
growth	   dependency	   on	   NSAID	   removal.	   For	   this	   purpose,	   we	   obtained	   a	  
number	   of	   isolates	   from	   a	  WWTP	   and	   simultaneously	   identified	   new	   species	  
not	  previously	  associated	  with	  NSAID	  biodegradation.	  
	  
Few	  studies	  have	  been	  conducted	  to	  understand	  the	  degradation	  of	  ibuprofen	  
and	   ketoprofen	   by	  microorganisms	   present	   in	   activated	   sludge.	   To	   date	   only	  
two	  microorganisms	  were	  isolated	  from	  activated	  sludge	  as	  being	  able	  to	  utilise	  
ibuprofen,	   a	  Nocardia	   sp.	   (Chen	   and	   Rosazza,	   1994)	   and	  Sphingomonas	   Ibu-­‐2	  
(Murdoch	   and	   Hay,	   2005).	   However,	   no	   kinetic	   studies	  were	   performed	  with	  
these	  strains	   in	  order	   to	  understand	  their	   ibuprofen	  removal	  performance.	  So	  
far,	   no	   microorganism	   has	   been	   isolated	   from	   activated	   sludge	   that	   is	  
associated	   to	   ketoprofen	  degradation,	  but	   the	   capability	  of	  white-­‐rot	   fungi	   to	  
degrade	  ketoprofen	  has	  been	  demonstrated	  (Marco-­‐Urrea	  et	  al.,	  2010).	  
	  
Therefore,	  the	  first	  aim	  of	  this	  work	  was	  to	  characterise	  and	  model	  the	  kinetics	  
of	   ibuprofen	   and	   ketoprofen	   biodegradation	   by	   activated	   sludge	   from	   three	  
different	  WWTP,	  varying	  the	  initial	  concentrations	  of	  each	  compound	  alone	  or	  
in	   a	   mixture.	   The	   second	   aim	   of	   this	   work	   was	   to	   isolate	   NSAID-­‐degrading	  
microorganisms	   and	   characterise	   their	   degradation	   efficiency.	   Ibuprofen	   was	  





pure	   cultures,	   which	   was	   subsequently	   described	   through	   a	   mathematical	  
model.	  
Material	  and	  Methods	  
Activated	  sludge	  sampling	  
Activated	   sludge	   and	   influent	   samples	   were	   collected	   from	   the	   recirculation	  
tank	  and	  from	  the	  primary	  clarifier,	   respectively,	  of	   three	  municipal	  WWTPs	  –	  
Beirolas	  WWTP	  (SIMTEJO,	  Lisbon),	  Fernão	  Ferro	  WWTP	  (SIMARSUL,	  Seixal)	  and	  
Setúbal	   WWTP	   (Águas	   do	   Sado,	   Setúbal).	   All	   of	   the	   plants	   treat	   mainly	  
municipal	   wastewater,	   where	   industrial	   discharges	   incorporate	   <20	   %	   of	   the	  
flow.	   The	   samples	   were	   transported	   to	   the	   laboratory	   in	   a	   refrigerated	  
isothermal	   container	   and	  used	   immediately.	   The	   activated	   sludge	  was	   settled	  
and	   the	   supernatant	   was	   discarded.	   Influent	   was	   filtered	   through	   a	   glass	  
microfiber	   filter	   GF/D	   (Whatman,	   Dassel,	   Germany)	   to	   remove	   suspended	  
particles	  and	  adjusted	   to	  pH	  7.	  Activated	  sludge	  samples	  were	  adjusted	   to	  an	  
average	  of	  3	  g	  L-­‐1	  (volatile	  suspended	  solids	  -­‐	  VSS)	  with	  wastewater	  influent.	  	  
	  
Degradation	  of	  ibuprofen	  and	  ketoprofen	  by	  activated	  sludge	  	  
	  
Biodegradation	   experiments	   were	   carried	   out	   in	   500	   mL	   Erlenmeyer	   flasks	  
placed	  in	  a	  rotary	  shaker	  at	  27	  ºC	  and	  at	  110	  rpm.	  Activated	  sludge	  was	  spiked	  
with	   ibuprofen	   and	   ketoprofen	   to	   test	   the	   following	   conditions:	   i)	   using	  
ibuprofen	   or	   ketoprofen	   as	   the	   sole	   carbon	   and	   energy	   source,	   ii)	   feeding	   a	  
mixture	  of	   the	   two	  NSAIDs	   to	   test	   substrate	   competition,	   iii)	   using	   two	   initial	  
concentrations	  -­‐	  1000	  µg	  L-­‐1	  or	  500	  µg	  L-­‐1	  for	  ibuprofen	  and	  250	  µg	  L-­‐1	  or	  100	  µg	  





taken	  at	  regular	  intervals	  during	  36	  h	  to	  measure	  the	  degradation	  of	  ibuprofen	  
and	   ketoprofen	   as	   described	   below.	   Autoclaved	   biomass	   and	   uninoculated	  
ibuprofen-­‐containing	  media	  (abiotic	  test)	  were	  used	  as	  controls	  in	  this	  study.	  
Putative	   NSAID	   degrading	   microorganism	   isolation,	   identification	   and	  
biodegradation	  characterisation	  
Putative	  NSAID	  degrading	  microorganisms	  were	  isolated	  from	  activated	  sludge	  
collected	   from	   the	  Beirolas	  WWTP	   (Lisbon,	  Portugal).	  Briefly,	   activated	   sludge	  
(3	   g	   L-­‐1)	   was	   incubated	   in	   minimal	   medium	   M9	   (Oehmen	   et	   al.,	   2009)	  
supplemented	  with	  500	  µg	  L-­‐1	  of	  ibuprofen	  or	  250	  µg	  L-­‐1	  of	  ketoprofen	  at	  28	  ºC	  
for	   15	   days.	   A	   new	   addition	   of	   ibuprofen	   or	   ketoprofen	   was	  made	   once	   the	  
parent	  compound	  had	  been	  fully	  removed	  from	  the	  medium,	  as	  determined	  by	  
ultra	   performance	   liquid	   chromatography.	   Ibuprofen	   and	   ketoprofen	  
degradation	   capacity	   of	   the	   microbial	   community	   was	   evaluated	   during	   the	  
period	   of	   incubation.	   In	   order	   to	   identify	   possible	   NSAID	   degrading	  
microorganisms,	   samples	   were	   serially	   diluted	   in	   sterile	   saline	   solution	   (NaCl	  
0.85	  %,	  w/v),	  spread	  on	  agar	  plates	  containing	  minimal	  medium	  supplemented	  
with	  250	  µg	  L-­‐1	  of	  ibuprofen	  or	  ketoprofen	  and	  15	  g	  L-­‐1	  agar	  and	  incubated	  at	  28	  
ºC	  for	  3-­‐4	  days.	  Individual	  colonies	  were	  selected,	  re-­‐inoculated	  onto	  the	  same	  
medium	  supplemented	  with	  1	  g	  L-­‐1	  of	  yeast	  extract	  (Oxoid,	  Hampshire,	  England)	  
and	  tryptone	  (Oxoid,	  Hampshire,	  England)	  (50	  %	  of	  each)	  for	  isolation	  into	  pure	  
cultures.	  Pure	  cultures	  were	  stored	  in	  Tryptone	  Soya	  Agar	  (Oxoid)	  at	  4	  ºC.	  	  
	  
The	  biodegradation	  capacity	  of	   the	   isolated	  microorganisms	  was	  evaluated	  by	  
cultivating	   them	   in	   250	   mL	   Erlenmeyer	   flasks	   containing	   100	   mL	   of	   minimal	  
medium	  supplemented	  with	  1	  g	  L-­‐1	  of	  yeast	  extract	  and	  tryptone	  (50	  %	  of	  each)	  
and	   100	   µg	   L-­‐1	   of	   the	   corresponding	   NSAID.	   Cultures	   were	   incubated	   on	   a	  





the	   NSAIDs	   were	   identified	   by	   Biopremier	   (Lisbon,	   Portugal)	   through	  
sequencing	   the	   16S	   rRNA	   gene,	   using	   the	   primers	   PA/907r	   (Muyzer	   et	   al.,	  
1995).	  
	  
The	  effect	  of	  initial	  ibuprofen	  concentration	  on	  the	  degradation	  performance	  of	  
one	   isolate	   (I11)	   was	   also	   assessed.	   The	   isolate	   was	   grown	   in	   Tryptone	   Soya	  
Broth	  (TSB)	  medium	  (Oxoid)	  up	  to	  the	  mid-­‐logarithmic	  growth	  phase	  (assessed	  
through	   optical	   density	   measurements	   at	   600nm),	   after	   which	   cells	   were	  
pelleted	  by	  centrifugation	  at	  6000	  g	   for	  5	  min	  at	  4	  ºC	  and	  washed	   twice	  with	  
M9	  medium.	  0.2	  g	  L-­‐1	  of	  this	  biomass	  was	  used	  as	  inoculum	  for	  the	  degradation	  
tests.	  Experiments	  were	  conducted	   in	  250	  mL	   flasks	  containing	  100	  mL	  of	  M9	  
medium.	   Different	   initial	   concentrations	   (250	   μg	   L-­‐1	   and	   1000	   μg	   L-­‐1)	   of	  
ibuprofen	   were	   tested	   with	   or	   without	   the	   presence	   of	   yeast	   extract	   and	  
tryptone	  (initial	  concentration	  of	  3	  g	  L-­‐1,	  50	  %	  of	  each).	  Flasks	  were	   incubated	  
on	  a	  horizontal	  shaker	  at	  110	  rpm,	  28	  ºC	  for	  approximately	  100	  hours.	  
The	   bacterial	   isolate	   I11	  was	   also	   tested	   at	   different	   initial	   concentrations	   of	  
yeast	  extract	  and	  tryptone	  (initial	  concentrations	  of	  0.5	  g	  L-­‐1,	  1	  g	  L-­‐1,	  2	  g	  L-­‐1,	  3	  g	  
L-­‐1	   and	   5	   g	   L-­‐1,	   containing	   50	   %	   of	   each	   substrate)	   using	   an	   initial	   ibuprofen	  
concentration	   of	   250	   μg	   L-­‐1.	   A	   pre-­‐culture	   of	   I11	   was	   grown	   in	   TSB	   medium	  
without	  ibuprofen	  up	  to	  the	  mid-­‐logarithmic	  growth	  phase.	  Cells	  were	  pelleted	  
by	   centrifugation	   at	   6000	   g	   for	   5	   min	   at	   4	   ºC	   and	   washed	   twice	   with	   M9	  
medium.	  Biomass,	  at	  a	  concentration	  of	  0.2	  g	  L-­‐1,	  was	  used	  to	  inoculate	  250	  mL	  
Erlenmeyer	  flasks	  with	  100	  mL	  of	  M9	  medium	  containing	  the	   ibuprofen,	  yeast	  
extract	   and	   tryptone.	   Autoclaved	   cells	   and	   uninoculated	   ibuprofen-­‐containing	  








Analytical	  methods	  	  
	  
All	   reagents,	   acetonitrile	   (Fisher	   Scientific,	   Fair	   Lawn,	   USA),	   85	   %	   phosphoric	  
acid	  (Sigma	  Aldrich,	  Germany)	  and	  methanol	  (Fisher	  Scientific,	  Fair	  Lawn,	  USA),	  
were	  of	  HPLC	  gradient	  grade,	  with	  a	  purity	  of	  ≥	  99%,	  according	  to	  the	  supplier.	  
Prior	  to	  use,	  solutions	  were	  filtered	  through	  0.2	  µm	  SPARTAN	  filters	  (Whatman,	  
Dassel,	  Germany).	  The	  laboratory	  water	  used	  in	  the	  study	  was	  provided	  by	  the	  
Milli-­‐Q	   water	   system	   (Millipore,	   CA,	   USA).	   Ibuprofen	   and	   ketoprofen	   were	  
obtained	  from	  Sigma-­‐Aldrich	   (Germany).	  Total	  suspended	  solids	   (TSS)	  and	  VSS	  
were	  determined	  according	  to	  Standard	  Methods	  (APHA	  et	  al.,	  1995).	  
	  
Samples	  were	  taken	  during	  the	  biodegradation	  assays,	  centrifuged	  at	  6000	  g	  for	  
5	   min	   and	   the	   supernatant	   filtered	   through	   a	   0.2	   µm	   SPARTAN	   (Whatman,	  
Dassel,	   Germany)	   filter	   prior	   to	   ibuprofen	   analysis.	   The	   ibuprofen	   and	  
ketoprofen	   quantification	   was	   determined	   using	   ultra	   performance	   liquid	  
chromatography	   (UPLC)	   as	   previously	   described	   (Almeida	   et	   al.,	   2012).	  
Ibuprofen	  was	  detected	  at	  220	  nm	  and	  ketoprofen	  at	  257	  nm.	  
Results	  and	  discussion	  
Ibuprofen	  and	  ketoprofen	  biodegradation	  by	  activated	  sludge	  
Ibuprofen	   and	   ketoprofen	   biodegradation	  was	   studied	   using	   activated	   sludge	  
from	  three	  different	  WWTPs,	  using	  different	  concentrations	  of	  each	  compound,	  
alone	  or	   in	  a	  mixture,	   in	  order	  to	  study	  possible	  substrate	  competition	  effects	  
and	  kinetic	  differences.	  Figures	  2.1	  and	  2.2	  show	  that	  each	  sludge	  was	  able	  to	  








Figure	   2.1.	   Experimental	   data	   (symbols)	   and	   kinetic	   model	   fitting	   (lines)	   for	   the	  
degradation	  of	  ibuprofen	  by	  the	  three	  activated	  sludges:	  a)	  Beirolas	  WWTP;	  b)	  Setúbal	  
WWTP	  and	  c)	  Fernão	  Ferro	  WWTP.	  	  
Correlation	  between	  experimental	  values	  and	  model	  predictions:	  a)	  R2	  =	  0.99,	  b)	  R2	  =	  







Figure	   2.2.	   Experimental	   data	   (symbols)	   and	   kinetic	   model	   (lines)	   fitting	   for	   the	  
degradation	   of	   ketoprofen	   for	   the	   three	   activated	   sludges:	   a)	   Beirolas	   WWTP;	   b)	  
Setúbal	  WWTP	  and	  c)	  Fernão	  Ferro	  WWTP.	  	  
Correlation	  between	  experimental	  values	  and	  model	  predictions:	  a)	  R2	  =	  0.95,	  b)	  R2	  =	  






In	   these	   tests,	   it	  was	   observed	   that	   biomass	   growth	  was	   negligible,	   since	   the	  
biomass	  concentration	  remained	  constant	  at	  3.0	  ±	  0.1	  g	  L-­‐1.	  Furthermore,	  there	  
was	  no	  ibuprofen	  or	  ketoprofen	  removal	  observed	  in	  the	  autoclaved	  sludge	  and	  
abiotic	   controls,	   confirming	   that	   the	   removal	   was	   due	   to	   biological	   activity.	  
Previous	   studies	   have	   shown	   that	   ibuprofen	   and	   ketoprofen	   are	   commonly	  
removed	  through	  biodegradation,	  while	  sorption	  and	  volatilisation	  seem	  to	  be	  
negligible	  (Joss	  et	  al.,	  2006;	  Ternes	  et	  al.,	  2004;	  Salgado	  et	  al.,	  2012),	  which	  is	  in	  
good	  agreement	  with	  our	  results.	  	  
	  
Furthermore,	   Figure	   2.1	   and	   Figure	   2.2	   show	   that	   all	   tested	   activated	   sludge	  
communities	   removed	   both	   NSAIDs,	   where	   neither	   stimulation	   nor	   inhibition	  
was	   observed	   in	   cases	   where	   ibuprofen	   and	   ketoprofen	   were	   fed	  
simultaneously	   as	   compared	   to	   the	   cases	   where	   each	   NSAID	   was	   fed	  
individually.	   A	   lag	   phase	  was	   observed	  prior	   to	   the	   commencement	   of	  NSAID	  
biodegradation	   in	  all	   tests,	  which	  was	  also	  observed	  during	  the	   ibuprofen	  and	  
ketoprofen	  biodegradation	  tests	  of	  Quintana	  et	  al.	   (2005).	  Moreover,	  for	  each	  
sludge,	   the	   total	   degradation	   time	   for	   each	   NSAID	   was	   similar	   at	   the	   two	  
different	   concentration	   levels	   tested.	   Indeed,	   in	   Figure	   2.1a,	   ibuprofen	   was	  
removed	  in	  approximately	  the	  same	  period	  of	  time	  (2h)	  when	  either	  1000	  µg	  L-­‐1	  
or	   250	   µg	   L-­‐1	   was	   added.	   Similar	   trends	   were	   observed	   for	   the	   other	   two	  
WWTPs,	   although	   the	   degradation	   time	   was	   6h.	   These	   results	   contrast	   with	  
those	  previously	  obtained	  by	  Collado	  et	  al.	   (2012),	  where	  a	   lag	  phase	  was	  not	  
observed	  for	  ibuprofen	  degradation,	  and	  the	  degradation	  rate	  of	  ibuprofen	  was	  
found	   to	   be	   higher	   at	   lower	   ibuprofen	   concentrations	   when	   using	   the	   same	  
initial	  biomass	  concentration.	  While	   it	   is	  unclear	  why	  our	  results	  contrast	  with	  





observed	   between	   these	   two	   studies	   highlight	   the	   importance	   of	   testing	   the	  
PhAC	  degradation	  profile	  for	  each	  specific	  activated	  sludge.	  
	  
The	   biodegradation	   of	   ketoprofen	   by	   the	   three	   activated	   sludges	   followed	   a	  
similar	   trend	   as	   compared	   to	   ibuprofen,	   although	   the	   kinetics	   were	  
considerably	   slower	   and	   the	   lag	   phase	   considerably	   longer.	   The	   fact	   that	  
ibuprofen	   was	   more	   easily	   biodegraded	   than	   ketoprofen	   is	   likely	   due	   to	  
differences	   in	   their	   chemical	   structures.	   Furthermore,	   Quintana	   et	   al.	   (2005)	  
also	  observed	  that	  ibuprofen	  biodegradation	  was	  faster	  than	  ketoprofen,	  which	  
is	  in	  good	  agreement	  with	  our	  results.	  
	  
Modelling	  NSAID	  biodegradation	  by	  activated	  sludge	  	  
	  
Previous	   studies	   focussed	   on	   modelling	   the	   biodegradation	   of	   PhACs	   from	  
activated	  sludge	  have	  generally	   found	  that	  either	   first-­‐order	  or	  Monod	  kinetic	  
expressions	   describe	  well	   the	   experimental	   data	   (Collado	   et	   al.,	   2012;	   Joss	   et	  
al.,	  2006,	  Lust	  et	  al.,	  2012;	  Plósz	  et	  al.,	  2010).	  However,	  this	  was	  not	  the	  case	  in	  
the	   present	   study.	   Chong	   (2009)	   proposed	   a	   model	   to	   describe	   xenobiotic	  
degradation	   that	   employed	   a	   modified	   logistical	   function,	   with	   a	   sigmoidal	  
shape.	   This	   showed	  much	  better	   agreement	  with	   the	  data	  obtained	   from	   the	  
three	  wastewater	   treatment	   plant	   sludges	   tested	   in	   this	   study,	   and	  was	   thus	  
chosen	  as	  the	  basis	  for	  model	  development.	  	  
	  
Chong	  (2009)	  proposed	  a	  model	  based	  on	  the	  acclimation	  of	  a	  biomass	  fraction	  
corresponding	   to	   the	   xenobiotic	   degraders.	   Since	   this	   degrader	   fraction	   of	  
activated	   sludge	   is	   difficult	   to	   measure	   in	   practice,	   we	   propose	   a	   modified	  
model	   where	   the	   sigmoidal	   function	   is	   applied	   directly	   to	   describe	   the	  





describing	   the	   degrading	   biomass	   fraction	   as	   proposed	   in	   Chong	   (2009).	  
Furthermore,	   the	   NSAID	   degradation	  was	   described	   by	   a	  modified-­‐first	   order	  
function	   with	   respect	   to	   the	   NSAID	   substrate	   (S),	   as	   opposed	   to	   a	   modified-­‐
Monod	  equation.	  This	  change	  minimises	  the	  number	  of	  parameters	  to	  estimate	  
in	   the	  model	   equation.	   Finally,	   the	   NSAID	   degradation	   is	   also	   described	   as	   a	  
function	  of	  the	  total	  biomass	  concentration	  (X),	  as	  shown	  in	  equation	  2.1:	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where	   a,	   b	   and	   c	   are	   constants.	   These	   constants	   were	   estimated	   using	   non-­‐
linear	   regression	   fitting	   to	   the	   experimental	   data	   using	   Aquasim	   (Reichert,	  
1994).	  The	  simultaneous	  parameter	  estimation	  for	  the	  three	  constants	  utilised	  
the	  experimental	  data	  of	  three	  tests	  at	  both	  initial	  concentrations	  (i.e.	  1000	  μg	  
L-­‐1	  and	  250	  μg	  L-­‐1	   for	   ibuprofen	  and	  250	  μg	  L-­‐1	  and	  100	  μg	  L-­‐1	   for	  ketoprofen)	  
alone	  or	  in	  combination	  with	  the	  other	  NSAID.	  The	  fourth	  test	  was	  utilised	  for	  
model	   validation.	   Using	   the	   estimated	   constants,	   the	   rate	   constant	   (k1)	   of	  
NSAID	  degradation	  can	  be	  calculated	  according	  to	  equation	  2.2:	  
!! = !"	  
while	  the	  length	  of	  the	  lag	  phase	  (L)	  can	  be	  calculated	  according	  to	  equation	  2.3	  
(Chong,	  2009):	  




As	  shown	   in	  Figures	  2.1(a-­‐c)	  and	  2.2(a-­‐c),	   the	  model	  predictions	  were	   in	  good	  
agreement	  with	  the	  experimental	  data	  describing	  ibuprofen	  and	  ketoprofen	  by	  
all	  three	  activated	  sludges.	  The	  estimated	  values	  of	  the	  parameters	  are	  shown	  
in	   Table	   2.1,	   and	   were	   used	   to	   describe	   both	   initial	   concentration	   levels	  
simultaneously	   for	   each	   compound	   at	   each	   plant,	   both	   when	   they	   were	   fed	  





Table	  2.1.	  Parameter	  values	  used	  for	  model	  simulation	  of	  the	  degradation	  of	  ibuprofen	  
and	  ketoprofen	  by	  activated	  sludge.	  
	  
Parameter	   Beirolas	  WWTP	   Setúbal	  WWTP	  
Fernão	  Ferro	  
WWTP	  
a	  ibuprofen	  (L	  g-­‐1)	   1.46	  ±	  0.18	   1.76	  ±	  0.45	   1.61	  ±	  0.45	  
a	  ketoprofen	  (L	  g-­‐1)	   1.21	  ±	  0.40	   0.96	  ±	  0.13	   3.12*	  
b	  ibuprofen	  (h-­‐1)	   2.95	  ±	  0.22	   1.27	  ±	  0.09	   1.04	  ±	  0.11	  
b	  ketoprofen	  (h-­‐1)	   0.52	  ±	  0.12	   0.32	  ±	  0.03	   0.25*	  
c	  ibuprofen	  (h)	   1.34	  ±	  0.08	   5.46	  ±	  0.33	   4.67	  ±	  0.48	  
c	  ketoprofen	  (h)	   5.88	  ±	  1.18	   14.7	  ±	  0.91	   21.81*	  
k1	  ibuprofen	  (L	  g
-­‐1	  h-­‐1)	   4.31	  ±	  0.89	   2.23	  ±	  0.77	   1.67	  ±	  0.69	  
k1	  ketoprofen	  (L	  g
-­‐1	  h-­‐1)	   0.63	  ±	  0.40	   0.31	  ±	  0.07	   -­‐	  
L	  ibuprofen	  (h)	   0.66	  ±	  0.13	   3.89	  ±	  0.45	   2.75	  ±	  0.71	  
L	  ketoprofen	  (h)	   2.03	  ±	  2.03	   8.45	  ±	  1.56	   -­‐	  
*The	  parameter	  estimator	  in	  Aquasim	  was	  unable	  to	  converge,	  therefore	  the	  standard	  deviations	  
for	  these	  experiments	  could	  not	  be	  estimated.	  
	  
As	   shown	   in	   Figures	   2.1	   and	   2.2,	   the	  model	   predicted	   well	   the	   experimental	  
data,	   with	   the	   only	   exceptions	   being	   the	   tests	   where	   ketoprofen	   was	   fed	   to	  
Fernão	   Ferro	   sludge	   at	   250	   μg	   L-­‐1.	   Indeed,	   these	   tests	   (Figure	   2.2c)	  were	   the	  
only	  tests	   that	  showed	  a	  different	  behaviour,	  as	   the	  sigmoidal	   trend	  of	  NSAID	  
biodegradation	   was	   less	   pronounced	   at	   this	   initial	   ketoprofen	   concentration.	  
While	   the	   reason	   for	   this	   difference	   is	   unclear,	   one	   possibility	   is	   that	   this	  
concentration	   of	   ketoprofen	  was	   inhibitory	   for	   this	   particular	   sludge,	   thereby	  
affecting	  its	  behaviour.	  
	  
Table	   2.1	   also	   shows	   the	   k1	   and	   L	   values	   for	   each	   test	   performed	  with	   the	   3	  
sludges.	  For	  all	  WWTP	  sludges,	  the	  k1	  was	  significantly	  higher	  and	  the	  L	  values	  
were	  significantly	   lower	  for	   ibuprofen	  degradation	  as	  compared	  to	  ketoprofen	  
degradation.	  It	  is	  clear	  that	  the	  Beirolas	  sludge	  displayed	  significant	  advantages	  
as	   compared	   to	   the	   other	   2	  WWTPs.	   The	   lag	   phase	   was	   significantly	   shorter	  
with	   respect	   to	   both	   ibuprofen	   and	   ketoprofen	   biodegradation,	   and	   the	  





sludge	   required	   far	   less	   operational	   time	   to	   degrade	   both	   ibuprofen	   and	  
ketoprofen	  (Figure	  2.1	  and	  2.2),	  mainly	  due	  to	  the	  fact	  that	  the	  lag	  phase	  was	  
generally	  >4	  times	  shorter	  with	  this	  sludge	  as	  compared	  to	  the	  other	  2	  plants	  
for	  both	  NSAIDs.	  
	  
The	   different	   kinetic	   properties	   observed	   could	   be	   related	   to	   the	   different	  
microbial	  communities	  in	  each	  treatment	  plant.	  However,	  it	  was	  not	  clear	  from	  
the	   aforementioned	   experiments	   if	   the	   lag	   phase	   found	   for	   NSAID	  
biodegradation	  was	   due	   to	   the	   acclimation	   of	   degrading	  microorganisms	   and	  
coupled	  with	  their	  growth,	  as	  proposed	  by	  Chong	  (2009),	  or	  if	  it	  was	  rather	  due	  
to	  the	  induction	  and	  expression	  of	  the	  necessary	  NSAID-­‐degrading	  enzymes	  by	  
the	   same	   microbial	   community.	   For	   this	   reason,	   further	   experiments	   were	  
carried	   out	   to	   isolate	   ibuprofen	   and	   ketoprofen	   degraders,	  where	   one	   of	   the	  
isolates	   was	   characterised	   with	   respect	   to	   its	   NSAID	   degradation	   kinetics.	  
Unlike	   the	   activated	   sludge	   experiments,	   where	   the	   concentration	   of	   NSAID	  
degraders	   could	   not	   be	   measured,	   the	   growth	   of	   ibuprofen	   degraders	   could	  
readily	  be	  monitored	  throughout	  the	  pure	  culture	  experiments.	  
Isolation	  of	  putative	  ibuprofen	  and	  ketoprofen	  degrading	  organisms	  
Since	  Beirolas	  sludge	  was	  shown	  to	  have	  the	  best	  NSAID	  degradation	  kinetics	  in	  
the	   previous	   experiments,	   this	   sludge	   was	   used	   to	   obtain	   NSAID	   degrading	  
isolates	   through	   plating	   in	   NSAID-­‐containing	   agar.	   Sixty-­‐five	   microorganisms	  
were	  isolated,	  where	  twelve	  isolates	  were	  able	  to	  degrade	  either	  ibuprofen	  or	  
ketoprofen.	  The	  identification	  and	  NSAID	  removal	  efficiency	  of	  each	  isolate	  are	  
presented	  in	  Table	  2.2.	  It	  was	  the	  first	  time	  that	  each	  of	  these	  microorganisms	  
were	   reported	   as	   being	   capable	   of	   degrading	   either	   ibuprofen	  or	   ketoprofen.	  
While	   the	   isolates	   identified	   in	   this	   study	  were	   obtained	   from	  WWTP	   sludge,	  





study	  is	  needed	  in	  order	  to	  characterise	  and	  identify	  the	  microbial	  populations	  
responsible	  for	  PhAC	  biodegradation	  in	  WWTPs.	  
	  
Table	  2.2.	  Phylogenetic	  affiliation	  of	   isolates	  and	  their	  ability	   to	  degrade	   ibuprofen	  or	  




The	  biodegradation	  of	  ibuprofen	  by	  a	  pure	  culture	  	  
	  
The	   bacterial	   isolate	   I11	   showed	   the	   highest	   NSAID	   removal	   capacity	   as	  
compared	   to	   the	   other	   isolates	   (Table	   2.2),	   and	   was	   thus	   chosen	   for	   further	  
characterisation.	  
	  
The	   kinetics	   of	   degradation	   of	   ibuprofen	   by	   I11	   was	   assessed	   in	   this	   study	  
through	   a	   series	   of	   batch	   tests	   using	   either	   different	   initial	   ibuprofen	  
concentrations	   or	   different	   levels	   of	   additional	   carbon	   sources	   (yeast	   extract	  
and	   tryptone).	  Varying	   the	  carbon	  source	  addition	  was	  necessary	   to	   influence	  
the	  corresponding	  level	  of	  biomass	  growth	  by	  the	  isolate	  (Figure	  2.3),	  allowing	  







I2	   100	   Gordonia	  amicalis	   EU266486.1	   -­‐	   26	  
I4	   99	   Acinetobacter	  bouvetii	   JF681285	   -­‐	   12.8	  
I5	   99	   Paracoccus	  aminophilus	   NR_042715.1	   -­‐	   16.2	  
I11	   97	   Patulibacter	  americanus	   NR_042369	   -­‐	   35	  
K1	   100	   Methylobacterium	  populi	   NR_029082.1	   12	   -­‐	  
K3	   99	   Gordonia	  hydrophobica	   NR_026254.1	   22	   -­‐	  
K11	   100	   Tsukamurella	  spumae	   NR_042800.1	   20.6	   -­‐	  
K12	   99	   Paracoccus	  aminovorans	   NR_025857.1	   14.1	   -­‐	  
K13	   99	   Rhodococcus	  qingshengii	   NR_043535.1	   13.6	   -­‐	  
KA1	   100	   Gordonia	  terrae	   NR_037022.1	   15.3	   -­‐	  
KA2	   99	   Rhodococcus	  zopfii	   NR_041775.1	   14.9	   -­‐	  









Figure	   2.3.	   I11	   growth	   profile	   (g	   L-­‐1	   TSS)	   in	   the	   presence	   of	   250	   µg	   L-­‐1	   ibuprofen	   at	  
different	  concentrations	  of	  yeast	  extract	  and	  tryptone.	  	  
	  
	  
Unlike	   the	   experiments	   with	   activated	   sludge,	   the	   degradation	   of	   ibuprofen	  
began	  immediately	  after	  its	  addition	  to	  the	  medium	  without	  a	  lag	  phase	  (Figure	  
2.4).	  	  There	  was	  no	  biodegradation	  activity	  in	  the	  autoclaved	  and	  abiotic	  control	  
tests,	  confirming	  that	  the	  degradation	  activity	  was	  biologically	  mediated.	  
	  
I11	   was	   not	   able	   to	   use	   ibuprofen	   as	   the	   sole	   carbon	   source,	   although	  
degradation	   was	   observed	   in	   the	   presence	   of	   other	   carbon	   sources,	  
concomitantly	  with	  cell	  growth.	  In	  previous	  studies,	  two	  bacterial	  strains	  were	  
described	  as	  being	  able	  to	  utilise	  ibuprofen,	  a	  Norcardia	  sp.	  (Rosazza	  and	  Chen,	  
1994)	  and	  Sphingomonas	   Ibu-­‐2	  (Murdoch	  and	  Hay,	  2005).	  Only	  Sphingomonas	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Figure	   2.4.	   Predicted	   values	   (lines)	   and	   experimental	   values	   (symbols)	   for	   the	  
degradation	   of	   ibuprofen	   by	   the	   isolate	   I11	   at	   different	   initial	   concentrations	   of	  
tryptone	  and	  yeast	  extract.	  	  
R2	  =	  0.95	  between	  experimental	  values	  and	  model	  predictions.	  
	  
	  
Additionally,	   the	   effect	   of	   initial	   ibuprofen	   concentration	   on	   the	   degradation	  
performance,	  as	  sole	  carbon	  source	  or	  in	  the	  presence	  of	  other	  carbon	  sources	  
was	  investigated.	  After	  323	  h	  of	  incubation,	  I11	  was	  able	  to	  reduce	  28	  %	  and	  50	  
%	  of	  1000	  μg	   L-­‐1	   and	  250	  μg	   L-­‐1	  of	   ibuprofen,	   respectively	   (Figure	  2.5).	  At	   the	  
highest	   initial	  concentration	  of	   ibuprofen,	   the	  maximum	  degradation	  rate	  was	  
1.97	  μg	  L-­‐1	  h-­‐1,	  which	  is	  substantially	  higher	  than	  the	  0.88	  μg	  L-­‐1	  h-­‐1	  observed	  at	  
250	  μg	  L-­‐1.	  This	  shows	  that	   the	   ibuprofen	  degradation	  rate	  was	  dependent	  on	  
the	   ibuprofen	   initial	   concentration,	   similarly	   to	   what	   was	   observed	   in	   the	  
activated	  sludge	  experiments.	  	  
Moreover,	  it	  was	  shown	  that	  the	  degradation	  rate	  of	  ibuprofen	  increased	  with	  
an	  increase	  in	  the	  initial	  concentration	  of	  yeast	  extract	  and	  tryptone	  (Table	  2.3),	  





























Figure	   2.5.	   Predicted	   values	   (lines)	   and	   experimental	   values	   (symbols)	   for	   ibuprofen	  
degradation	  by	  the	  isolate	  I11	  at	  two	  initial	  concentrations	  (250	  µg	  L-­‐1	  and	  1000	  µg	  L-­‐1).	  
R2	  =	  0.97	  between	  experimental	  values	  and	  model	  predictions.	  
	  
	  
Table	   2.3.	   Ibuprofen	   and	   biomass	   maximum	   degradation	   rates	   at	   different	   initial	  




The	  simultaneous	  utilisation	  of	  supplemental	  carbon	  sources	  with	  a	  compound	  
that	  is	  less	  energetic	  (e.g.	  ibuprofen)	  may	  sustain	  cell	  growth	  and	  maintenance,	  
facilitating	   biodegradation	   of	   that	   compound.	   A	   similar	   effect	   was	   observed	  
during	   the	   degradation	   of	   nitrilotriacetic	   acid	   (NTA)	   by	   the	   bacterial	   strain	  
Chelatobacter	   heintzii,	   where	   a	   higher	   glucose	   fraction	   led	   to	   faster	   NTA	  




















Experiment	   0.5	  g	  L-­‐1	   1	  g	  L-­‐1	   2	  g	  L-­‐1	   3	  g	  L-­‐1	   5	  g	  L-­‐1	  
Maximum	  degradation	  
rate	  (µg	  L-­‐1	  h-­‐1)	   0.36	   0.53	   0.98	   1.25	   1.24	  
Maximum	  biomass	  growth	  





using	  a	  mixed	  culture	  degrading	  the	  xenobiotic	  herbicide	  propanil,	  where	  faster	  
propanil	  degradation	  was	  observed	  with	  propionate	  addition.	  
	  
From	  Table	   2.3,	   it	   can	   be	   observed	   that	  while	   the	  maximum	   cell	   growth	   rate	  
continued	   to	   increase	  with	   increasing	   initial	   carbon	   source	   concentration,	   the	  
maximum	  ibuprofen	  degradation	  rate	  in	  each	  test	  approached	  a	  plateau	  at	  1.25	  
μg	   L-­‐1	   h-­‐1,	   obtained	   using	   an	   initial	   ibuprofen	   concentration	   of	   250	   μg	   L-­‐1.	  
Nevertheless,	   a	   higher	   maximum	   degradation	   rate	   was	   obtained	   for	   a	  
concentration	   of	   1000	   μg	   L-­‐1	   of	   ibuprofen.	   This	   shows	   that	   the	   ibuprofen	  
degradation	  rate	  by	  I11	  is	  simultaneously	  dependant	  on	  the	  growth	  rate	  as	  well	  
as	  the	  ibuprofen	  concentration.	  	  
	  
Modelling	  the	  biodegradation	  of	  ibuprofen	  by	  a	  pure	  culture	  
	  
Since	   the	   biodegradation	   of	   ibuprofen	   by	   a	   pure	   culture	   showed	   different	  
behaviour	   as	   compared	   to	   activated	   sludge,	   the	   equation	   describing	   NSAID	  













where	   k2	   represents	   the	   ibuprofen	   degradation	   rate	   constant,	   So	   is	   the	   initial	  
concentration	   of	   ibuprofen	   present	   in	   the	   media,	   dX/dt	   represents	   the	   cell	  
growth	   rate,	   and	   z	   is	   an	   inhibition	   constant.	   The	   constants	   ‘k2’	   and	   ‘z’	   were	  
estimated	   using	   non-­‐linear	   regression	   fitting	   to	   the	   experimental	   data	   using	  
Aquasim	   (Reichert,	   1994).	   The	   simultaneous	   parameter	   estimation	   for	   both	  
constants	  utilised	  the	  experimental	  data	  of	  the	  five	  tests	  at	  the	  different	  initial	  





Table	  2.4.	  Parameter	  values	  used	  for	  model	  simulation	  of	  the	  degradation	  of	  ibuprofen	  
by	  the	  isolate	  I11.	  
	  
Parameter	   k2	  (µg	  g
-­‐1	  h-­‐1)	   z	  
Value	   2.76	  ±	  0.17	   65.7	  ±	  6.41	  
	  
Since	  the	  degradation	  of	  ibuprofen	  was	  found	  to	  only	  occur	  during	  the	  biomass	  
growth	   phase,	   equation	   2.4	   is	   dependent	   on	   the	   rate	   of	   biomass	   growth.	  
Furthermore,	   since	   the	   ibuprofen	   degradation	   rate	   was	   found	   to	   approach	   a	  
maximum	  at	  high	  biomass	  growth	  rates,	   it	  was	  necessary	   to	  add	  an	   inhibition	  
function	  that	  regulated	  this	  effect.	  This	  was	  achieved	  through	  the	  exponential	  
term	  in	  equation	  2.4.	  
	  
The	  model	  predictions	  and	  the	  experimental	  data	  for	  ibuprofen	  degradation	  by	  
I11	   are	   shown	   in	   Figure	   2.4.	   The	  model	  was	   able	   to	   describe	  well	   the	   trends	  
observed	   in	   each	   of	   the	   5	   tests.	   Furthermore,	   the	   model	   was	   applied	   to	  
describe	   the	   two	  tests	   fed	  with	  different	   ibuprofen	  concentrations	   (250	  μg	  L-­‐1	  
and	   1000	   μg	   L-­‐1)	   without	   changing	   any	   of	   the	  model	   parameters,	   in	   order	   to	  
validate	   the	  model.	   The	   results	   are	   shown	   in	   Figure	   2.5,	   whereby	   the	  model	  
also	  describes	  well	  the	  experimental	  data.	  
	  
It	   is	   clear	   from	   the	   results	   of	   this	   study	   that	   it	  was	   not	   possible	   to	   develop	   a	  
universal	  model	  to	  describe	  NSAID	  biodegradation	  by	  both	  activated	  sludge	  as	  
well	   as	   pure	   cultures,	   despite	   the	   fact	   that	   the	   same	   compounds	   were	   used	  
under	  similar	  environmental	  conditions.	  Furthermore,	  the	  differences	  observed	  
between	   xenobiotic	   biodegradation	   profiles	   reported	   in	   literature	   (Chong,	  
2009;	  Collado	  et	  al.,	  2012;	  Joss	  et	  al.,	  2006;	  Lust	  et	  al.,	  2012;	  Plósz	  et	  al.,	  2010;	  
Quintana	   et	   al.,	   2005)	   support	   the	   hypothesis	   that	   the	   applicability	   of	   PhAC	  





the	  loading	  rate	  of	  these	  compounds.	  When	  applied	  towards	  different	  WWTPs,	  
biodegradation	  models	  may	   require	   adaptation	   to	  describe	  different	   systems,	  
where	  model	  validation	  will	  be	  of	  high	  importance	  in	  these	  situations.	  Further	  
model	   development	   is	   recommended	   for	   the	   future	   in	   order	   to	   successfully	  
optimise	  PhAC	  biodegradation	  from	  WWTPs.	  This	  study	  advances	  our	  ability	  to	  
describe	   PhAC	   biodegradation	   and	   provides	   useful	   modelling	   options	   that	  
should	  be	  considered	  during	  future	  applications.	  
Conclusions	  
Iburofen	   and	   ketoprofen	   biodegradation	   kinetics	   were	   investigated	   using	  
activated	   sludge	   from	   three	   different	  WWTPs.	   A	   similar	   profile	  was	   observed	  
with	   each	   sludge,	   where	   a	   lag	   phase	   was	   found	   to	   occur	   prior	   to	   NSAID	  
biodegradation,	  and	  when	  the	  two	  NSAIDs	  were	  simultaneously	  supplied,	  their	  
removal	  was	   independent	   from	   the	   other.	   This	   activated	   sludge	   performance	  
was	  described	  using	  a	  model	  where	  the	  degradation	  rate	  was	  a	  function	  of	  the	  
NSAID	   concentration.	   Twelve	   ibuprofen/ketoprofen	   degrading	   isolates	   were	  
identified	  from	  one	  of	  the	  WWTP.	  The	  ibuprofen	  biodegradation	  kinetics	  of	  one	  
of	  these	  isolates	  (I11)	  was	  shown	  to	  be	  dependent	  on	  the	  biomass	  growth	  rate	  
as	   well	   as	   the	   NSAID	   concentration,	   which	   was	   incorporated	   in	   a	   different	  
model.	   Overall,	   this	   work	   provides	   a	   step	   forward	   towards	   describing	   PhAC	  
removal	   in	   WWTPs.	   The	   behaviour	   of	   NSAID	   removal	   may	   be	   subject	   to	  
variation	   between	   WWTPs,	   thus	   PhAC	   biodegradation	   models	   may	   require	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A	   Gram-­‐positive,	   aerobic,	   non-­‐motile,	   non-­‐endospore-­‐forming	   rod	   with	  
ibuprofen	   degrading	   capacity,	   designated	   I11T,	   was	   isolated	   from	   activated	  
sludge	  from	  a	  wastewater	  treatment	  plant.	  The	  major	  respiratory	  quinone	  was	  
demethylmenaquinone	   DMK-­‐7,	   C18:1	   CIS	   9	   was	   the	   predominant	   fatty	   acid,	  
phosphatidylglycerol	  was	   the	   predominant	   polar	   lipid,	   the	   cell	  wall	   contained	  
meso-­‐diaminopimelic	  acid	  as	  the	  diagnostic	  diamino	  acid	  and	  the	  G+C	  content	  
of	  the	  genomic	  DNA	  was	  74.1	  mol%.	  On	  the	  basis	  of	  16S	  rRNA	  gene	  sequence	  
analysis,	   the	   closest	   phylogenetic	   neighbours	   of	   strain	   I11T	   were	   Patulibacter	  
ginsengiterrae	   CECT	   7603T	   (96.8	   %),	   Patulibacter	   minatonensis	   DSM	   18081T	  
(96.6	   %),	   and	   Patulibacter	   americanus	   DSM	   16676T	   (96.6	   %).	   The	   phenotypic	  
characterisation	   supports	   the	   inclusion	   of	   strain	   I11T	   within	   the	   genus	  
Patulibacter.	  However,	   distinctive	   features	   and	   the	   16S	   rRNA	   gene	   sequence	  
analysis	   suggest	   the	   proposal	   of	   a	   new	   species.	   Therefore,	   the	   name	  
Patulibacter	  medicamentivorans	  sp.	  nov.	  is	  proposed,	  and	  the	  type	  strain	  is	  I11T	  








Biodegradation	   of	   pharmaceutically	   active	   compounds	   (PhACs),	   such	   as	  
ibuprofen,	   has	   been	   an	   increasing	   concern	   in	   recent	   years	   due	   to	   their	  
detection	   in	   natural	   matrices	   such	   as	   soil,	   sediments	   and	   water	   and	   to	   their	  
potential	   risk	   to	   the	   environment	   and	   health	   of	   living	   beings	   (Santos	   et	   al.,	  
2010).	  The	  presence	  of	  ibuprofen,	  a	  non-­‐steroidal	  anti-­‐inflammatory	  drug,	  and	  
other	  PhACs	  in	  the	  environment	  is	  mostly	  due	  to	  their	  inefficient	  removal	  from	  
wastewater	   treatment	   plants	   (WWTP).	   Microbial	   degradation	   plays	   an	  
important	   role	   in	   wastewater	   treatment	   processes	   and	   several	   studies	   are	  
being	  conducted	  in	  order	  to	  understand	  and	  improve	  microbial	  degradation	  of	  
PhACs	  in	  WWTP	  (Ying	  et	  al.,	  2009;	  Onesios	  et	  al.,	  2009;	  Salgado	  et	  al.,	  2012).	  	  
	  
The	  strain	  described	  in	  this	  study,	  designated	  I11T,	  was	  isolated	  from	  activated	  
sludge	  of	  Beirolas	  WWTP	  (Lisbon,	  Portugal).	  Although	  sharing	  some	  phenotypic	  
and	  phylogenetic	  characteristics	  with	  members	  of	  the	  genus	  Patulibacter,	  strain	  
I11T	   could	   not	   be	   affiliated	   to	   any	   of	   its	   described	   species.	   The	   genus	  
Patulibacter	  was	   first	   proposed	   by	   Takahashi	   et	   al.	   (2006)	   with	   Patulibacter	  
minatonensis	   and	   further	   emended	   by	   Reddy	   and	   Garcia-­‐Pichel	   (2009)	   to	  
include	   Patulibacter	   americanus.	   Recently,	   Patulibacter	   ginsengiterrae	   was	  
isolated	   from	   a	   ginseng	   field	   (Kim	   et	   al.,	   2012a)	   and	   characterised	   as	   a	   new	  
species	  belonging	  to	  the	  genus	  Patulibacter.	  Based	  on	  a	  polyphasic	  taxonomic	  










Materials	  and	  Methods	  
	  
Activated	  sludge	  (3	  g	  L-­‐1)	  collected	  from	  Beirolas	  WWTP	  (Lisbon,	  Portugal)	  was	  
inoculated	   in	  minimal	  medium	   (Oehmen	  et	  al.,	   2009)	   supplemented	  with	  500	  
μg	  L-­‐1	  of	   ibuprofen	  as	   the	  only	   carbon	  source	  and	  grown	  at	  28	   °C	  on	  a	   rotary	  
shaker	   at	   110	   r.p.m.	   for	   approximately	   15	   days.	  Within	   this	   period	   of	   time,	   a	  
new	  ibuprofen	  addition	  was	  carried	  out	  whenever	  all	  the	  parent	  compound	  had	  
been	   removed	   from	   the	  medium,	   as	   determined	   by	   high	   performance	   liquid	  
chromatography	   (Almeida	   et	   al.,	   2012).	   After	   15	   days	   the	   enrichment	   culture	  
was	   serially	   diluted	   by	   a	   series	   of	   ten-­‐fold	   dilutions	   in	   sterile	   saline	   solution	  
(0.85	   %	   NaCl,	   w/v)	   and	   streaked	   on	   agar	   plates	   containing	   minimal	   medium	  
supplemented	  with	  250	  μg	  L-­‐1	  of	   ibuprofen	  and	  15	  g	  L-­‐1	  agar.	  After	  1	  week	  of	  
incubation	   at	   28	   °C,	   all	   the	   colonies	  with	   distinct	  morphotypes	  were	   isolated	  
and	  purified	  on	   the	   same	  medium.	  Among	   the	   isolated	  organisms,	   strain	   I11T	  
showed	  higher	  ibuprofen	  degradation	  capacity.	  Strain	  I11T	  was	  stored	  in	  culture	  
medium	   supplemented	   with	   20	   %	   glycerol	   at	   -­‐80	   °C.	   For	   the	   experiments	  
reported	   in	   this	   study,	   strain	   I11T	  was	   subcultured	   in	  Tryptic	   Soya	  Broth	   (TSB,	  
Oxoid)	  or	  on	  Tryptic	  Soya	  Agar	  (TSA,	  Oxoid),	  at	  28	  °C	  for	  3	  days,	  unless	  stated	  
otherwise.	   Type	   strains	   Patulibacter	   minatonensis	   DSM	   18081T,	   Patulibacter	  
americanus	  DSM	  16676T	  and	  Patulibacter	  ginsengiterrae	  CECT	  7603T	  were	  used	  
for	  comparison	  purposes	  under	  identical	  growth	  conditions.	  	  
	  
The	   colony	   and	   cell	   morphology,	   Gram-­‐staining,	   cytochrome	   c	   oxidase	   and	  
catalase	  tests,	  production	  of	  endospores	  and	  motility	  were	  analysed	  based	  on	  
the	  methodologies	  of	  Murray	  et	   al.	   (1994)	  and	  Smibert	   and	  Krieg	   (1994).	   The	  
temperature	   (4,	   10,	   15,	   20,	   25,	   27,	   30,	   32,	   37,	   39,	   42,	   45	   and	   48	   ºC),	   salinity	  
(1.5,	   2.5,	   3.5,	   5.5,	   7.5	   and	   10	   %	   (w/v)	   of	   NaCl)	   and	   pH	   ranges	   (5-­‐9	   with	  





turbidity	  (600	  nm)	  of	  cultures	  grown	  in	  50	  mL	  falcon	  tubes	  containing	  5	  mL	  TSB,	  
and	  incubated	  at	  32	  ºC.	  The	  pH	  of	  the	  TSB	  medium	  was	  adjusted	  using	  MES	  (pH	  
5.0-­‐6.0),	  MOPS	  (pH	  6.0-­‐8.0)	  and	  CAPS	  (pH	  8.0-­‐9.0)	  and	  further	  sterilised	  using	  a	  
0.2	  μm	  Whatman	  filter.	  
	  
Antibiotic	   susceptibility	   was	   determined	   by	   the	   Kirby-­‐Bauer	   disk	   diffusion	  
method	   (Bauer	   et	   al.,	   1966),	   using	   antibiotic	   disks	   from	  Oxoid	   containing	   the	  
following	  (μg):	  ampicillin	  (10),	  amikacin	  (30),	  aztreonam	  (30),	  bacitracin	  (10	  U),	  
ceftriaxone	   (30),	   ciprofloxacin	   (5),	   ceftazidime	   (30),	   chloramphenicol	   (30),	  
erythromycin	   (15),	   gentamicin	   (10),	   novobiocin	   (30),	   polymyxin	   B	   (300	   U),	  
tetracycline	  (30)	  and	  vancomycin	  (30).	  Additional	  physiological	  and	  biochemical	  
characteristics	   were	   determined	   using	   API	   20NE	   and	   API	   ZYM	   test	   strips	  
(bioMérieux),	   and	   GP2	   microplate	   from	   the	   Biolog	   identification	   system,	  
according	  to	  the	  manufacturer’s	  instructions.	  
	  
The	   polar	   lipids	   were	   analysed	   as	   described	   previously	   (Vaz-­‐Moreira	   et	   al.,	  
2007)	   using	   the	   methods	   of	   Manaia	   et	   al.	   (2004).	   Isoprenoid	   quinones	   were	  
extracted	   and	   purified	   as	   described	   by	   Collins	   et	   al.	   (1977)	   and	   analysed	   by	  
HPLC	  and	  electron-­‐impact	  mass	  spectrometry	  (320	  Singlequad	  equipped	  with	  a	  
direct	   insertion	   probe,	   Varian)	   as	   described	   by	   Yi	   et	   al.	   (2007).	   	   Cellular	   fatty	  
acids	  were	  extracted	  from	  cells	  cultivated	  on	  TSA	  at	  28	  °C.	  Strain	   I11T	  and	  the	  
three	   reference	   strains	   grew	   similarly	   well	   and	   provided	   sufficient	   cells	   of	  
comparable	  physiological	  age	  from	  the	  third	  streak	  quadrant	  of	  the	  plates	  after	  
cultivation	   under	   the	   given	   conditions	   for	   72	   hours.	   Fatty	   acid	  methyl	   esters	  
were	  obtained	  following	  the	  method	  of	  Stead	  et	  al.	   (1992)	  and	  were	  analysed	  
by	   gas	   chromatography	   using	   the	   Microbial	   Identification	   System	   (MIDI,	  
Sherlock	   Version	   6.1;	   database,	   ACTIN6;	   gas	   chromatograph,	   model	   6890N,	  





GC/MS	   (320	   Singlequad	   equipped	   with	   a	   gas	   chromatograph	   CP-­‐3800	   and	   a	  
column	  VF-­‐5ms	  [30m	  x	  0.25	  mm	  I.D.,	  film	  thickness	  0.25	  µm],	  Varian).	  The	  cell	  
wall	  diamino	  acid	  of	  strain	  I11T	  was	  determined	  from	  whole-­‐cell	  hydrolysates	  as	  
described	  by	  Hasegawa	  and	  Takizawa	  (1983).	  
	  
Both,	  16S	  rRNA	  gene	  sequence	  and	  the	  G+C	  content	  value	  were	  obtained	  from	  
the	   whole	   genome	   sequencing	   of	   I11T	   strain	   (Almeida	   et	   al.,	   2012).	   The	  
identification	  of	  phylogenetic	  neighbours	  was	  initially	  carried	  out	  by	  the	  BLAST	  
(Altschul	  et	  al.,	  1997)	  and	  megaBLAST	  (Zhang	  et	  al.,	  2000)	  programs	  against	  the	  
database	  of	   type	   strains	  with	   validly	   published	  prokaryotic	   names	   (Kim	  et	   al.,	  
2012b).	  The	  top	  thirty	  sequences	  with	  the	  highest	  scores	  were	  then	  selected	  for	  
the	   calculation	   of	   pairwise	   sequence	   similarity	   using	   global	   alignment	  
algorithm,	   which	   was	   implemented	   at	   the	   EzTaxon-­‐e	   server	   (http://eztaxon-­‐
e.ezbiocloud.net/;	   Kim	   et	   al.,	   2012b).	   Phylogenetic	   analysis	   was	   performed	  
using	  MEGA	  version	  5	  (Tamura	  et	  al.,	  2011).	  Sequence	  similarity	  was	  estimated	  
using	  the	  model	  of	  Jukes	  and	  Cantor	  (1969)	  and	  values	  were	  used	  to	  construct	  
the	   phylogenetic	   tree	   by	   the	   neighbour-­‐joining	   method.	   Tree	   stability	   was	  
assessed	   by	   comparison	   with	   other	   trees	   constructed	   with	   the	   maximum	  
parsimony	   and	   maximum-­‐likelihood	   methods.	   Bootstrap	   analysis	   was	  
performed	  employing	  1000	  re-­‐samplings.	  A	  total	  of	  1296	  nucleotide	  positions	  in	  
each	   16S	   rRNA	   gene	   were	   included	   in	   the	   analysis.	   Non-­‐homologous	   and	  
ambiguous	  nucleotide	  positions	  were	  excluded	  from	  the	  calculations.	  
	  
Results	  and	  Discussion	  
	  
After	   3	   days	   on	   TSA	   at	   28	   °C,	   strain	   I11T	   formed	   irregular,	   semi-­‐translucent	  
creamy	  white	   colonies	  with	   undulate	  margins,	   and	  1-­‐2	  mm	   in	   diameter.	   Cells	  





non-­‐spore	  forming	  rods.	  Growth	  was	  not	  observed	  below	  20	  °C	  or	  above	  39	  °C,	  
with	  an	  optimum	  at	  around	  32	  °C.	  Good	  growth	  occurred	  at	  pH	  6.0-­‐7.5.	  Growth	  
with	   more	   than	   1.5	   %	   salinity	   was	   not	   observed.	   Strain	   I11T	   degraded	  
ibuprofen.	  Other	  phenotypic	  characteristics	  were	  summarized	  in	  Table	  3.1	  and	  
in	  the	  species	  description.	  
	  
The	   complete	   16S	   rRNA	   gene	   sequence	   (1541nt)	   obtained	   from	   the	   whole	  
genome	  sequencing	  of	  strain	  I11T	  and	  determined	  using	  RNAmmer	  (Almeida	  et	  
al.,	   2012)	   shared	   sequence	   similarities	   of	   96.8	  %	  with	  P.	   ginsengiterrae	  CECT	  
7603T,	   96.6	   %	   with	   P.	   minatonensis	   DSM	   18081T	   and	   P.	   americanus	   DSM	  
16676T,	   and	   93	   %	   or	   less,	   with	   other	   Rubrobacteriales	   members.	   The	  
neighbour-­‐joining	   tree	   placed	   I11T	   in	   a	   cluster	   within	   the	   genus	   Patulibacter	  
(Figure	   3.1)	   but	   with	   a	   distinct	   position	   suggesting	   that	   the	   novel	   strain	  
deserves	   a	   separate	   species	   status.	   Since	   it	   has	   been	   observed	   that	   strains	  
belonging	   to	   the	   same	   species	   share	   commonly	   >	   97	   %	   16S	   rRNA	   gene	  
sequence	   similarity	   (Stackebrandt	   and	  Goebel,	   1994;	   Tindall	   et	   al.,	   2010)	   and	  
the	  sequence	  similarity	  between	  strain	   I11T	  and	  the	  other	  type	  strains	  did	  not	  
exceed	   this	   value,	   DNA-­‐DNA	   hybridisation	   was	   not	   conducted	   for	   species	  
delineation	  in	  this	  study.	  
	  
The	  inclusion	  of	  strain	  I11T	  within	  the	  genus	  Patulibacter	  is	  supported	  by	  some	  
genotypic	   and	   chemotaxonomic	   features.	   Indeed,	   the	   genomic	   DNA	   G+C	  
content	  of	  I11T	  strain	  was	  74.1	  mol%,	  which	  fell	  within	  the	  range	  of	  72-­‐75	  mol%	  
observed	   for	   the	   other	   species	   of	   this	   genus	   (Kim	   et	   al.,	   2012a).	   The	  
peptidoglycan	   diamino	   acid	   of	   strain	   I11T	   was	  meso-­‐diaminopimelic	   acid	   and	  
the	  predominant	  cellular	  fatty	  acid	  was	  C18:1	  CIS	  9	  (46.4	  %,	  Table	  3.2),	  similar	  to	  
other	  Patulibacter	  members	   (Takahashi	   et	   al.,	   2006;	  Reddy	   and	  Garcia-­‐Pichel,	  





Table	  3.1.	  Distinctive	  characteristics	  of	  the	  strain	   I11T	  and	  of	  the	  other	  type	  strains	  of	  
Patulibacter	  species.	  
	  
Strains:	  P.	  ginsengiterrae	  CECT	  7603T,	  P.	  americanus	  DSM	  16676T	  and	  P.	  minatonensis	  
DSM	   18081T.	   Data	   are	   from	   this	   study	   unless	   otherwise	   indicated.	   -­‐,	   Negative;	   +,	  
positive;	  v,	  variable	  and	  ND,	  no	  data	  available.	  
	  
	  










Colony	  pigmentation	   White	   White	   Pink	   Pale	  yellow	  
Motility	   -­‐	   +	   +	   +	  
pH	  range	  for	  growth**	   5.5-­‐8.0	   5.5-­‐9.0a	   5.0-­‐9.0b	   6.0-­‐8.0c	  
T	  range	  for	  growth	  
(ºC)**	   20-­‐39	   5-­‐37
a	   10-­‐30b	   16-­‐28c	  
3%	  NaCl	   -­‐	   +	   -­‐	   -­‐	  
Oxidase	   -­‐	   +	   -­‐	   -­‐	  
Nitrate	  reduction	   +	   -­‐	   -­‐	   -­‐	  
Tween	  40	   +	   +	   +	   -­‐	  
Tween	  80	   +	   +	   +	   -­‐	  
Carbon	  utilisation	   	   	   	   	  
	  	  L-­‐Alanine	   +	   -­‐*	   -­‐	   -­‐	  
	  	  D-­‐Arabitol	   +	   +*	   -­‐	   -­‐	  
	  	  L-­‐Arabinose	   -­‐	   +	   +*	   +	  
	  	  Citrate	   -­‐	   -­‐*	   -­‐	   -­‐	  
	  	  D-­‐Fructose	   +	   -­‐	   -­‐	   +	  
	  	  Gentiobiose	   +	   -­‐	   -­‐	   -­‐	  
	  	  Glycogen	   -­‐	   -­‐*	   -­‐	   -­‐	  
	  	  Ibuprofen	   +	   -­‐	   -­‐	   -­‐	  
	  	  Inositol	   -­‐	   -­‐*	   -­‐	   -­‐*	  
	  	  D-­‐mannitol	   -­‐	   +	   -­‐	   -­‐*	  
	  	  D-­‐mannose	   -­‐	   -­‐*	   +*	   +	  
	  	  D-­‐melibiose	   -­‐	   +	   -­‐*	   -­‐	  
	  	  D-­‐trehalose	   -­‐	   -­‐*	   -­‐	   -­‐	  
Enzymes	   	   	   	   	  
	  	  Alkaline	  phosphatase	   +	   -­‐	   +	   -­‐*	  
	  	  Cystine	  arylamidase	  	   +	   +	   -­‐	   -­‐	  
	  	  β-­‐glucosidase	   +	   -­‐	   -­‐	  	   -­‐	  
	  	  Urease	   -­‐	   -­‐*	   -­‐	   -­‐	  
Susceptibility	  	   	   	   	   	  
	  Bacitracin	   +	   -­‐	   +	   +	  















	  Chloramphenicol	   +	   +*	   +	   -­‐*	  
	  Tetracyclin	   -­‐	   -­‐	   +	   +	  
	  Isoprenoid	  quinone	   DMK-­‐7	   DMK-­‐7	   MK-­‐7(H2)	   DMK-­‐7	  
DNA	  G+C	  content	  
(mol%)**	   74.1	   74.6
a	   72.0b	   72.0c	  
*Differs	  from	  the	  original	  description.	  
**Data	  were	  taken	  from:	  a,	  Kim	  et	  al.	  (2012a);	  b,	  Reddy	  and	  Garcia-­‐Pichel	  (2009);	  c,	  







Figure	  3.1.	  Neighbour-­‐joining	  phylogenetic	  tree	  derived	  from	  16S	  rRNA	  gene	  sequences	  
(1296	   bp),	   showing	   the	   relationships	   of	   strain	   I11T	   with	   members	   of	   the	   genus	  
Patulibacter	  and	  other	  closest	  genera.	  	  
All	   the	   branches	   were	   also	   recovered	   by	   the	   maximum-­‐likelihood	   and	   maximum	  





Solirubrobacter pauli B33D1T (AY039806)
Solirubrobacter soli Gsoil 355T (AB245334)
Solirubrobacter ginsenosidimutans BXN5-15T (EU332825)
Conexibacter woesei DSM 14684T (AJ440237)
Conexibacter arvalis KV-962T (AB597950)
Patulibacter medicamentivorans I11T (AGUD01000068.1|:8968-10508) 
Patulibacter ginsengiterrae P4-5T (EU710748)
Patulibacter americanus CP177-2T (AJ871306)
Patulibacter minatonensis KV-614T (AB193261)
Thermoleophilum minutum ATCC 35268 (AJ458464)
Thermoleophilum album ATCC 35263T (AJ458462)
Gaiella occultaF2-233T (JF423906)
Rubrobacter radiotolerans JCM 2153T (U65647)
Rubrobacter xylanophilus DSM 9941T (CP000386)
Rubrobacter taiwanensis LS-293T (AF465803)



















The	   respiratory	  quinone	  extracted	   from	  strain	   I11T	  eluted	  by	  a	   retention	   time	  
shorter	   by	   5	   %	   than	   this	   of	   menaquinone	  MK-­‐7	   from	   Bacillus	   subtilis	   subsp.	  
subtilis	   DSM10T	   and	   was	   identified	   by	   mass	   spectrometry	   as	  
demethylmenaquinone	   DMK-­‐7	   (base	   peak	   211	   m/z,	   molecular	   ion	   636	   m/z).	  
DMK-­‐7	  represented	  92.2	  %	  of	  the	  sum	  of	  all	  integrated	  peaks.	  The	  area	  of	  other	  
five	  additional	  minor	  peaks,	  which	  could	  not	  be	  attributed	  to	  any	  menaquinone	  
standards	   used	   [MK-­‐5,	   MK-­‐6,	   MK-­‐7,	   MK-­‐8,	   MK-­‐7(H2),	   MK-­‐8(H2)	   or	   MK-­‐9(H2)],	  
varied	  between	  0.5	   and	  2.6	  %.	   The	  polar	   lipid	   profile	   of	   I11T	   consisted	  of	   the	  
major	   phosphatidylglycerol	   (PG),	   four	   unknown	   phospholipids	   (PL1-­‐PL4)	   and	  
small	   amounts	   of	   diphosphatidylglycerol	   (DPG)	   (Supplementary	   Figure	   7.1).	   A	  
similar	   polar	   lipid	   profile	   was	   described	   for	   Patulibacter	   gisengiterrae	   CECT	  
7603T	  (Kim	  et	  al.,	  2012a).	  
	  
The	   new	   species	   status	   of	   strain	   I11T	   was	   supported	   by	   other	   physiological,	  
biochemical	   and	   chemotaxonomic	   differences	   (Tables	   3.1	   and	   3.2).	   The	  
presence	   of	   demethylmenaquinone	   DMK-­‐7	   as	   the	   main	   respiratory	   quinone,	  
and	   the	   presence	   of	   higher	   proportion	   of	   C17:0	   10-­‐methyl	   in	   the	   fatty	   acids	  
profile	   of	   strain	   I11T	   are	   among	   these	   distinctive	   features.	   Based	   on	   these	  
differences	   strain	   I11T	   is	   suggested	   to	   represent	   a	   novel	   species	   within	   the	  
genus	   Patulibacter,	   for	   which	   the	   name	   Patulibacter	   medicamentivorans	   sp.	  












Table	  3.2.	  Cellular	  fatty	  acid	  compositions	  of	  strain	  I11T	  (1)	  and	  its	  closest	  phylogenetic	  
neighbours	   P.	   ginsengiterrae	   CECT	   7603T	   (2),	   P.	   americanus	   DSM	   16676T	   (3)	   and	   P.	  
minatonensis	  DSM	  18081T	  (4).	  
	  
All	   strains	  were	   cultivated	   on	   TSA	   at	   28	   °C	   for	   72	   hours	   and	   tested	   in	   parallel	   in	   the	  
present	  study.	  
	  
Fatty	  acid	   1	   2	   3	   4	  
Saturated	  straight-­‐chain	   	   	   	   	  
C9:0	   0.1	   	   	   	  
C10:0	   2.4	   	   	   0.1	  
C12:0	   1.1	   	   	   	  
C14:0	   0.5	   	   0.2	   	  
C15:0	   	   	   0.3	   	  
C16:0	   0.8	   3.1	   4.7	   2.7	  
C17:0	   	   	   0.5	   	  
C18:0	   1.2	   3.1	   2.7	   1.7	  
C19:0	  	   	   	   0.6	   0.6	  
C20:0	   	   	   0.5	   	  
Unsaturated	  straight-­‐chain	   	   	   	   	  
C16:1	  B	   	   	   	   0.4	  
C16:1	  CIS	  9	   2.0	   0.5	   3.4	   0.9	  
C17:1	  CIS	  9	   0.6	   0.6	   3.1	   	  
C18:1	  CIS	  9	   46.4	   48.8	   56.2	   54.5	  
C20:1	  CIS	  11	   0.6	   	   	   	  
C18:3	  CIS	  6,12,14	   	   	   3.2	   	  
Saturated	  branched-­‐chain	   	   	   	   	  
iso-­‐C10:0	   1.5	   	   	   	  
iso-­‐C12:0	   1.7	   	   	   	  
iso-­‐C14:0	   3.4	   1.5	   	   0.3	  
iso-­‐C16:0	   2.9	   0.8	   	   1.7	  
iso-­‐C18:0	   4.9	   0.8	   	   1.5	  
anteiso-­‐C11:0	   0.4	   	   	   	  
anteiso-­‐C13:0	   0.4	   	   	   	  
anteiso-­‐C15:0	   3.2	   8.8	   11.5	   5.6	  
anteiso-­‐C17:0	   2.5	   3.7	   2.0	   9.4	  
anteiso-­‐C19:0	   0.7	   0.7	   1.6	   1.8	  
C17:0	  10-­‐methyl	   9.3	   0.8	   1.0	   1.9	  
Unsaturated	  branched-­‐chain	   	   	   	   	  
iso-­‐C16:1	  F	   0.2	   	   	   	  
iso-­‐C18:1	  H	   0.2	   	   	   	  
iso-­‐C19:1	  I	   	   	   	   1.4	  
Hydroxy	  branched-­‐chain	   	   	   	   	  





Fatty	  acid	   1	   2	   3	   4	  
anteiso-­‐C15:0	  2OH	   6.8	   9.4	   3.9	   13.7	  
Summed	  Features	   	   	   	   	  
Sum	  In	  Feature	  7	  (C18:1	  CIS11/t9/t6	  /	  C18:1	  TRANS	  
6/t9/c11)	   1.1	   0.9	   2.9	   1.1	  
Sum	  In	  Feature	  9	  (un	  18.846/18.858	  /	  C19:0	  CYCLO	  C9-­‐
10/un)	   	   15.3	   	   	  
	  
	  
Description	  of	  Patulibacter	  medicamentivorans	  sp.	  nov.	  
	  
Patulibacter	  medicamentivorans	  (me.di.ca.men.ti.vo'rans	  N.L.	  n.	  medicamentus	  
pharmaceutical	   drug;	   L.	   part.	   adj.	   vorans	   devouring;	   N.L.	   adj.	  
medicamentivorans	  eater	  of	  pharmaceutical	  drug).	  
	  
Cells	  are	  aerobic,	  Gram-­‐stain-­‐positive,	  catalase	  positive,	  oxidase	  negative,	  non-­‐
motile,	  non-­‐sporulating	  rods	  (0.3-­‐0.4x1.0-­‐1.1	  μm).	  Colonies	  on	  TSA	  are	  creamy	  
white,	   semi-­‐translucent,	   irregular	   with	   undulate	   margins.	   Optimum	  
temperature	  and	  pH	  for	  growth	  are	  32	  °C	  and	  6.0-­‐7.5,	   respectively.	  Growth	   is	  
not	   observed	   in	   media	   containing	   more	   than	   1.5	   %	   (w/v)	   NaCl.	   The	   Biolog	  
substrates	   dextrin,	   mannan,	   Tween	   40,	   Tween	   80,	   D-­‐arabitol,	   arbutin,	   D-­‐
cellobiose,	   D-­‐fructose,	   gentiobiose,	   α-­‐D-­‐glucose,	  maltotriose,	   D-­‐melezitose,	   3-­‐
methyl-­‐D-­‐glucose,	   β-­‐methyl-­‐D-­‐glucoside,	   palatinose,	   L-­‐rhamnose,	   D-­‐ribose,	  
salicin,	   D-­‐tagatose,	   turanose,	   D-­‐xylose,	   acetic	   acid,	   β-­‐hydroxybutyric	   acid,	   α-­‐
ketovaleric	   acid,	   D-­‐lactic	   acid	   methyl	   ester,	   succinic	   acid	   mono-­‐methyl	   ester,	  
propionic	   acid,	   pyruvic	   acid,	   L-­‐alanine,	   glycyl-­‐L-­‐glutamic	   acid,	   D-­‐fructose-­‐6-­‐
phosphate	  and	  D-­‐glucose-­‐6-­‐phosphate	  are	  utilised.	   It	   is	  able	   to	   reduce	  nitrate	  
and	  has	  enzyme	  activity	  for	  alkaline	  phosphatase,	  esterase	  (C4),	  esterase	  lipase	  
(C8),	  lipase	  (C14),	  leucine	  and	  cystine	  arylamidase,	  acid	  phosphatase,	  naphthol-­‐





cyclodextrin,	  β-­‐cyclodextrin,	  glycogen,	  inulin,	  N-­‐acetyl-­‐D-­‐glucosamine,	  N-­‐acetyl-­‐
β-­‐D-­‐mannosamine,	   amygdalin,	   L-­‐arabinose,	   L-­‐fucose,	   D-­‐galactose,	   D-­‐
galacturonic	   acid,	   D-­‐gluconic	   acid,	   m-­‐inositol,	   α-­‐D-­‐lactose,	   lactulose,	   D-­‐
mannitol,	   D-­‐mannose,	   D-­‐melibiose,	   α-­‐methyl-­‐D-­‐galactoside,	   β-­‐methyl-­‐D-­‐
galactoside,	   α-­‐methyl-­‐D-­‐glucoside,	   α-­‐methyl-­‐D-­‐mannoside,	   D-­‐psicose,	   D-­‐
raffinose,	   sedoheptulosan,	   D-­‐sorbitol,	   stachyose,	   sucrose,	   D-­‐trehalose,	   xylitol,	  
α-­‐hydroxybutyric	   acid,	   γ-­‐hydroxybutyric	   acid,	   p-­‐hydroxyphenylacetic	   acid,	   α-­‐
ketoglutaric	  acid,	  lactamide,	  D-­‐malic	  acid,	  pyruvic	  acid	  methyl	  ester,	  succinamic	  
acid,	  succinic	  acid,	  N-­‐acetyl-­‐L-­‐glutamic	  acid,	  L-­‐alaninamide,	  D-­‐alanine,	  L-­‐alanyl-­‐
glycine,	  L-­‐asparagine,	  L-­‐glutamic	  acid,	  L-­‐pyroglutamic	  acid,	  L-­‐serine,	  putrescine,	  
2,3-­‐butanediol,	   glycerol,	   adenosine,	   2´-­‐deoxy	   adenosine,	   inosine,	   thymidine,	  
uridine,	   adenosine-­‐5´-­‐monophosphate,	   thymidine-­‐5´-­‐monophosphate,	   uridine-­‐
5´-­‐monophosphate,	  α-­‐D-­‐glucose-­‐1-­‐phosphate	  and	  D-­‐L-­‐α-­‐glycerol	  phosphate	  are	  
not	  utilized.	  The	  API	  20	  NE	  substrates	  L-­‐arabinose,	  D-­‐mannose,	  D-­‐mannitol,	  N-­‐
acetyl-­‐glucosamine,	   D-­‐maltose,	   potassium	   gluconate,	   capric	   acid,	   adipic	   acid,	  
trisodium	   citrate,	   and	   phenylacetic	   acid	   are	   not	   utilised.	   Indole	   production	   is	  
not	  observed.	  Fermentation	  of	  D-­‐glucose	  does	  not	  occur,	  and	  activities	  of	  valine	  
arylamidase,	   trypsin,	   α-­‐chymotrypsin,	   α-­‐galactosidase,	   β-­‐galactosidase,	   β-­‐
glucuronidase,	   α-­‐glucosidase,	   N-­‐acetyl-­‐β-­‐glucosaminidase,	   α-­‐mannosidase,	   α-­‐
fucosidase,	   arginine	  dihydrolase,	   urease	   and	  gelatinase	   are	  not	  detected.	   It	   is	  
susceptible	  to	  ampicillin	  (10	  μg),	  amikacin	  (30	  μg),	  bacitracin	  (10	  U),	  ceftazidime	  
(30	   μg),	   ceftriaxone	   (30	   μg),	   ciprofloxacin	   (5	   μg),	   chloramphenicol	   (30	   μg),	  
erythromycin	  (15	  μg),	  gentamicin	  (10	  μg),	  novobiocin	  (30	  μg),	  polymyxin	  B	  (300	  
U)	  and	  vancomycin	  (30	  μg),	  and	  resistant	  to	  aztreonam	  (30	  μg)	  and	  tetracycline	  
(30	   μg).	   The	   cell	   wall	   peptidoglycan	   contains	   meso-­‐	   diaminopimelic	   acid.	  
Demethylmenaquinone	  DMK-­‐7	   is	   the	  predominant	  respiratory	  quinone.	  Major	  





lipids	   are	   phosphatidylglycerol	   (PG),	   diphosphatidylglycerol	   (DPG)	   and	   four	  
unknown	  phospholipids	  (PL1-­‐PL4).	  
	  
The	   type	   strain	   I11T	  (=DSM	   25962T	   =CECT	   8141T)	   was	   isolated	   from	   activated	  




The	   authors	   thank	   Anika	   Wasner	   and	   Gabriele	   Pötter	   (both	   from	   DSMZ),	   Dr	  
Dulce	  Brito	  and	  Susana	  Tenedório	  (IBET/ASU)	  for	  excellent	  technical	  assistance.	  
Fundação	   para	   a	   Ciência	   e	   Tecnologia	   is	   acknowledged	   for	   funding	   through	  
projects	   PTDC/EBB-­‐EBI/098862/2008,	   PEst-­‐OE/EQB/LA0004/2011	   and	   PEst-­‐




Almeida,	   B.,	   Kjeldal,	   H.,	   Lolas,	   I.,	   Knudsen,	   A.	   D.,	   Carvalho,	   G.,	   Nielsen,	   K.	   L.,	   Barreto	  
Crespo,	   M.	   T.,	   Stensballe,	   A.,	   Nielsen,	   J.	   L.,	   2012.	   Quantitative	   proteomic	  
analysis	   of	   ibuprofen-­‐degrading	   Patulibacter	   sp.	   strain	   I11.	   Biodegradation.	  
doi:10.1007/s10532-­‐012-­‐9610-­‐5.	  
Altschul,	  S.	  F.,	  Madden,	  T.	  L.,	  Schaeffer,	  A.	  A.,	  Zhang,	  J.,	  Zhang,	  Z.,	  Miller,	  W.,	  Lipman,	  D.	  
J.,	  1997.	  Gapped	  BLAST	  and	  PSI-­‐BLAST:	  a	  new	  generation	  of	  protein	  database	  
search	  programs.	  Nucleic	  Acids.	  Res.	  25,	  3389-­‐3402.	  
Bauer,	  A.	  W.,	  Kirby,	  W.	  M.,	  Sherris,	  J.	  C.,	  Turck,	  M.,	  1966.	  Antibiotic	  susceptibility	  testing	  
by	  a	  standardized	  single	  disk	  method.	  Am.	  J.	  Clin.	  Pathol.	  45,	  493-­‐496.	  
Collins,	   M.	   D.,	   Pirouz,	   T.,	   Goodfellow,	   M.,	   Minnikin,	   D.	   E.,	   1977.	   Distribution	   of	  
menaquinones	   in	   actinomycetes	   and	   corynebacteria.	   J.	   Gen.	  Microbiol.	   100,	  
221-­‐230.	  
Hasegawa,	   T.,	   Takizawa,	  M.,	   1983.	   A	   rapid	   analysis	   for	   chemical	   grouping	   of	   aerobic	  
actinomycetes.	  J.	  Gen.	  Appl.	  Microbiol.	  29,	  319-­‐322.	  	  
Jukes,	  T.	  H.,	  Cantor,	  C.	  R.,	  1969.	  Evolution	  of	  protein	  molecules.	  In	  Mammalian	  Protein	  
Metabolism,	  vol.	  3,	  pp.	  21–132.	  Edited	  by	  H.	  N.	  Munro.	  New	  York:	  Academic	  
Press.	  
Kim,	  K.	  K.,	  Lee,	  K.	  C.,	  Lee,	  J.-­‐S.,	  2012a.	  Patulibacter	  ginsengiterrae	  sp.	  nov.,	  isolated	  from	  





Kim,	  O.	  S.,	  Cho,	  Y.	  J.,	  Lee,	  K.,	  Yoon,	  S.	  H.,	  Kim,	  M.,	  Na,	  H.,	  Park,	  S.	  C.,	  Jeon,	  Y.	  S.,	  Lee,	  J.	  
H.,	   Yi,	  H.,	  Won,	   S.,	   Chun,	   J.,	   2012b.	   Introducing	  EzTaxon-­‐e:	   a	  prokaryotic	  16S	  
rRNA	   Gene	   sequence	   database	   with	   phylotypes	   that	   represent	   uncultured	  
species.	  Int.	  J.	  Syst.	  Evol.	  Microbiol.	  62,	  716–721.	  
Manaia,	   C.	  M.,	  Nogales,	   B.,	  Weiss,	  N.,	  Nunes,	  O.	   C.,	   2004.	  Gulosibacter	  molinativorax	  
gen.	   nov.,	   sp.	   nov.,	   a	   molinate-­‐degrading	   bacterium,	   and	   classification	   of	  
‘Brevibacterium	  helvolum’	  DSM	  20419	  as	  Pseudoclavibacter	  helvolus	  gen.	  nov.,	  
sp.	  nov.	  Int	  .J.	  Syst.	  Evol.	  Microbiol.	  54,	  783–789.	  
Murray,	  R.	  G.	  E.,	  Doetsch,	  R.	  N.,	  Robinow,	  F.,	  1994.	  Determinative	  and	  cytological	  light	  
microscopy.	   In	  Methods	   for	   General	   and	  Molecular	   Bacteriology,	   pp.	   21–41.	  
Edited	  by	  P.	  Gerhardt,	  R.	  G.	  E.	  Murray,	  W.	  A.	  Wood	  &	  N.	  R.	  Krieg.	  Washington,	  
DC:	  American	  Society	  for	  Microbiology.	  
Oehmen,	  A.,	  Fradinho,	  J.,	  Serra,	  S.,	  Carvalho,	  G.,	  Capelo,	  J.	  L.,	  Velizarov,	  S.,	  Crespo,	  J.	  G.,	  
Reis,	  M.	  A.,	   2009.	   The	  effect	  of	   carbon	   source	  on	   the	  biological	   reduction	  of	  
ionic	  mercury.	  J.	  Hazard.	  Mater.	  165,	  1040-­‐1048.	  
Onesios,	   K.	   M.,	   Yu,	   J.	   T.,	   Bouwer,	   E.	   J.,	   2009.	   Biodegradation	   and	   removal	   of	  
pharmaceuticals	   and	  personal	   care	  products	   in	   treatment	   systems:	   a	   review.	  
Biodegradation	  20,	  441-­‐466.	  
Reddy,	  G.	  S.	  N.,	  Garcia-­‐Pichel,	  F.,	  2009.	  Description	  of	  Patulibacter	  americanus	  sp.	  nov.,	  
isolated	   from	   biological	   soil	   crusts,	   emended	   description	   of	   the	   genus	  
Patulibacter	   Takahashi	   et	   al.	   2006	   and	   proposal	   of	   Solirubrobacterales	   ord.	  
nov.	  and	  Thermoleophilales	  ord.	  nov.	  Int.	  J.	  Syst.	  Evol.	  Microbiol.	  59,	  87-­‐94.	  
Salgado,	  R.,	  Marques,	  R.,	  Noronha,	   J.	   P.,	   Carvalho,	  G.,	  Oehmen,	  A.,	  Reis,	  M.	  A.,	   2012.	  
Assessing	  the	  removal	  of	  pharmaceuticals	  and	  personal	  care	  products	  in	  a	  full-­‐
scale	  activated	  sludge	  plant.	  Environ.	  Sci.	  Poll.	  Res.	  Int.	  19,	  1818-­‐1827.	  
Santos,	   L.	   H.	   M.	   L.	   M.,	   Araujo,	   A.	   N.,	   Fachini,	   A.,	   Pena,	   A.,	   Delerue-­‐Matos,	   C.	  
Montenegro,	   M.	   C.	   B.	   S.	   M.,	   2010.	   Ecotoxicological	   aspects	   related	   to	   the	  
presence	   of	   pharmaceuticals	   in	   the	   aquatic	   environment.	   J.	   Hazard.	   Mater.	  
175,	  45-­‐95.	  
Smibert,	  R.	  M.,	  Krieg,	  N.	  R.,	  1994.	  Phenotypic	  characterization.	  In	  Methods	  for	  General	  
and	   Molecular	   Bacteriology,	   pp.	   607–654.	   Edited	   by	   P.	   Gerhardt,	   R.	   G.	   E.	  
Murray,	   W.	   A.	   Wood	   &	   N.	   R.	   Krieg.	   Washington,	   DC:	   American	   Society	   for	  
Microbiology.	  
Stackebrandt,	   E.,	   Goebel,	   B.	   M.	   (1994).	   Taxonomic	   note:	   A	   place	   for	   DNA-­‐DNA	  
reassociation	  and	  16S	  rRNA	  sequence	  analysis	  in	  the	  present	  species	  definition	  
in	  bacteriology.	  Int.	  J.	  Syst.	  Bacteriol.	  44,	  846-­‐849.	  
Stead,	   D.	   E.,	   Sellwood,	   J.	   E.,	   Wilson,	   J.,	   Viney,	   I.,	   1992.	   Evaluation	   of	   a	   commercial	  
microbial	  identification	  system	  based	  on	  fatty	  acid	  profiles	  for	  rapid,	  accurate	  
identification	  of	  plant	  pathogenic	  bacteria.	  J.	  Appl.	  Bacteriol.	  72,	  315-­‐321.	  
Takahashi,	  Y.,	  Matsumoto,	  A.,	  Morisaki,	  K.,	  Omura,	  S.,	  2006.	  Patulibacter	  minatonensis	  
gen.	   nov.,	   sp.	   nov.,	   a	   novel	   actinobacterium	   isolated	   using	   an	   agar	   medium	  
supplemented	  with	  superoxide	  dismutase,	  and	  proposal	  of	  Patulibacteraceae	  
fam.	  nov.	  Int.	  J.	  Syst.	  Evol.	  Microbiol.	  56,	  401–406.	  
Tamura,	  K.,	  Peterson,	  D.,	  Peterson,	  N.,	   Stecher,	  G.,	  Nei,	  M.,	  Kumar,	   S.,	   2011.	  MEGA5:	  





Evolutionary	  Distance,	  and	  Maximum	  Parsimony	  Methods.	  Mol.	  Biol.	  Evol.	  28,	  
2731-­‐2739.	  
Tindall,	  B.	   J.,	  Rosselló-­‐Móra,	  R.,	  Busse,	  H.	   -­‐J.,	   Ludwig,	  W.,	  Kampfer	  P.,	  2010.	  Notes	  on	  
the	  characterization	  of	  prokaryote	  strains	  for	  taxonomic	  purposes.	  Int.	  J.	  Syst.	  
Evol.	  Microbiol.	  60,	  249–266.	  
Vaz-­‐Moreira,	   I.,	  Nobre,	  M.	  F.,	  Nunes,	  O.	  C.,	  Manaia,	  C.	  M.,	  2007.	  Gulbenkiania	  mobilis	  
gen.	   nov.,	   sp.	   nov.,	   isolated	   from	   treated	  municipal	   wastewater.	   Int.	   J.	   Syst.	  
Evol.	  Microbiol.	  57,	  1108–1112.	  
Yi,	  H.,	   Schumann,	  P.,	   Chun,	   J.,	   2007.	  Demequina	  aestuarii	   gen.	   nov.,	   sp.	   nov.,	   a	  novel	  
actinomycete	   of	   the	   suborder	   Micrococcineae,	   and	   reclassification	   of	  
Cellulomonas	   fermentans	  Bagnara	  et	  al.	  1985	  as	  Actinotalea	   fermentans	   gen.	  
nov.,	  comb.	  nov.	  Int.	  J.	  Syst.	  Evol.	  Microbiol.	  57,	  151-­‐156.	  
Ying,	   G.-­‐G.,	   Kookana,	   R.	   S.,	   Kolpin,	   D.	   W.,	   2009.	   Occurrence	   and	   removal	   of	  
pharmaceutically	  active	  compounds	  in	  sewage	  treatment	  plants	  with	  different	  
technologies.	  J.	  Environ.	  Monit.	  11,	  1498-­‐1505.	  
Zhang,	   Z.,	   Schwartz,	   S.,	  Wagner,	   L.,	   	  Miller,	  W.,	   2000.	  A	   greedy	  algorithm	   for	   aligning	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Ibuprofen	   is	   the	   third	   most	   consumed	   pharmaceutical	   drug	   in	   the	   world.	  
Several	  isolates	  have	  been	  shown	  to	  degrade	  ibuprofen,	  but	  very	  little	  is	  known	  
about	  the	  biochemistry	  of	  this	  process.	  This	  study	  investigates	  the	  degradation	  
of	   ibuprofen	  by	  Patulibacter	   sp.	   strain	   I11	  by	  quantitative	  proteomics	   using	   a	  
metabolic	   labelling	   strategy.	   The	  whole	   genome	   of	  Patulibacter	   sp.	   strain	   I11	  
was	   sequenced	   to	   provide	   a	   species-­‐specific	   protein	   platform	   for	   optimal	  
protein	  identification.	  The	  bacterial	  proteomes	  of	  actively	  ibuprofen-­‐degrading	  
cells	  and	  cells	  grown	  in	  the	  absence	  of	  ibuprofen	  was	  identified	  and	  quantified	  
by	   gel	   based	   shotgun-­‐proteomics.	   In	   total	   251	   unique	   proteins	   were	  
quantitated	   using	   this	   approach.	   Biological	   process	   and	   pathway	   analysis	  
indicated	   a	   number	   of	   proteins	   that	  were	   up-­‐regulated	   in	   response	   to	   active	  
degradation	   of	   ibuprofen,	   some	   of	   them	   are	   known	   to	   be	   involved	   in	   the	  
degradation	   of	   aromatic	   compounds.	   Data	   analysis	   revealed	   that	   several	   of	  







The	   emergence	   of	   pharmaceutically	   active	   compounds	   (PhACs)	   in	   natural	  
matrices	   such	   as	   soil,	   sediments	   and	   water	   has	   been	   an	   issue	   of	   increasing	  
concern	  in	  recent	  years.	  Several	  studies	  have	  been	  carried	  out	  to	  elucidate	  the	  
magnitude	  of	  the	  risks	  that	  PhACs	  may	  impose	  to	  the	  environment	  and	  health	  
of	   living	   beings	   (Daughton	   and	   Ternes	   1999;	   Pal	   et	   al.,	   2010;	   Murray	   et	   al.,	  
2010;	   Santos	   et	   al.,	   2010).	   Many	   PhACs	   are	   potentially	   harmful	   to	   the	  
environment	  and	  the	  public	  health,	  and	  several	  PhACs	  are	  considered	  to	  have	  
mutagenic,	  carcinogenic	  and	  endocrine	  disruptor	  effects	  (Daughton	  and	  Ternes	  
1999;	  Pal	  et	  al.,	  2010;	  Kummerer	  2009;	  Santos	  et	  al.,	  2010).	  Other	  compounds	  
appear	  harmless	  when	  considered	  individually,	  but	  a	  potential	  risk	  of	  unknown	  
additive	  or	   synergistic	   effects	   in	   the	  presence	  of	  mixtures	  of	   compounds	  may	  
exist.	  Presence	  of	  PhACs	  in	  the	  environment	  suggests	  their	   inefficient	  removal	  
in	  wastewater	   treatment	   plants	   (WWTPs).	   PhACs	   can	   typically	   be	   detected	   in	  
the	  ng	  L-­‐1	  to	  µg	  L-­‐1	  range	  in	  influents	  and	  have	  highly	  varying	  removal	  degrees	  in	  
wastewater	  treatment	  (Heberer	  2002;	  Kolpin	  et	  al.,	  2002;	  Onesios	  et	  al.,	  2009;	  
Daughton	  and	  Ternes	  1999;	  Salgado	  et	  al.,	  2010;	  2011;	  Santos	  et	  al.,	  2010).	  
	  
Elimination	   of	   organic	   contaminants	   and	   some	   micropollutants	   from	  
wastewater	   treatment	   is	   due	   to	   the	   action	   of	   different	   removal	  mechanisms,	  
such	  as	  sorption,	  biodegradation	  and	  abiotic	  degradation	  (Salgado	  et	  al.,	  2012).	  
Removal	  of	  polar	  acidic	  pharmaceuticals	  seems	  to	  be	  predominantly	   removed	  
by	   microbial	   degradation	   in	   wastewater	   treatment	   systems	   (Salgado	   et	   al.,	  
2012;	  Quintana	  et	  al.,	  2005).	  	  
	  
Ibuprofen	  is	  a	  non-­‐steroidal	  anti-­‐inflammatory	  drug	  (NSAID)	  detected	  in	  the	  ng	  





been	  carried	  out	  all	  over	   the	  world	   (Daughton	  and	  Ternes	  1999;	  Kolpin	  et	  al.,	  
2002;	  Onesios	  et	  al.,	  2009;	  Salgado	  et	  al.,	  2010;	  2011;	  2012;	  Ying	  et	  al.,	  2009).	  
Ibuprofen	  is	  globally	  the	  third	  most	  produced	  pharmaceutical	  compound	  and	  a	  
highly	   diffuse	   consumption	   makes	   it	   one	   of	   the	   most	   frequently	   detected	  
compounds	   in	   wastewater	   (Buser	   et	   al.,	   1999).	   Typical	   values	   of	   ibuprofen	  
detection	  range	  from	  22	  µg	  L-­‐1	  to	  84	  µg	  L-­‐1	  in	  raw	  sewage	  and	  treated	  effluent	  
water,	   respectively,	  while	   up	   to	   5	   µg	   L-­‐1	   has	   been	  detected	   in	   surface	  waters	  
(Santos	  et	  al.,	  2010;	  Pal	  et	  al.,	  2010).	  
	  
Only	   few	   studies	   have	   focused	   on	   the	   biochemistry	   of	   the	   biodegradation	   of	  
PhACs.	   Studies	   on	   the	   biodegradation	   of	   ibuprofen	   in	   activated	   sludge	   have	  
suggested	   the	   formation	   of	   hydroxy-­‐ibuprofen,	   carboxy-­‐ibuprofen,	   and	  
carboxy-­‐hydratropic	   acid	   (carboxy-­‐HA)	   as	   degradation	   products	   (Quintana	   et	  
al.,	  2005;	  Buser	  et	  al.,	  1999;	  Zwiener	  et	  al.,	  2002;	  Zwiener	  and	  Frimmel	  2003;	  
Winkler	  et	  al.,	  2001).	  Genetic	  and	  metabolite	  analysis	  of	  ibuprofen	  degradation	  
by	   Sphingomonas	   Ibu-­‐2,	   revealed	   several	   key	  metabolites	   possibly	   associated	  
with	   ibuprofen	   degradation,	   such	   as	   ibuprofen	   CoA;	   1,2-­‐cis-­‐diol-­‐2-­‐
hydroibuprofen	   CoA	   and	   4-­‐isobutylcatechol	   –	   and	   a	   cluster	   of	   five	   putative	  
genes	  (ipfABDEF)	  was	  used	  to	  propose	  a	  degradation	  pathway	  for	  ibuprofen	  by	  
this	   isolate	   (Murdoch	   and	   Hay	   2005;	   Kagle	   et	   al.,	   2009).	   This	   approach	   has	  
provided	   insights	   that	   are	   potentially	   of	   great	   significance	   for	   the	  
understanding	  of	   ibuprofen	  microbial	   degradation.	  However,	   it	   remains	   to	  be	  
elucidated	   if	   phylogenetically	   different	   microorganisms	   as	   well	   as	   the	   strain	  
Sphingomonas	   Ibu-­‐2	   do	   in	   fact	   degrade	   ibuprofen	   through	   this	   proposed	  
pathway	  or	  by	  some	  other	  unknown	  mechanism.	  
	  
Quantitative	   proteomics	   has	   proven	   to	   be	   a	   valuable	   tool	   for	   analysing	   the	  





compounds	   or	   under	   the	   influence	   of	   different	   physico-­‐chemical	   parameters	  
(Kim	   et	   al.,	   2007;	   2009).	   Proteomics	   has	   also	   been	   succesfully	   applied	   for	  
studying	   the	   biodegradation	   of	   aromatic	   hydrocarbons	   such	   as	   benzoate,	  
aniline,	  and	  phenol	  by	  several	  microorganisms,	  e.g.	  Acinetobacter	  (Giuffrida	  et	  
al.,	  2001;	  Park	  et	  al.,	  2006;	  Pessione	  et	  al.,	  2003)	  and	  Pseudomonas	  strains	  (Loh	  
and	  Cao	  2008),	  as	  well	  as	  several	  mycobacterial	   (Kim	  et	  al.,	  2004;	  Liang	  et	  al.,	  
2006)	  and	  rhodococcal	  species	  (Navarro-­‐Llorens	  et	  al.,	  2005;	  Patrauchan	  et	  al.,	  
2005;	  Tomas-­‐Gallardo	  et	  al.,	  2006).	  Many	  microorganisms	  capable	  of	  degrading	  
micropollutants	   induce	   the	   expression	   of	   enzymes	   involved	   in	   the	   metabolic	  
pathway(s)	  related	  to	  the	  degradation	  itself,	  when	  grown	  in	  the	  presence	  of	  the	  
target	   compound.	   These	   induced	   proteins	   can	   be	   identified	   by	   quantitative	  
comparisons	   of	   the	   proteomes	   expressed	   in	   presence	   and	   absence	   of	   the	  
micropollutant,	   which	   give	   direct	   measurement	   of	   protein	   expression	   levels	  
(Kim	   et	   al.,	   2007;	   2009).	   Furthermore,	   proteomics	   is	   a	   powerful	   tool	   for	  
providing	  functional	  information	  on	  prokaryotic	  gene	  expression	  at	  the	  protein	  
level	  essentially	  allowing	  for	  bridging	  the	  gap	  between	  genome	  and	  phenotype.	  	  
	  
The	  main	  objective	  of	  this	  study	  was	  to	  investigate	  the	  degradation	  pathway	  of	  
ibuprofen	   by	   Patulibacter	   sp.	   strain	   I11,	   a	   bacterial	   strain	   isolated	   from	  
activated	   sludge,	   using	   quantitative	   proteomics	   combined	   with	   genetic	  
information	   of	   the	   microorganism.	   Global	   changes	   in	   the	   proteome	   of	  
Patulibacter	   sp.	   strain	   I11	   when	   grown	   in	   the	   presence	   and	   absence	   of	  
ibuprofen,	   were	   characterised	   by	   stable	   isotope	   metabolic	   labelling	   in	  
combination	   with	   1-­‐D	   gel	   based	   shotgun-­‐proteomics.	   To	   the	   best	   of	   our	  
knowledge,	  this	  study	  is	  the	  first	  proteomic	  analysis	  on	  an	  ibuprofen-­‐degrading	  
microorganism,	   providing	   novel	   information	   on	   the	   potential	   proteins	   related	  





understanding	   the	   conditions	   that	   promote	   the	   degradation	   of	   this	   NSAID	   in	  
WWTPs.	  
Material	  and	  Methods	  
Bacterial	  isolation	  and	  characterization	  
The	  bacterial	  strain	   I11,	  used	   in	  this	  study,	  was	   isolated	  from	  activated	  sludge	  
collected	  from	  Beirolas	  WWTP	  (Lisbon,	  Portugal).	  Activated	  sludge	  (3	  g	  L-­‐1)	  was	  
inoculated	   in	  M9	  minimal	  medium	   (Oehmen	   et	   al.,	   2009)	   supplemented	  with	  
500	  μg	  L-­‐1	  of	  ibuprofen	  and	  grown	  at	  28	  ºC	  for	  15	  days.	  Ibuprofen	  degradation	  
capacity	  of	  the	  enriched	  microbial	  community	  was	  evaluated	  during	  the	  period	  
of	   incubation.	   Ibuprofen	   was	   followed	   by	   high	   performance	   liquid	  
chromatography	  and	  regularly	  added	  to	  avoid	  depletion.	  I11	  was	  subsequently	  
isolated	  from	  this	  microbial	  enrichment	  by	  a	  series	  of	  ten-­‐fold	  dilutions	  in	  0.85	  
%	   (w/v)	   NaCl	   streaked	   on	   agar	   plates	   containing	   minimal	   medium	  
supplemented	  with	  250	  μg	  L-­‐1	  of	   ibuprofen	  and	  15	  g	  L-­‐1	  agar.	  The	  plates	  were	  
incubated	   at	   28	   ºC	   for	   3-­‐4	   days	   and	   individual	   colonies	   were	   selected,	   re-­‐
inoculated	  onto	   the	  same	  medium	  supplemented	  with	  1	  g	  L-­‐1	  of	  yeast	  extract	  
(Oxoid,	  Hampshire,	  England)	  and	  tryptone	  (Oxoid,	  Hampshire,	  England)	  (50%	  of	  
each)	   for	   isolation	   into	   pure	   cultures.	   Cells	   were	   subjected	   to	   ibuprofen	  
biodegradation	  in	  OD2-­‐medium	  (Silantes,	  München,	  Germany)	  and	  M9	  medium	  
supplemented	  with	  1	  g	  L-­‐1	  yeast	  extract	  and	  tryptone	   in	  batch	  experiments	  at	  
different	  initial	  ibuprofen	  concentrations	  (1,000	  μg	  L-­‐1,	  250	  μg	  L-­‐1	  and	  50	  μg	  L-­‐1).	  	  
All	  incubations	  were	  aerobic	  and	  run	  at	  28	  ºC	  on	  a	  rotary	  table	  (110	  rpm),	  and	  






Bacterial	  cultivation	  conditions	  and	  protein	  sample	  preparation	  for	  proteomic	  
analysis	  	  
	  
A	  differential	  proteomic	  approach	  was	  carried	  out	  by	  metabolic	  labelling	  of	  the	  
proteome	   of	   strain	   I11	   grown	   in	   the	   presence	   or	   absence	   of	   ibuprofen	   as	  
outlined	   in	   Figure	   4.1.	   Two	   independent	   experiments	   were	   conducted	   by	  
metabolically	   labelling	   biological	   replicates	   using	   a	   forward	   and	   reverse	  


















Figure	   4.1.	   Analytical	   scheme	   for	   the	   relative	   quantification	   of	   proteins	   derived	   from	  























Figure	  4.2.	  A	  schematic	  of	  the	  forward	  and	  reverse	  metabolic	  labelling	  of	  the	  bacterial	  
isolate	  Patulibacter	  sp.	  I11	  grown	  in	  the	  presence	  and	  absence	  of	  ibuprofen.	  Following	  
labelling,	   proteins	   were	   extracted	   processed	   and	   subjected	   to	   tandem	   mass	  
spectrometry.	  
	  
Pre-­‐cultures	  of	  the	  isolate	  I11	  were	  aerobically	  cultured	  in	  Erlenmeyer	  flasks	  at	  
28	   ºC,	   110	   rpm	   with	   unlabelled	   or	   15N-­‐labelled	   OD2-­‐medium	   (Silantes,	  
München,	   Germany).	   The	   forward	   and	   reverse	   labelling	   strategy	   served	   the	  
purpose	   of	   evaluating	   potential	   influence	   of	   the	   14N-­‐	   and	   15N-­‐medium	   on	  
protein	   expression	   levels.	   10	   mL	   of	   pre-­‐culture,	   grown	   until	   mid-­‐logarithmic	  
growth	  phase	  (OD600~0.6),	  was	  used	  as	  inoculum.	  The	  forward/reverse	  labelling	  
experiment	  was	  carried	  out	  aerobically	   in	  100	  mL	  Erlenmeyer	   flasks	   in	  a	   total	  





or	   without	   65	   μg	   L-­‐1	   of	   ibuprofen.	   Cultures	   were	   harvested	   at	   the	   mid-­‐
logarithmic	  growth	  phase	  (OD600~0.6).	  Cells	  were	  pelleted	  by	  centrifugation	  at	  
6,000	  xg	  for	  10	  min	  at	  4	  ºC.	  The	  supernatant	  was	  discarded	  and	  the	  pellet	  was	  
resuspended	   in	   phosphate	   buffered	   saline	   (PBS)	   supplemented	  with	   protease	  
inhibitors	   (Complete,	   Mini,	   EDTA-­‐free	   Protease	   Inhibitor	   Cocktail	   Tablets;	   1	  
Tablet	   in	   50	  mL	   solution;	   Boehringer	  Mannheim,	  Mannheim,	   Germany).	   Cells	  
were	   subsequently	   disrupted	   by	   sonication	   (Sonopuls	   HD2200,	   Bandelin	  
Electronic,	  Berlin,	  Germany)	  running	  10	  cycles	  at	  20	  W	  for	  1	  min,	  maintaining	  a	  
1	  min	  break	   in-­‐between	  cycles	  and	  keeping	   samples	  on	  ethanol/ice	  bath.	  Cell	  
debris	   was	   removed	   by	   centrifugation	   at	   6,000	   xg	   for	   10	   min	   at	   4	   ºC.	   The	  
supernatant	  was	  collected	  and	  centrifuged	  at	  30,000	  xg	  for	  60	  min	  at	  4	  ºC.	  The	  
supernatant	   and	   the	   pellet	   (resuspended	   in	   150	   µL	  MilliQ	  water)	   constituted	  
the	   cytosolic	   and	   the	   membrane	   fraction,	   respectively.	   Protein	   content	   was	  
determined	  using	  the	  BCA	  Protein	  Assay	  kit	  (Thermo	  Fisher	  Scientific,	  Rockford,	  
IL),	   and	   the	   14N-­‐	   and	   15N-­‐labelled	   samples	   were	   mixed	   in	   a	   1:1	   ratio	   in	  
accordance	   with	   the	   forward/reverse	   labelling	   strategy	   (Figure	   4.2).	   Samples	  
were	   subsequently	   resuspended	   in	   SDS-­‐sample	   buffer	   containing	   40	   mM	  
dithiothreitol	  and	  denatured	  at	  95	  ºC	   (5	  min),	  and	  separated	  on	  a	  12	  %	   (w/v)	  
SDS-­‐PAGE	   gel	   (Bio-­‐Rad,	   USA).	   The	   gel	   bands	   were	   visualized	   with	   Coomassie	  
Brilliant	  Blue	  staining.	  Each	  lane	  was	  excised	  into	  16	  pieces,	  and	  then	  subjected	  
to	   in-­‐gel	   reduction,	   alkylation,	   and	   tryptic	   digestion	   as	   previously	   described	  
(Shevchenko	  et	  al.,	  2006).	  Samples	  were	  resuspended	   in	  5%	  (w/v)	   formic	  acid	  









Identification	   and	   quantification	   of	   proteins	   by	   NanoFlow-­‐LC-­‐ESI	   Q-­‐ToF	  
tandem	  MS	  
	  
Automated	   LC-­‐ESI	   MS/MS	   was	   performed	   using	   a	   hybrid	   Q-­‐ToF	   Mass	  
Spectrometer	  (Bruker	  microTOFQ,	  Bremen,	  Germany)	  and	  a	  nano-­‐HPLC	  system	  
(Agilent1200;	   Santa	   Clara	   CA,	   United	   States)	   mounted	   with	   a	   single	   column	  
setup.	  A	   reversed	  phase	  nanocolumn	   (15	   cm,	  75	  µm	   id)	  was	  packed	   in-­‐house	  
with	   ReproSil-­‐Pur	   C18-­‐AQ	   3.5	   µm	   resin	   (Dr.	   Maisch	   GmbH,	   Ammer-­‐Buch-­‐
Entringen,	  Germany)	  using	  a	  high-­‐pressure	  vessel.	  The	  sample	  was	  loaded	  with	  
a	  flow	  rate	  of	  350	  nL	  min-­‐1	  and	  subsequently	  eluted	  at	  200	  nL	  min-­‐1	  using	  a	  35	  
min	  gradient	  of	  5-­‐40	  %	  (v/v)	  acetonitrile	  in	  0.6	  %	  (v/v)	  acetic	  acid	  and	  0.005	  %	  
(v/v)	   heptafluorobutyric	   acid.	   The	   mass	   spectrometer	   was	   operated	   in	   data	  
dependent	  acquisition	  mode	  to	  automatically	  switch	  between	  MS	  and	  MS/MS	  
acquisition	   selecting	   the	   three	   most	   abundant	   precursor	   ions.	   The	   mass	  
spectrometer	   was	   calibrated	   externally	   using	   Tunemix	   (Agilent	   G1969-­‐85010)	  
prior	  to	  sample	  acquisition	  resulting	  in	  a	  sub	  5	  ppm	  mass	  accuracy	  (R	  13.000).	  
	  
Analysis	  of	  proteome	  data	  using	  bioinformatics	  tools	  
	  
The	   MS/MS	   data	   was	   deconvoluted,	   deisotoped,	   and	   exported	   in	   a	   Mascot	  
generic	  format	  (mgf-­‐files)	  prior	  to	  database	  searching.	  The	  data	  were	  analysed	  
using	  the	  MS/MS	  ion	  search	  by	  the	  Mascot	  2.3	  search	  engine	  (Matrix	  Science,	  
UK)	   against	   in-­‐house	   protein	   database	   (4,408	   sequences;	   1,430,678	   residues)	  
based	   on	   full	   genome	   sequencing	   (isolate	   I11	   whole	   genome,	   see	   below).	  
Protein	  modifications	  were	  fixed	  for	  carbamidomethylation	  of	  Cys	  and	  variable	  
oxidation	   of	   Met.	   The	   trypsin-­‐derived	   peptide	   and	   peptide	   fragment	   mass	  
accuracy	  were	  set	  to	  0.05	  Da.	  Results	  from	  the	  automatic	  database	  search	  were	  





Identified	   proteins	   were	   further	   quantified	   by	   Matrixscience	   Distiller	   toolbox	  
with	   the	   following	   settings	   for	   Matrixscience	   Distiller	   2.3	   (Ratio	   name	   B/U;	  
Fraction	   0.7;	   Correlation	   0.9;	   Peptide_SD	  0.1;	   Protein	   score	   50;	   Peptide	   score	  
15;	  Max	  ppm	  50;	   Significance	   level	   0.05;	  Boundary	   factor	  4;	   Significance	   level	  
confidence	   interval	   0.95).	   Following	   statistical	   analysis	   proteins	   were	   Gene	  
Ontology	  (GO)	  categorized	  using	  STRAP	  (Bhatia	  et	  al.,	  2009).	  
	  
RNA	  isolation	  and	  real-­‐time	  PCR	  analysis	  
	  
I11	  strain	  was	  grown	  under	  similar	  conditions	  to	  those	  described	  earlier	  for	  the	  
proteomic	   labelling.	   	  Bacterial	  cells	  were	  harvested	  at	  two	  time	  points,	  before	  
spiking	  the	  culture	  with	  65	  μg	  L-­‐1	  of	  ibuprofen	  (at	  OD600~0.6)	  and	  1h	  after.	  5	  mL	  
culture	   from	   each	   time	   point	   were	   collected	   and	   cells	   were	   harvested	   by	  
centrifugation	   at	   6,000	   xg	   for	   10	   min	   and	   immediately	   frozen	   by	   dipping	   in	  
liquid	  nitrogen	  and	  stored	  at	  -­‐80°C.	  Total	  RNA	  was	  extracted	  from	  frozen	  pellets	  
using	   the	   Ribopure	   Bacterial	   kit	   (Ambion)	   according	   to	   the	   manufacturer's	  
instructions.	   The	   RNA	  was	   then	   treated	  with	   DNase	   I	   (Fermentas)	   to	   remove	  
trace	  amounts	  of	  genomic	  DNA.	  	  The	  RNA	  quality	  was	  checked	  by	  running	  1	  %	  
agarose	   gel	   and	   the	   concentration	   was	   quantified	   using	   NanoDrop	  
spectrophotometer	  (NanoDrop	  Technologies,	  USA).	  The	  incubations	  were	  done	  
in	  duplicate.	  	  
	  
Complementary	  DNA	  (cDNA)	  was	  synthesized	  by	  reverse	  transcription	  of	  equal	  
amounts	   of	   total	   RNA	   (0.5	   μg)	   from	   each	   time	   point	   (in	   total	   4)	   using	   the	  
AffinityScript	   qPCR	   cDNA	  Synthesis	   kit	   (Stratagene)	   following	   the	   kit	   protocol.	  
Triplicate	  25	  μL	  SYBR-­‐based	  real-­‐time	  PCR	  reactions	  were	  run	  containing:	  12.9	  
μL	  Brilliant	  III	  SYBR	  Green	  REAL-­‐TIME	  PCR	  Master	  mix	  (Stratagene),	  0.8	  μg	  μL-­‐1	  





ROX	  reference	  dye	  (Stratagene),	  and	  5	  μL	  of	  undiluted	  cDNA	  for	  target	  genes,	  
or	   5	   μL	   of	   1:100	   dilution	   for	   the	   reference	   gene.	   Reactions	   were	   run	   on	  
Mx3005P	  (Stratagene)	  3	  min	  at	  95	  °C,	  40	  cycles	  of	  30	  s	  at	  95	  °C,	  20	  s	  at	  60	  °C,	  20	  
s	  at	  72	  °C,	  and	  finally	  melting	  profile	  analysis.	  Fluorescence	  was	  measured	  after	  
each	   annealing	   step.	   The	   specificity	   of	   the	   PCR	   reactions	   performed	   for	   each	  
run	  was	   confirmed	  by	   the	  melting	   curve	   analysis	   and	   gel	   electrophoresis.	   For	  
data	  analysis,	  the	  fold	  change	  in	  expression	  was	  calculated	  for	  each	  target	  gene	  
between	   the	   two	   time	   points	   using	   the	   CT	   method	   (Liu	   and	   Saint,	   2002)	   as	  
described	  in	  detail	  in	  (Schmittgen	  and	  Livak,	  2008).	  For	  the	  normalization	  of	  the	  
results,	   the	   expression	   of	   the	   16S	   rRNA	   gene	   was	   used	   as	   an	   endogenous	  
reference	   (Talaat	   et	   al.,	   2002;	   Zhang	   et	   al.,	   2000).	   The	   gene-­‐specific	   primers	  
used	   in	   this	   study	   were	   designed	   using	   the	   GeneFisher	   (Bielefeld	   University,	  
Bielefeld,	   Germany)	   and	   synthesized	   by	   Invitrogen	   Life	   Technologies	   and	   are	  




Samples	  were	  taken	  during	  the	  metabolic	  labelling,	  centrifuged	  at	  6,000	  xg	  for	  
5	   min	   and	   the	   supernatant	   filtered	   through	   a	   0.2	   µm	   SPARTAN	   (Whatman,	  
Dassel,	  Germany)	  filter	  prior	  to	  ibuprofen	  analysis.	  	  
	  
The	   ibuprofen	   quantification	   was	   determined	   by	   an	   ultra-­‐high-­‐speed	   liquid	  
chromatography	   system	   (ACQUITY	   UPLC	   System,	   Waters	   Chromatography,	  
Milford,	  MA,	  USA)	  equipped	  with	  a	  photodiode	  array	  detector	  and	  Empower2	  
data	   acquisition	   software	   (Waters	   Chromatography).	   Samples	  were	   separated	  
using	   a	   reversed	   phase	   C18	   column	   (Hibar	   Purospher	   STAR	   RP-­‐18,	   3	   µM,	  
Merck).	   Ibuprofen	   was	   eluted	   in	   isocratic	   mode,	   using	   50%	   (v/v)	   acetonitrile	  





eluents,	   for	   3.5	   min,	   at	   35	   ºC	   with	   a	   constant	   flow	   rate	   of	   0.30	   mL	   min-­‐1.	  
Ibuprofen	   was	   detected	   at	   220	   nm	   and	   samples	   were	   injected	   twice	   in	   a	  
volume	  of	  20	  µL.	  The	  retention	  time	  of	  the	  compound	  (2.9	  min)	  was	  compared	  
with	   a	   standard	   for	   identification,	   and	   the	   peak	   area	   was	   used	   for	  
quantification.	  	  
	  
All	   reagents,	   acetonitrile	   (Fisher	   Scientific,	   Fair	   Lawn,	   USA),	   phosphoric	   acid	  
85%	  (Sigma	  Aldrich,	  Germany)	  and	  methanol	  (Fisher	  Scientific,	  Fair	  Lawn,	  USA),	  
were	  of	  HPLC	  gradient	  grade,	  with	  a	  purity	  of	  ≥	  99%,	  according	  to	  the	  supplier.	  
Prior	  to	  use,	  solutions	  were	  filtered	  through	  Whatman	  filters	  (Dassel,	  Germany)	  
–	  SPARTAN™	  (0.2	  µm)).	  The	  water	  used	  in	  the	  study	  was	  produced	  by	  the	  Milli-­‐
Q	   water	   system	   (Millipore,	   CA,	   USA).	   Ibuprofen	   was	   obtained	   from	   Sigma-­‐
Aldrich	  (Germany).	  
	  
Bacterial	  whole-­‐genome	  sequencing	  
	  
Library	  preparation	  for	  Illumina	  sequencing	  
	  
DNA	  was	  purified	  from	  the	  bacterial	  isolate	  I11	  cultivated	  on	  LB-­‐medium	  using	  
the	  UltraClean	  Microbial	  DNA	   Isolation	  Kit	   (MoBio,	  Carlsbad,	  CA).	  A	   library	   for	  
paired-­‐end	  sequencing	   (PE)	  was	  prepared	   from	  5	  µg	  of	  PicoGreen	   (Invitrogen,	  
UK)	   quantified	   DNA	   using	   Paired-­‐End	   Sample	   Prep	   Kit	   (Illumina,	   CA,	   USA),	  
according	   to	   manufacturer´s	   instructions.	   Briefly,	   DNA	   was	   fragmented	   by	  
nebulization	   to	   generate	   fragments	   <	   800	   bp.	   The	   genomic	   fragments	   were	  
blunt	  ended	  and	  phosphorylated	  and	  a	  single	  ‘A’	  nucleotide	  was	  added	  to	  the	  3’	  
ends	   of	   the	   fragments.	   Adapters	   were	   ligated	   to	   the	   A-­‐tailed	   fragments	  
according	  to	  the	  manufacturer’s	  instructions.	  Size	  fractionation	  and	  purification	  





containing	   DNA	   in	   the	   500	   bp	   range	   were	   cut,	   purified	   and	   the	   library	  
enrichment	  was	  achieved	  by	  using	  12	  PCR	  cycles	  with	  primers	  PE1.0	  and	  PE2.0	  
supplied	   by	   the	   kit	   manufacturers.	   Finally,	   the	   PE	   library	   was	   purified	   using	  
QIAquick	  PCR	  Purification	  Kit	  (Qiagen,	  Germany)	  and	  validated	  by	  running	  10	  %	  
of	  the	  product	  on	  an	  agarose	  gel.	  The	  stock	  was	  kept	  at	  -­‐20	  ºC	  until	  used.	  
	  
Sequencing	  and	  de	  novo	  genome	  assembly	  
	  
The	  flow	  cell	  was	  prepared	  according	  to	  the	  manufacturer’s	  instructions	  using	  a	  
Paired-­‐End	   Cluster	   Generation	   Kit	   (Illumina,	   CA,	   USA).	   PE	   sequencing	   was	  
performed	  on	  an	   Illumina	  GAII	   (Illumina,	  CA,	  USA).	  Five	  picomolar	  of	   the	   final	  
library	  was	  used	   to	  achieve	  approximately	  200,000	  clusters	  per	   tile	  producing	  
paired-­‐end	  reads	  of	  a	  2	  x	  72	  bp	  in	  length.	  Base-­‐calling	  was	  performed	  with	  the	  
GAPipeline	  1.5	  using	  default	  parameters,	  which	  include	  purity	  filtering	  (chastity	  
0.6).	  All	  PE	  reads	  were	  trimmed	  for	  length	  and	  quality	  using	  the	  CLC	  Genomics	  
Workbench	   v.4.5.1	   (CLCBio,	   Denmark)	   with	   a	   quality	   score	   limit	   of	   0.01.	   All	  
reads	   resulting	   in	   less	   than	   35	   bp	   in	   length	   were	   discarded.	   The	   de	   novo	  
assembly	   of	   the	   PE	   reads	   was	   performed	   using	   both	   the	   CLC	   Genomics	  
Workbench	   and	   ABySS	   v.	   1.2.7	   (Simpson	   et	   al.,	   2009)	   (k	   =	   47	   and	   n	   =	   10).	  
Default	  parameters	  were	  used	   for	  assembly	   in	  CLC	  except	   that	   the	   size	   range	  
(minimum	  and	  maximum)	  between	  the	  PE	  reads	  was	  adjusted	   to	  100-­‐600	  bp.	  
The	  resulting	  contigs	  from	  CLC	  and	  ABySS	  were	  merged	  into	  one	  set	  of	  contigs	  
using	  Minimus	  from	  the	  AMOS	  software	  package	  (Sommer	  et	  al.,	  2007).	  Finally,	  
the	   annotation	   of	   the	   genome	  was	   determined	  by	   uploading	   the	   contigs	   into	  
RAST	  (Rapid	  Annotations	  using	  Subsystem	  Technology)	  server	  (Aziz	  et	  al.,	  2008)	  
and	   structural	   rRNAs	   and	   tRNAs	   were	   determined	   using	   RNAmmer	   and	  







In	   this	   study	   a	   bacterial	   strain	   (I11)	   isolated	   from	  activated	   sludge	   capable	   of	  
degrading	   ibuprofen	  was	   subjected	   to	   quantitative	   proteomics,	   characterizing	  
the	  relative	  changes	  in	  the	  proteome	  associated	  with	  growing	  this	  strain	  in	  the	  
presence/absence	  of	  ibuprofen.	  	  
	  
Strain	   I11	   did	   not	   grow	   on	   ibuprofen	   as	   a	   sole	   source	   of	   carbon	   and	   energy	  
(data	  not	  shown).	  However,	  simultaneous	  growth	  and	  degradation	  of	  ibuprofen	  
was	  observed	  on	  M9	  medium	  supplemented	  with	  yeast	  extract	  and	  tryptone	  at	  
different	  initial	  ibuprofen	  concentrations	  and	  in	  OD2-­‐medium	  (Figure	  4.3).	  	  
	  
The	  effect	  of	   the	   initial	   concentration	  of	   ibuprofen	  on	   the	  degradation	  by	   I11	  
revealed	   that	   after	   300	   h	   the	   concentration	   of	   the	   parent	   compound	   was	  
reduced	  28	  %	  and	  50	  %	  when	   grown	   in	  M9	  media	  with	   1000	   and	  250	  μg	   L-­‐1,	  
respectively.	   A	   reduction	   of	   62	   %	   and	   92	   %	   after	   90	   h	   was	   observed	   on	  M9	  
medium	  and	  OD2-­‐medium,	  respectively,	  for	  the	  initial	  ibuprofen	  concentration	  
of	  50	  μg	  L-­‐1.	  
	  
Metabolic	   labelling	   of	   this	   isolate	   with	   15N,	   using	   a	   forward/reverse-­‐labelling	  
strategy,	   was	   applied	   yielding	   biological	   duplicates	   	   (see	   Figure	   7.2	   in	   the	  
supplemental	   material).	   Ibuprofen	   degradation	   always	   followed	   a	   linear	  
degradation	   throughout	   the	   first	   30	   h.	   To	   avoid	  Patulibacter	   sp.	   I11	   entering	  
stationary	   growth	   phase,	   all	   incubations	   were	   carried	   out	   until	   the	   mid-­‐

























Figure	  4.3.	  Degradation	  of	  ibuprofen	  and	  growth	  performance	  of	  Patulibacter	  sp.	  I11	  in:	  
a	  M9	  medium	  supplemented	  with	  yeast	  extract	  and	  tryptone	  and	  1,000	  or	  250	  μg	  L-­‐1	  of	  
ibuprofen;	  b	  M9	  medium	  supplemented	  with	  yeast	  extract	  and	  tryptone	  and	  50	  μg	  L-­‐1	  
of	  ibuprofen,	  and	  OD2-­‐medium	  supplemented	  with	  50	  μg	  L-­‐1	  ibuprofen.	  
	  
Whole	  genome	  sequencing	  
	  
To	   increase	   the	   efficiency	   of	   the	   MS-­‐based	   protein	   identification,	   which	   is	  
known	  to	  decrease	  as	  amino	  acid	  divergence	  between	  measured	  peptides	  and	  
database	   entries	   increases	   (VerBerkmoes	   et	   al.,	   2009),	   whole-­‐genome	  
sequencing	   of	   I11	   was	   carried	   out.	   The	   assembly	   resulted	   in	   a	   total	   of	   358	  





bp	   and	   an	   N50	   contig	   length	   of	   24.7	   kb.	   The	   uncompleted	   draft	   genome	  
included	   5,093,141	   bases	   (5.1	   Mb)	   and	   comprised	   4,408	   predicted	   coding	  
sequences	   (CDSs),	   with	   a	   G+C	   content	   of	   74	   %.	   Among	   the	   4,408	   predicted	  
protein	   coding	   sequences,	   1,387	   (31.4	   %)	   were	   of	   unknown	   function.	   The	  
retrieved	   assembled	   genome	  was	   annotated	  by	  RAST	   (Aziz	   et	   al.,	   2008)	   using	  
sequence-­‐based	  comparison	  against	  genome	  database	  of	  Conexibacter	  woesie	  
(CP001854),	  closest	  phylogenetic	  sequenced	  genome	  available	  with	  the	  highest	  
protein	   similarity	   with	   I11.	   A	   comparative	   alignment	   with	   16S	   rRNA	   gene	  
sequences	   showed	   that	   this	   strain	   had	   a	   96	   %	   similarity	   with	   Patulibacter	  
minatonensis	   (AB193261).	   This	   Whole	   Genome	   Shotgun	   project	   has	   been	  
deposited	   at	   DDBJ/EMBL/GenBank	   under	   the	   accession	   AGUD00000000.	   The	  
version	  described	  in	  this	  paper	  is	  the	  first	  version,	  AGUD01000000.	  
	  
Quantitative	  proteome	  analysis	  of	  ibuprofen	  degrading	  bacteria	  
	  
The	   14N-­‐	   and	   15N-­‐labelled	   cells	   were	   harvested,	   lysed	   and	   fractionated	   into	   a	  
cytosolic	   and	   a	   membrane	   fraction	   and	   mixed	   in	   accordance	   with	   the	  
forward/reverse-­‐labelling	   strategy	   and	   separated	   by	   SDS-­‐PAGE.	   No	   major	  
differences	   were	   evident	   by	   direct	   visualization	   when	   comparing	   the	   isolate	  
grown	  under	  the	  two	  different	  sets	  of	  conditions	  (Figure	  4.4).	  
	  
For	   each	   of	   the	   two	   biological	   replicates	   (forward	   and	   reverse	   labelling	  
experiment)	   the	  membrane	   and	   the	   cytosolic	   fraction	   were	   nested	   following	  
statistical	  analysis.	  In	  total,	  25	  %	  of	  all	  proteins	  proposed	  by	  the	  genome	  could	  
be	  identified.	  Specifically,	  251	  unique	  proteins,	   identified	  and	  quantified,	  were	  
found	  to	  be	  statistically	  significant	  (p<0.05).	  Of	  these,	  251	  proteins,	  99	  proteins	  
were	  shared	  between	  the	  forward	  and	  the	  reverse	  labelling	  experiments,	  when	  





73	   proteins	   were	   exclusively	   present	   in	   the	   forward	   labelling	   experiment	  
whereas	  79	  proteins	  were	  exclusive	  to	  the	  reverse	  labelling	  experiment	  (Figure	  
7.3).	   For	   all	   of	   the	   251	   quantified	   proteins,	   full	   length	   protein	   sequences	  
retrieved	   from	   functionally	   annotated	   genome	   of	   Patulibacter	   sp.	   strain	   I11	  
were	   blasted	   against	   the	   UniRef100	   database,	   yielding	   the	   closest	   protein	  
homologue.	  Proteins	  (closest	  homologues)	  were	  categorized	  based	  upon	  Gene	  
Ontology	  Categories	  (GOC)	  revealing	  similar	  distributions	  between	  the	  forward	  




Figure	   4.4.	   Sodium	  dodecyl	   sulfate–polyacrylamide	  gel	  electrophoresis	  of	  Patulibacter	  
sp.	  I11	  cultured	  in	  OD2-­‐medium	  supplemented	  with	  ibuprofen.	  	  
	  
a	  Membrane	   and	  b	   cytosolic	   associated	   fractions,	   from	   culture	   grown	   in:	  1	   15N-­‐OD2	  
with	  ibuprofen;	  2	  14N-­‐OD2	  without	  ibuprofen;	  3	  15NOD2	  without	  ibuprofen	  and	  4	  14N-­‐









Up-­‐regulated	  proteins	  in	  the	  presence	  of	  ibuprofen	  
	  
Comparative	   analysis	   revealed	   that	   in	   total,	   72	   proteins	   (nesting	   forward	   and	  
reversed	   labelled	   replicates)	   were	   differentially	   up-­‐regulated,	   i.e.	   defined	   as	  
having	   a	   log2	   ratio	   above	   0.9,	   in	   response	   to	   ibuprofen	   feeding.	   Of	   these	   72	  
proteins,	  64	  were	  unique.	  Out	  of	  the	  64	  unique	  up-­‐regulated	  proteins,	  12	  were	  
observed	   in	   both	   the	   forward	   and	   the	   reverse	   labelling	   experiment	  
(supplementary	   material	   Figure	   7.4	   A).	   25	   proteins	   were	   exclusive	   to	   the	  
forward	   labelling	   experiment	   whereas	   15	   were	   exclusive	   to	   the	   reverse	  
labelling	  experiment.	  
	  
Proteins	   were	   functionally	   characterised	   using	   3	   levels	   of	   Gene	   Ontology:	  
biological	   process,	   molecular	   function	   and	   cellular	   component.	   “Cellular	  
processes”	  was	   found	   to	  be	   the	  predominant	  biological	  process,	  with	  75	  %	  of	  
the	  GO	  annotated	  proteins	  falling	  within	  this	  category.	  44	  %	  of	  these	  proteins	  
were	   annotated	   as	   being	   associated	   with	   the	   ribosome.	   As	   for	   molecular	  
function	  annotation,	  “Binding”	  and	  “Catalytic	  activity”	  accounted	  for	  40	  %	  and	  
38.3	  %	  of	  the	  GO	  annotated	  proteins,	  respectively.	  	  
	  
Proteins	   which	   had	   a	   log2	   ratio	   above	   1.5	   were	   dominated	   by	   putative	  
uncharacterized	   proteins.	   In	   an	   attempt	   to	   elucidate	   potential	   biological	  
relevance	  of	  these	  proteins,	  function	  prediction	  was	  attempted	  by	  blasting	  the	  
sequences	  of	  the	  hypothetical	  proteins	  of	  Patulibacter	  sp.	  strain	  I11	  against	  the	  
UniRef100	   database,	   using	   UniProt	   BLAST.	   However,	   no	   function	   could	   be	  
inferred	  based	  upon	  protein	  homology,	  with	  this	  approach.	  Function	  prediction	  
was	   also	   attempted	   with	   ProtFun	   2.2	  
(http://www.cbs.dtu.dk/services/ProtFun/),	   a	   tool	   that	   performs	   ab	   initio	  





proteins,	  D3FA23	  was	  predicted	  as	  having	  a	  possible	  lyase	  function	  and	  D3F6B1	  
as	  a	  possible	   stress	   response	  protein	   (supplementary	  material	   Table	  7.2).	   The	  
tool	   used	   for	   the	   prediction	   was	   developed	   for	   eukaryotic	   cells	   and	   was	  
expected	   to	  have	  a	   lower	   accuracy	  of	   prediction	   for	  prokaryotes.	  However,	   it	  
has	   been	   demonstrated	   that	   the	   tool	   performs	   better	   on	   prokaryotes	   than	  
expected,	  and	  is	  able	  to	  yield	  meaningful	  results	  (Jensen	  et	  al.,	  2002).	  
	  
Within	   the	   group	   of	   proteins	   categorized	   as	   being	   involved	   in	   metabolic	  
processes,	   several	   proteins	   related	   to	   the	   degradation	   of	   aromatic	  
hydrocarbons	  were	   identified.	  A	  number	  of	  proteins	  were	  highly	  up-­‐regulated	  
in	   response	   to	   ibuprofen	   feeding	   (log2	   ratio	   >	   1.5):	   Aminotransferase	   class	   III	  
(E6SEB9),	   Acyl-­‐CoA	   synthetase	   (AMP-­‐forming)	   (J2XUN5),	   protein	   containing	   a	  
Rieske	  (2Fe-­‐2S)	  iron-­‐sulphur	  domain	  (D3F3V3),	  Enoyl-­‐CoA	  hydratase/isomerase	  
(D3F114),	   nuclear	   export	   factor	   GLE1	   (D3F2P4)	   as	   well	   as	   several	  
uncharacterised	   proteins	   (Table	   4.1).	   Proteins	   involved	   in	   catalytic	   processes	  
represented	   an	   abundant	   group	   of	   up-­‐regulated	   proteins	   with	   a	   possible	  
correlation	  with	   ibuprofen	   degradation	   and	  were	   composed	   of	   cytochrome	   b	  
and	   c,	   several	   dehydrogenases	   and	   oxidoreductases	   (Table	   4.1).	   Proteins	  
involved	  in	  fatty-­‐acid	  metabolism	  and	  energy	  metabolism	  were	  found	  to	  be	  up-­‐
regulated	   as	  well,	   and	   are	   possibly	   related	   to	   energy	   gain	   response.	   Growing	  
the	  isolate	  I11	  in	  the	  presence	  of	  65	  μg	  L-­‐1	  of	  ibuprofen	  does	  not	  appear	  to	  have	  
triggered	  a	  cellular	  stress	  response;	  only	  two	  proteins	  related	  to	  stress	  stimulus,	  
the	   60kDa	   chaperonin	   (D3F2T2)	   and	   the	   predicted	   stress	   response	   protein	  









Table	  4.1.	  Differentially	  expressed	  proteins	  (Log2	  ≥0.9)	  of	  the	  forward	  and	  the	  reversed	  
(numbers	   in	   brackets)	   labeled	   biological	   replicates	   of	   Patulibacter	   sp.	   I11	   grown	   in	  
presence/absence	  of	  ibuprofen.	  
	  
GI	  numberA	   AccessionB	   %	  IdentityC	   DescriptionD	   Log2	  ratioE	   Protein	  ScoreF	   #G	   FractionH	  













367468470	   D3F114	   59	   Enoyl-­‐CoA	  hydratase/isomerase	   3,7	   145	   2	   C	  









367471428	   D3F178	   34	   Putative	  uncharacterized	  protein	   2,4	   482	   24	   M	  
367470191	   E6SEB9	   57	   Aminotransferase	  class-­‐III	   2,4	   96	   8	   C	  
367468134	   J2XUN5	   51	   Acyl-­‐CoA	  synthetase	  (AMP-­‐forming)	   2,3	   314	   6	   M	  




















































367469421	   F1YMM4	   33	   Glycosidase	   1,4	   749	   16	   M	  









367470912	   D3FEF4	   33	   PpiC-­‐type	  peptidyl-­‐prolyl	  cis-­‐trans	  isomerase	   1,3	   958	   64	   M	  
367471028	   D3EZ72	   27	   Putative	  uncharacterized	  protein	   (1,3)	   (881)	   (46)	   (M)	  
367470919	   D3FEE9	   65	   Putative	  uncharacterized	  protein	   (1,3)	   (252)	   (8)	   (C)	  
367470503	   D3F3V1	   58	  
Cytochrome	  b	  subunit	  of	  










367470155	   D3FEU2	   74	   Elongation	  factor	  G	   1,2	   1109	   24	   M	  


















367469831	   D3FBI3	   67	  
Daunorubicin	  resistance	  










367469604	   Q8XZ05	   57	  
Probable	  dihydrolipoamide	  
acetyltransferase	  
component	  of	  pyruvate	  
dehydrogenase	  complex	  
(E2)	  protein	  
1,1	   104	   2	   C	  
367469495	   D3F0K9	   70	  
Carbamoyl-­‐phosphate	  
synthase	  L	  chain	  ATP-­‐
binding	  protein	  
1,1	   453	   8	   M	  





GI	  numberA	   AccessionB	   %	  IdentityC	   DescriptionD	   Log2	  ratioE	   Protein	  ScoreF	   #G	   FractionH	  













367467388	   D3FDE9	   67	   Oxidoreductase	  alpha	  (Molybdopterin)	  subunit	   (1,1)	   (113)	   (7)	   (M)	  
367469830	   D3FBI2	   59	   ABC-­‐2	  type	  transporter	   1,0	   161	   4	   M	  









367469164	   D3FBH9	   65	   Extracellular	  solute-­‐binding	  protein	  family	  1	   1,0	   369	   8	   M	  
367470502	   D3F8X9	   43	   Putative	  uncharacterized	  protein	   1,0	   130	   4	   M	  
367469765	   D3F3V2	   65	   Cytochrome	  b/b6	  domain	  protein	   1,0	   128	   4	   M	  
367467620	   D3F8Q5	   73	   Aminotransferase	  class-­‐III	   1,0	   130	   3	   M	  
367469524	   D3FAW8	   68	   6-­‐phosphofructokinase	   (1,0)	   (417)	   (8)	   (C)	  
367467800	   D3F2P4	   33	   Nuclear	  export	  factor	  GLE1	   (1,0)	   (292)	   (13)	   (M)	  
367467449	   C9W357	   50	   Amino	  acid/metabolite	  permease	   (1,0)	   (181)	   (9)	   (M)	  
367470156	   D3FEU3	   87	   Elongation	  factor	  Tu	   1,0	   821	   104	   M	  
367471419	   D3F251	   35	   Putative	  uncharacterized	  protein	   0,9	   607	   12	   M	  
367467099	   D4KJY6	   31	   Putative	  uncharacterized	  protein	   0,9	   222	   5	   M	  
367471018	   D3F5M2	   67	   Enoyl-­‐[acyl-­‐carrier-­‐protein]	  reductase	  [NADH]	   0,9	   463	   16	   M	  
367467622	   Q1AWV4	   42	   Tfp	  pilus	  assembly	  protein	  PilE	   0,9	   260	   14	   M	  
367469219	   E4M2D6	   45	  
Phosphate	  ABC	  
transporter	  substrate-­‐
binding	  protein,	  PhoT	  
family	  
0,9	   113	   4	   M	  
367467446	   Q1AR79	   68	   Betaine-­‐aldehyde	  dehydrogenase	   0,9	   275	   6	   C	  
367469269	   D3F5Z5	   75	   Acyl-­‐CoA	  dehydrogenase	  domain	  protein	   (0,9)	   (189)	   (5)	   (M)	  
367469961	   D8TVG4	   27	   Putative	  uncharacterized	  protein	   (0,9)	   (594)	   (34)	   (M)	  
367469169	   Q3K4T7	   43	   Transcriptional	  regulatory	  protein	  AlgP	   (0,9)	   (204)	   (6)	   (M)	  
Duplicate	  proteins	  have	  been	  eliminated	  based	  upon	  number	  of	  quantitated	  peptides	  
used	  for	  protein	  quantitation	  (#)	  and	  protein	  score.	  Ribosomal	  proteins	  were	  excluded	  
from	  the	  list.	  
a	  NCBI	  GenBank	  accession	  number	  
b	   UniProt	   accession	   number	   of	   the	   closets	   protein	   homologue,	   obtained	   by	   blasting	   the	  
translated	  sequence	  retrieved	  from	  GenBank	  using	  UniProt	  blast	  
c	  %	  identity	  of	  the	  closest	  protein	  orthologue	  
d	  Description	  of	  the	  closest	  protein	  orthologue	  
e	  Log2	  ratio	  obtained	  from	  the	  quantitative	  proteomics	  analysis	  
f	  Protein	  Score	  obtained	  from	  the	  quantitative	  proteomics	  analysis	  
g	   The	   number	   of	   quantitated	   peptides	   upon	   which	   the	   quantitative	   value	   (log2	   ratio)	   was	  
determined	  





Several	  proteins	  related	  to	  the	  up-­‐take	  and	  degradation	  of	  other	  aromatic	  acids	  
(i.e.	  benzoate	  and	  phenylacetic	  acid)	  were	  found	  up-­‐regulated	  in	  the	  presence	  
of	   ibuprofen:	   enoyl-­‐CoA	   hydratase/isomerase	   (D3F114),	   Acyl-­‐CoA	   synthetase	  
(AMP-­‐forming)	   (J2XUN5)	   and	   Rieske	   (2Fe-­‐2S)	   iron-­‐sulphur	   domain	   protein	  
(D3F3V3).	   Similarly	   proteins	   related	   to	   transport	   and	   binding	   of	   extracellular	  
compounds	   were	   up-­‐regulated	   in	   the	   presence	   of	   ibuprofen	   and	   might	   be	  
related	   to	   the	   uptake	   of	   this	   compound:	   ABC-­‐2	   type	   transporter	   (D3FBI2),	  
daunorubicin	   resistance	  ABC	   transporter	  ATPase	   (D3FBI3)	  and	  an	  extracellular	  
solute-­‐binding	  protein	  type	  1	  family	  (D3FBH9).	  
	  
Down-­‐regulated	  proteins	  in	  the	  presence	  of	  ibuprofen	  
	  
Proteome	  analysis	   revealed	   the	  down-­‐regulation	  of	   a	   total	   of	   103	  proteins	   of	  
which	  96	  proteins	  were	  unique;	  35	  and	  27	  were	  exclusive	   to	   the	   forward	  and	  
reverse	  labelling	  experiment,	  respectively;	  17	  were	  common	  to	  both	  (Figure	  7.4	  
B).	  	  
	  
The	   majority	   of	   these	   proteins	   are	   related	   to	   binding	   of	   extracellular	  
compounds	   (41	   %)	   and	   catalytic	   activities	   inside	   the	   cell	   (41	   %).	   	   The	   most	  
prominent	  down-­‐regulated	  proteins,	  with	  a	  log2	  ratio	  between	  -­‐4	  to	  -­‐1.5	  were	  
proteins	   involved	   in	   transport,	   mainly	   as	   binding	   proteins	   –	   Htaa	   domain	  
protein	   (D3FBZ2),	   several	   periplasmic	   binding	   proteins	   (B5H4G4,	   D3M8C8,	  
D3F9P9)	   and	   PKD	   domain	   protein	   (D3F790)	   -­‐	   catalytic	   activity	   like	   NADH-­‐
quinone	  oxidoreductase	  subunit	   I	   (D3FDL4),	  NADH	  dehydrogenase	   I-­‐D	  subunit	  
(D3FDK9),	   acyl-­‐CoA	   dehydrogenase	   domain	   protein	   (D3F5Z5),	   and	   several	  
putative	   uncharacterized	   proteins	   (Table	   4.1).	   Other	   down-­‐regulated	   proteins	  
were	   involved	   in:	   TCA	   cycle	   (citrate	   synthase	   (D3FCP7),	   isocitrate	  





and	  succinyl-­‐CoA	  ligase	  [ADP-­‐forming]	  subunit	  alpha	  (D3F0L5),	  translation/post	  
translational	  modifications	  (30S	  and	  50S	  ribosomal	  proteins),	  transport	  systems	  
(ABC	  transporter	  related	  protein	  (D3FCG2),	  predicted	  cobalt	  transporters	  CbtA	  
(F2RKH7),	   and	   some	   proteins	   related	   to	   stress	   response	   like	   peroxidase	  




The	   genome	   sequence	   of	   Patulibacter	   sp.	   strain	   I11	   was	   analysed	   for	   the	  
presence	  of	  putative	  orthologous	  genes	  known	  to	  be	  involved	  in	  aromatic	  acid	  
degradation.	  The	  focus	  was	  on	  those	  previously	  hypothesized	  to	  be	  involved	  in	  
the	   biodegradation	   of	   ibuprofen	   (Kagle	   et	   al.,	   2009)	   and	   in	   two	   other	  
structurally	  similar	  aromatic	  hydrocarbons,	  phenylacetic	  acid	  (Ferrandez	  et	  al.,	  
1998)	  and	  benzoate	  (Craven	  et	  al.,	  2009).	  	  
	  
Sphingomonas	   strain	   Ibu-­‐2	  was	   previously	   isolated	   from	   activated	   sludge	   and	  
characterized	   for	   its	  ability	   to	  use	   ibuprofen	  as	  a	  sole	  carbon	  source	   (Kagle	  et	  
al.,	  2009).	   In	  that	  study,	  genetic	  and	  biochemical	  analysis	  revealed	  a	  cluster	  of	  
genes	  (ipfABDEF)	  that	  were	  proposed	  to	  be	  involved	  in	  ibuprofen	  catabolism.	  A	  
search	   in	   the	   strain	   I11	   genome	   revealed	   five	   orthologous	   genes	   whose	  
products	   share	   33-­‐40	   %	   amino	   acid	   sequence	   similarity	   with	   those	   found	   in	  
Sphingomonas	   Ibu-­‐2	   (Supplementary	   material	   Table	   7.3).	   Only	   one	   of	   these	  
genes,	   ipfF,	   which	   sharing	   33	   %	   amino	   acid	   similarity,	   was	   found	   to	   be	   up-­‐
regulated	   in	   this	   study	   encoding	   for	   Acyl-­‐CoA	   synthetase	   (AMP-­‐forming)	  
(J2XUN5).	   Interestingly,	   a	   protein	   containing	   a	   Rieske	   (2Fe-­‐2S)	   iron-­‐sulphur	  
domain	   (D3F3V3)	   was	   found	   up-­‐regulated	   in	   ibuprofen-­‐grown	   cells	   sharing	  





In	  the	  same	  line,	  Acinetobacter	  strain	  ADP1	  was	  shown	  to	  degrade	  benzoate	  as	  
the	  sole	  carbon	  source	  (Craven	  et	  al.,	  2009).	  Two	  clusters	  of	  genes,	  ben	  genes	  
(benABCDEKPM)	   and	   cat	   genes	   (catABCDFIJM)	   have	   been	   described	   to	   be	  
involved	   in	   the	   metabolism	   of	   aromatic	   hydrocarbons	   including	   benzoate	  
(Craven	   et	   al.,	   2009).	   Protein	   blast	   of	   the	   two	   clusters	   of	   genes	   against	   the	  
predicted	   proteome	   of	   Patulibacter	   sp.	   I11	   yielded	   a	   24-­‐43	   %	   identity	   (Table	  
7.3).	  	  
	  
Finally,	   13	   catabolic	   enzymes	   (paaABCEFGHIJKLMN)	   were	   reported	   in	   the	  
aerobic	  degradation	  of	  phenylacetic	  acid	  in	  E.coli	  strain	  -­‐	  K12	  (Ferrandez	  et	  al.,	  
1998).	   Fifteen	   of	   the	   genes	   encoding	   these	   enzymes	   were	   recognized	   in	   the	  





Incubation	   of	   I11	   in	   OD2-­‐medium	   under	   the	   same	   conditions	   used	   for	   the	  
proteomic	  approach	  was	  conducted	  to	  analyse	  an	  early	  response	   in	   ibuprofen	  
induction	   genes.	   qPCR	  was	   employed	   in	   order	   to	   confirm	   the	  proteomic	   data	  
and	  to	  investigate	  to	  which	  extent	  the	  ibuprofen	  up-­‐regulated	  proteins	  found	  in	  
this	  study	  correlated	  with	  its	  transcript	  levels.	  Transcript	  levels	  of	  the	  six	  genes	  
encoding	   proteins	   whose	   levels	   appeared	   to	   increase	   in	   the	   presence	   of	  
ibuprofen	   in	   the	  differential	  proteomic	  approach	  and	   the	   ipf	   genes	  previously	  
proposed	   to	   be	   involved	   in	   ibuprofen	   degradation	   (Kagle	   et	   al.,	   2009)	   were	  
measured	  (Table	  4.2	  and	  4.3).	  	  Based	  on	  the	  change	  in	  transcript	  levels	  prior	  to	  
addition	  of	   ibuprofen	  and	  1h	  after	   ibuprofen	  addition	   to	   the	  medium	  positive	  






Table	   4.2.	   Transcript	   levels	   of	   the	   six	   genes	   encoding	   proteins	   up-­‐regulated	   in	   the	  




B	   %	  IdentityC	   Description
D	   Log2	  ratioE	   Fold	  changeF	  





367468470	   D3F114	   59	   Enoyl-­‐CoA	  hydratase/isomerase	   3,7	   1.21	  ±	  0.10	  
367468134	   J2XUN5	   51	   Acyl-­‐CoA	  synthetase	  (AMP-­‐forming)	   2,3	   1.60	  ±	  0.14	  
367470501	   D3F3V3	   61	   Rieske	  (2Fe-­‐2S)	  iron-­‐sulphur	  domain	  protein	   1,4	  (0,9)	   -­‐1.49	  ±	  0.09	  
367469831	   D3FBI3	   67	   Daunorubicin	  resistance	  ABC	  transporter	  ATPase	  subunit	  
1,1	  
(0,9)	   1.24	  ±	  0.14	  
367469830	   D3FBI2	   59	   ABC-­‐2	  type	  transporter	   1,0	   1.22	  ±	  0.10	  
367469164	   D3FBH9	   65	   Extracellular	  solute-­‐binding	  protein	  family	  1	   1,0	   1.43	  ±	  0.15	  
	  
a	  NCBI	  GenBank	  accession	  number	  
b	  UniProt	  accession	  number	  of	  the	  closets	  protein	  homologue,	  obtained	  by	  blasting	  the	  
translated	  sequence	  retrieved	  from	  GenBank	  using	  UniProt	  blast	  
c	  %	  identity	  of	  the	  closets	  protein	  homologue	  
d	  Description	  of	  the	  closets	  protein	  homologue	  
e	  Log2	  ratio	  obtained	  from	  the	  quantitative	  proteomics	  analysis	  
f	  Fold	  change	   in	  target	  gene	  relative	  to	  untreated	  as	  measured	  by	  qPCR	  and	  analysed	  
using	  the	  CT	  method	  
	  
These	  positive	  correlations	  were	  corrected	  for	  sampling	  and	  analysis	  biases	  by	  
adjusting	  to	  the	  levels	  of	  I11-­‐16S	  rRNA	  gene	  and	  the	  increase	  in	  fold	  was	  found	  
to	  range	  between	  1.21	  ±	  0.10	  and	  1.60	  ±	  0.14	  (n=3).	  Negative	  correlation	  was	  
observed	  only	   for	  D3F3VE	   (-­‐1.49	   ±	   0.09;	   n=3).	   Elevated	   transcript	   levels	  were	  
detected	   for	   the	  4	  of	   the	  5	   tested	   ipf	  genes	  with	  a	   fold	   increase	  ranging	   from	  
1.53	  ±	  0.12	  and	  2.9	  ±	  0.16	  (n=3)	  	  (Table	  4.3).	  Interestingly,	  only	  IpfF	  that	  shared	  
51	  %	   amino	   acid	   similarity	  with	   J2XUN5	   (up-­‐regulated	   at	   the	   proteome	   level)	  
was	   not	   up-­‐regulated	   at	   the	   transcript	   level.	   None	   of	   the	   other	   ipf	   gene	  






Table	  4.3.	  Transcript	  levels	  of	  Patulibacter	  sp.	  I11	  genes,	  similar	  Sphingomonas	  Ibu-­‐2	  ipf	  




a	  NCBI	  accession	  number	  of	  Patulibacter	  sp.	  strain	  I11	  genes	  
b	  UniProt	  accession	  number	  of	  Sphingomonas	  Ibu-­‐2	  genes	  
c	  Fold	  change	  in	  target	  gene	  relative	  to	  untreated	  as	  measured	  by	  qPCR	  and	  analysed	  




This	  work	  describes	  the	  first	  characterization	  of	  the	  changes	  in	  the	  proteome	  of	  
a	   bacterial	   strain	   isolated	   from	   activated	   sludge	   in	   response	   to	   ibuprofen	  
degradation,	  using	  a	  combination	  of	  genomic	  and	  proteomic	  techniques.	  A	  pure	  
culture	   of	  Patulibacter	   sp.	   strain	   I11	  was	   obtained	   from	   activated	   sludge	   and	  
showed	   capable	   of	   degrading	   ibuprofen	   in	   M9	   medium	   supplemented	   with	  
another	  carbon	  source	  and	  in	  rich	  media	  such	  as	  OD2-­‐medium	  under	  different	  
initial	  concentrations	  of	  ibuprofen	  with	  up	  to	  92	  %	  removal	  within	  90	  h.	  	  Using	  
isotopic	   labelling	   relative	   quantification	   of	   protein	   expression	   levels	   in	   the	  
presence/absence	  of	  ibuprofen	  was	  carried	  out.	  
Name	  
(orf	  no.)A	  






























synthetase	  and	  ligase	  





Metabolic	  labelling	  incubations	  were	  carried	  out	  at	  the	  mid-­‐logarithmic	  growth	  
phase	  with	  similar	  ibuprofen	  reduction	  in	  all	  tested	  cultures.	  Comparison	  of	  the	  
proteomes	   obtained	   from	   the	   exponential	   growth	   stage	   ensured	   that	   events	  
related	  to	  oxidative	  stress,	  cell	  lysis	  and	  death	  were	  kept	  at	  a	  minimum.	  In	  the	  
present	  study,	  only	  a	  few	  stress-­‐related	  proteins	  were	  identified.	  	  
	  
The	   genome	   of	   the	   isolate	   I11	   was	   sequenced	   and	   used	   as	   a	   reference	  
sequence	   for	   identifying	   proteins	   from	   the	   MS	   data.	   The	   closest	   related	  
genome	  available	  to	  this	  strain	  was	  from	  C.	  woesie	  (CP001854),	  which	  was	  used	  
in	   the	   genome	   annotation.	   Sequence	   analysis	   of	   the	   16S	   rRNA	   gene	   of	   this	  
isolate	   revealed	  a	  96	  %	   similarity	  with	  P.	  minatonensis	   (AB193261).	  C.	  woesie	  
and	  Patulibacter	  minatonensis	  are	  both	  gram-­‐positive	  soil-­‐isolated	  members	  of	  
the	   class	  Actinobacteria.	   Other	   ibuprofen	   degrading	  microorganisms	   found	   in	  
literature	  are	  the	  proteobacterial	  Sphingomonas	  Ibu-­‐2	  (Murdoch	  and	  Hay	  2005)	  
and	   the	   actinobacterial	  Nocardia	   sp.	   (Chen	   and	   Rosazza,	   1994)	   although	   the	  
latter	  does	  not	  grow	  on	  ibuprofen.	  	  Interestingly,	  this	  was	  the	  first	  time	  that	  a	  
member	   of	   the	   genus	   Patulibacter	   was	   isolated	   from	   activated	   sludge	   and	  
reported	  as	  being	  able	  to	  remove	  ibuprofen.	  	  
	  
A	   sub-­‐fractionation	   of	   the	   soluble	   (cytosolic	   proteins)	   and	   non-­‐soluble	  
(membrane	   proteins)	   protein	   fractions	   was	   carried	   out	   prior	   to	   1D-­‐gel	   based	  
shotgun-­‐proteomics	  in	  order	  to	  increase	  proteome	  coverage	  and	  resolution.	  In	  
total	  251	  unique	  proteins	  were	   identified	  and	  quantified,	  corresponding	  to	  an	  
approximately	  5	  %	  coverage	  of	  the	  proteome	  of	  the	  Patulibacter	  sp.	  strain	  I11.	  
A	   bias	   toward	   high-­‐abundance	   proteins	   exists,	   affecting	   protein	   identification	  
and	  protein	  quantitation,	   and	   resulting	   in	   limited	  proteome	  coverage.	  A	   large	  
number	   of	   proteins	   within	   the	   group	   of	   highly	   up-­‐regulated	   proteins	   were	  





uncharacterized	   proteins	   resulted	   in	   the	   identification	   of	   two	   of	   them:	   a	  
putative	   lyase	   and	   a	   stress	   response	   protein.	   Several	   lyases	   are	   known	   to	  
participate	   in	   the	   degradation	   of	   aromatic	   compounds	   (Nadeau	   et	   al.,	   2003).	  
Proteins	   related	   to	   metabolism	   of	   ibuprofen	   may	   not	   be	   among	   the	   most	  
abundant	  proteins	  and	  might	   therefore	   lead	   to	  difficulties	   in	   identifying	   some	  
of	   the	   proteins	   involved	   in	   ibuprofen	   degradation	   pathway.	   Nevertheless,	  
among	  the	  quantified	  and	   identified	  proteins,	  several	  are	   likely	  to	  be	   involved	  
in	   ibuprofen	  degradation.	   Some	  of	   these	  proteins	  were	   identified	   as	  having	   a	  
possible	  role	  in	  the	  actual	  degradation	  whereas	  others	  are	  likely	  related	  to	  the	  
ibuprofen	   uptake	  mechanism.	  Most	   notably,	   proteins	   that	   are	   related	   to	   the	  
degradation	   of	   aromatic	   hydrocarbons	   (e.g.	   phenylacetic	   acid	   and	   benzoate)	  
were	   up-­‐regulated	   in	   the	   presence	   of	   ibuprofen.	   General	   consensus	   was	  
observed	   between	   the	   up-­‐regulated	   proteins	   found	   in	   the	   proteomic	   analysis	  
and	   the	   transcript	   levels	   of	   the	   corresponding	   genes	   as	   estimated	   by	   qPCR.	  
Among	   these	   proteins	   is	   an	   AMP-­‐forming	   synthetase	   that	   is	   known	   to	   be	  
essential	   for	   the	   aerobic	   catabolism	   of	   aromatic	   hydrocarbons	   in	   other	  
microorganisms,	  such	  as	  Pseudomonas	  putida	  U	  (Luengo	  et	  al.,	  2007;	  Martinez-­‐
Blanco	  et	  al.,	  1990).	  This	  type	  of	  enzyme	  is	  commonly	  involved	  in	  the	  first	  step	  
of	   CoA-­‐dependent	   degradation	   pathway,	   catalysing	   the	   formation	   of	   an	   acyl-­‐
CoA	  ester	  with	  the	  release	  of	  AMP	  (Pérez-­‐Pantoja	  et	  al.,	  2009).	   In	  the	  present	  
study,	   Acyl-­‐CoA	   synthetase	   (AMP-­‐forming)	   (J2XUN5)	   was	   up-­‐regulated	   in	   the	  
presence	   of	   ibuprofen	   with	   a	   log2	   ratio	   of	   2.35,	   as	   suggested	   earlier	   in	   the	  
ibuprofen	   degradation	   pathway	   by	   Sphingomonas	   Ibu-­‐2	   (Kagle	   et	   al.,	   2009),	  
which	  strongly	   indicates	  that	   it	  has	  a	  similar	  role	   in	  Patulibacter	  sp.	  strain	   I11.	  	  
However,	  qPCR	  results	  indicated	  that	  the	  orthologous	  gene	  ipfF	  in	  I11	  is	  not	  up-­‐
regulated	  at	   the	   transcription	   level.	   	   Thus	   it	   is	   not	  possible	   to	   conclude	   if	   the	  
Acyl-­‐CoA	  synthetase	  (AMP-­‐forming)	  (J2XUN5)	  found	  up-­‐regulated	   in	  this	  study	  





this	   question.	   Similarly,	   one	   protein	   containing	   a	   Rieske	   (2Fe-­‐2S)	   iron-­‐sulphur	  
domain	  was	  up-­‐regulated	   in	   the	  presence	  of	   ibuprofen,	  having	  a	   log2	   ratio	  of	  
1.4.	  Several	  Rieske-­‐domain	  containing	  proteins	  are	  well	  known	  for	  participating	  
in	   the	   initial	   oxidation	  of	   aromatic	   ring	   structure	  by	   the	  addition	  of	  dioxygen.	  
Bacterial	  hydrocarbon	  dioxygenases,	  are	  an	  example	  of	  proteins	  that	  belong	  to	  
a	   large	   family	  of	  Rieske	  non-­‐heme	   iron	  oxygenases	   (Gibson	  and	  Parales	  2000;	  
Pérez-­‐Pantoja	   et	   al.,	   2009).	   However,	   the	   qPCR	   results	   did	   not	   confirm	   an	  
increase	   of	   this	   gene	   in	   response	   to	   ibuprofen	   degradation.	   Lastly,	   enoyl-­‐CoA	  
hydratase/isomerase	   was	   highly	   up-­‐regulated;	   this	   enzyme	   is	   well	   known	   for	  
catalysing	  the	  hydroxylation	  of	  double	  bonds	  after	  the	  opening	  of	  the	  aromatic	  
ring	  (Pérez-­‐Pantoja	  et	  al.,	  2009).	  In	  the	  case	  of	  phenylacetic	  acid	  catabolism	  by	  
E.coli	  and	  Pseudomonas	  putida	  U,	  an	  ortholog	  to	  this	  enzyme	  was	  shown	  to	  be	  
involved	   in	   the	   last	   step	  of	   the	   catabolic	  pathway	  of	   this	   aromatic	   compound	  
(Pérez-­‐Pantoja	  et	  al.,	  2009;	  Luengo	  et	  al.,	  2007).	  	  
	  
The	   overall	   up-­‐regulation	   of	   the	   described	   catalytic	   proteins	  might	   suggest	   a	  
similar	  transformation	  of	   ibuprofen	  and	  ibuprofen	  metabolites	  by	  Patulibacter	  
sp.	   strain	   I11.	   Besides	   the	   actual	   degradation,	   several	   proteins	   potentially	  
associated	  with	  the	  uptake	  of	  the	  compound	  were	  up-­‐regulated	  in	  response	  to	  
ibuprofen.	  An	  ABC	  transporter	  related	  protein,	  which	  is	  likely	  to	  be	  involved	  in	  
the	   uptake	   of	   ibuprofen,	   was	   observed	   to	   be	   up-­‐regulated	   as	   a	   response	   to	  
ibuprofen	  presence.	  The	  uptake	  of	  ibuprofen	  is	  the	  initial	  step	  necessary	  for	  its	  
degradation,	   and	   previous	   reports	   have	   shown	   that	   ABC	   transporter	   related	  
proteins,	   cytochromes	   and	   NADH-­‐dehydrogenases	   were	   up-­‐regulated	   in	   cells	  
grown	   on	   aromatic	   hydrocarbons	   such	   as	   benzoate	   by	   Corynebacterium	  
glutamicum	   (Haussmann	  et	   al.,	   2009)	   and	  Pseudomonas	  putida	   strain	  KT2440	  





Rodrigues	   et	   al.,	   2010)	   and	   4-­‐chlorophenol	   by	  Pseudomonas	   putida	   (Cao	   and	  
Loh	  2009).	  	  
	  
In	   an	   attempt	   to	   complement	   the	   proteomic	   analysis,	   the	   genome	   of	  
Patulibacter	   sp.	   strain	   I11	   was	   studied	   in	   relation	   to	   the	   degradation	   of	  
ibuprofen	   by	   Sphingomonas	   Ibu-­‐2	   (Kagle	   et	   al.,	   2009)	   and	   by	   other	   aromatic	  
hydrocarbons.	  	  
	  
Benzoate	   and	   phenylacetic	   acid	   degradation	   were	   well	   described	   in	   other	  
studies	   and	   were	   used	   as	   model	   compounds	   in	   several	   studies	   focusing	   on	  
aromatic	  degradation	  (Ferrandez	  et	  al.,	  1998;	  Loh	  and	  Cao	  2008;	  Luengo	  et	  al.,	  
2007;	   Patrauchan	   et	   al.,	   2005).	   Some	   of	   the	   proteins	   described	   in	   this	   work	  
shared	  similar	   functions	  with	  the	  proteins	   involved	   in	  the	  degradation	  of	  such	  
compounds.	   For	   this	   reason	   Patulibacter	   sp.	   strain	   I11	   genome	   was	   also	  
screened	   for	   genes	   involved	   in	   the	  degradation	  of	  benzoate	   and	  phenylacetic	  
acid,	   which	   share	   structural	   similarity	   to	   ibuprofen.	   The	   presence	   of	   these	  
genes	   in	   I11	   genome	   could	   potentially	   reveal	   the	   versatility	   of	   this	   organism	  
towards	   the	   degradation	   of	   other	   aromatic	   compounds.	   Similar	   genes	   were	  
detected	  that	  account	  for	  the	  degradation	  of	  benzoate	  by	  Acinetobacter	  strain	  
ADP1	   (Craven	   et	   al.,	   2009),	   phenylacetic	   acid	   by	  E.coli	   K12	   	   (Ferrandez	   et	   al.,	  
1998)	   and	   ibuprofen	   by	   Sphingomonas	   Ibu-­‐2	   (Kagle	   et	   al.,	   2009),	   but	   having	  
different	   percentages	   of	   similarity.	   I11	   is	   phylogenetically	   distinctly	   related	   to	  
previously	   described	   ibuprofen	  degraders,	   and	   this	   could	   account	   for	   the	   low	  
protein	  similarity	  to	   ipf	  genes	  previously	  proposed	  to	  be	  involved	  in	   ibuprofen	  
degradation.	   The	   most	   similar	   genes	   among	   this	   set	   of	   genes	   detected	   in	  
Patulibacter	  sp	  I11	  were	  the	  ones	  described	  for	  the	  degradation	  of	  benzoate.	  A	  
proteome	   search	   for	   the	   expression	  of	   the	   genes	   proposed	   to	   be	   responsible	  





revealed	   that	   only	   a	   similar	   protein	   to	   IpfF,	   was	   expressed.	   This	   protein	  
(J2XUN5)	  shares	  51	  %	  identity	  with	  IpfF	  from	  Sphingomonas	  sp.	  Ibu-­‐2.	  However,	  
the	  transcription	  of	  this	  gene	  was	  not	  induced	  by	  the	  presence	  of	  ibuprofen	  by	  
I11.	   The	   ipfABDE	   genes	   were	   not	   found	   up-­‐regulated	   at	   proteomic	   level	   but	  
were	   induced	   by	   I11	   in	   the	   presence	   of	   ibuprofen.	   The	   expression	   of	   these	  
genes	  by	  I11	  and	  its	  previous	  report	  in	  ibuprofen	  degradation	  by	  Sphingomonas	  
sp.	   Ibu-­‐2	   supports	   the	   possible	   involvement	   of	   these	   enzymes	   in	   ibuprofen	  
degradation	  by	  Patulibacter	  sp	  strain	  I11.	  	  
	  
The	  differences	  observed	  between	  the	  proteomic	  data	  and	  the	  qPCR	  data,	  with	  
the	  negative	  correlation	  for	  D3F3VE	  and	  the	  positive	  results	  for	  the	  expression	  
ipf	   genes,	   could	   be	   explained	   partly	   by	   fundamental	   biological	   differences	  
between	   the	   transcription	   and	   translation	   processes,	   and/or	   by	   experimental	  
challenges	  and	  the	  relative	  low	  coverage	  in	  the	  proteome	  (Hedge	  et	  al.,	  2003).	  	  
	  
The	   abundance	   of	   putative	   uncharacterized	   proteins	   among	   the	   up-­‐regulated	  
proteins	   illustrates	   the	   extent	   of	   novelty	   within	   functionally	   important	  
individual	  proteins,	  and	  possibly	  entire	  cellular	  processes/pathways	  involved	  in	  
ibuprofen	  degradation.	  Four	  orthologous	  genes	  proposed	  to	  be	  involved	  in	  the	  
degradation	   of	   ibuprofen	   by	   Sphigomonas	   sp.	   Ibu-­‐2	   was	   also	   found	   to	   be	  
present	  and	  expressed	  in	  response	  to	  the	  presence	  of	  ibuprofen	  in	  Patulibacter	  
sp.	   I11.	  Verification	  of	   role	  of	   the	   identified	  proteins	   requires	   further	   analysis	  
such	  as	  expression	  studies	  and	  protein	  characterization.	  
	  
In	   summary,	   this	   work	   clearly	   represents	   novel	   information	   regarding	   the	  
cellular	   response	   of	   an	   ibuprofen-­‐degrading	  microorganism	   to	   this	   important	  
NSAID.	  The	  Patulibacter	  sp.	  described	  here	  is	  the	  first	  gram	  positive	  isolate	  with	  





identified	   and	   found	   to	   be	   up-­‐regulated	   in	   the	   presence	   of	   low	   levels	   of	  
ibuprofen.	  These	  proteins	  constitute	  potential	  candidates	  that	  may	  be	  involved	  
in	   enzymatic	   degradation	   pathways	   for	   the	   micropollutant	   ibuprofen.	   The	  
details	   of	   such	   pathway(s)	   and	   how	   they	   are	   regulated	   in	   situ,	   for	   the	  
biodegradation	  of	  this	  important	  micropollutant,	  remain	  largely	  unknown.	  This	  
study	   demonstrates	   the	   value	   of	   such	   a	   genomic	   and	   proteomic	   approach	   in	  
providing	   a	   better	   understanding	   of	   ibuprofen	   biodegradation	   in	   the	  
environment	  and	  in	  wastewater	  treatment	  systems.	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The	  use	  of	  mixed	  microbial	  cultures	  enriched	  for	  biological	  mercury	  removal	  is	  
explored	   in	   this	   paper,	   focusing	   on	   the	   ecological	   shifts	   occurring	   throughout	  
acclimatization	   to	   mercury	   and	   on	   the	   long-­‐term	   stability	   of	   four	   microbial	  
enrichments.	  The	  16S	  rRNA	  genetic	  profiles	  obtained	  by	  denaturing	  gradient	  gel	  
electrophoresis	   (DGGE)	   revealed	   that	   the	   glucose	   and	   ethanol	   cultures	   had	  
similar	  profiles,	  whereas	   the	  acetate	  cultures	  diverged	   into	  a	   totally	  dissimilar	  
cluster.	   Quantification	   of	   the	  merA	   gene	   copies	   in	   each	   enrichment	   showed	  
higher	   values	   for	   the	   glucose	   culture,	   followed	   by	   the	   ethanol	   and	   then	   the	  
acetate	  cultures,	  which	  was	  consistent	  with	  the	  mercury	  removal	  performance	  
throughout	   the	   study.	   Isolates	   were	   obtained	   from	   the	   four	   cultures	   and	  
analyzed	  with	   respect	   to	   their	   genetic	   (16S	   rRNA	   gene)	   and	   functional	   (merA	  
gene)	  phylogenies	   in	  order	  to	   identify	  mercury-­‐resistant	  species	  enriched	  with	  
different	   carbon	   sources.	   All	   mercury-­‐resistant	   isolates	   obtained	   from	   the	  
glucose	  and	  ethanol	  cultures	  belonged	  to	  the	  Gammaproteobacteria,	  whereas	  
acetate	   cultures	   also	   contained	   members	   of	   other	   phyla,	   with	   differences	   in	  
merA	   sequences.	  Higher	  phylogenetic	   than	   functional	  diversity	  of	   the	   isolates,	  
together	  with	  increasing	  merA	  copies	  even	  after	  culture	  stabilisation,	  highlight	  






Mercury	   is	   the	  most	   toxic	  heavy	  metal,	  with	  no	  associated	  biological	   function	  
(Wagner-­‐Dobler	  et	  al.,	  2003).	  Mercury	  pollution	  arises	  from	  sources	  such	  as	  the	  
chlor-­‐alkali	   industry,	   coal	   burning	   and	   gold	   mining,	   and	   is	   one	   of	   the	   most	  
frequently	  found	  heavy	  metals	  in	  industrial	  wastewater	  (Jaysankar	  et	  al.,	  2007).	  
Once	   discharged	   into	   the	   environment,	   mercury	   tends	   to	   accumulate	   in	   the	  
aquatic	   media	   and	   soils,	   where	   it	   can	   contaminate	   drinking	   water	   aquifers.	  
Therefore,	   the	   maximum	   recommended	   mercury	   concentration	   from	  
discharged	  wastewater	  varies	  on	  a	  site-­‐to-­‐site	  basis,	  although	   is	  generally	  ≤50	  
μg	  Hg	  L-­‐1.	  	  	  
	  
Wastewater	   treatment	   and	   soil	   remediation	   of	   mercury	   can	   be	   mediated	  
biologically,	   since	   the	   mercury	   resistance	   (mer)	   operon	   confers	   some	  
microorganisms	   with	   the	   capacity	   to	   transport	   Hg2+	   and	   organomercurial	  
compounds	  across	  the	  cell	  membrane	  and	  reduce	   it	  to	   insoluble	  Hg0.	  The	  mer	  
operon	  can	  be	  present	  in	  chromosomal	  DNA,	  but	  is	  often	  associated	  to	  mobile	  
genetic	  elements,	  such	  as	  transposons	  and	  plasmids	  (Osborn	  et	  al.,	  1997).	  This	  
suggests	   that,	   together	   with	   growth	   of	   mercury	   resistant	   species	   by	   cell	  
division,	  horizontal	  gene	  transfer	  plays	  an	  important	  role	  in	  the	  adaptation	  of	  a	  
microbial	   community	   to	  mercury	   contamination,	   resulting	   in	   high	   diversity	   of	  
mercury-­‐resistant	   populations	   (Osborn	   et	   al.,	   1997).	   The	   central	   part	   of	   this	  
operon	   is	   the	  merA	  gene,	  which	  encodes	   for	   the	  mercuric	   reductase	  or	  MerA	  
enzyme.	  
	  
The	   biological	   mercury	   reduction	   mechanism	   has	   been	   applied	   for	   the	  
detoxication	   of	   mercury-­‐contaminated	   wastewater	   (Chang	   and	   Law,	   1998;	  





(Oehmen	  et	  al.,	  2006).	  The	  reduced	  form	  of	  mercury	  can	  then	  be	  removed	  by	  
stripping	   into	   the	   gaseous	   phase	   and	   subsequent	   adsorption	   (Deckwer	   et	   al.,	  
2004).	  These	  studies	  have	  generally	  employed	  pure	  cultures	  (von	  Castein,	  et	  al,	  
1999;	  Wagner-­‐Dobler	  et	  al.,	  2000),	  although	  mixed	  cultures	  are	  advantageous	  
in	   wastewater	   treatment,	   due	   to	   the	   difficulty	   in	   maintaining	   aseptic	  
conditions.	  Biological	  mercury	  reduction	  requires	  an	  external	  carbon	  source	  to	  
the	  industrial	  wastewater	  in	  order	  to	  promote	  bacterial	  growth.	  Previously,	  our	  	  
group	   compared	   two	  mixed	   cultures	   fed	  with	   either	   glucose	   or	   acetate	   after	  
applying	   a	   short-­‐term	   swap	   in	   the	   carbon	   source,	   and	   concluded	   that	   the	  
glucose-­‐fed	  culture	  had	  a	  higher	  mercury	  removal	  efficiency	  than	  the	  acetate-­‐
fed	  culture	  (Oehmen	  et	  al.,	  2009);	  however,	  this	  study	  did	  not	  assess	  the	  long-­‐
term	   stability	   of	   these	  mixed	   cultures,	   nor	   did	   it	   investigate	   their	   community	  
structure	   beyond	   determination	   of	   the	   most	   dominant	   microbial	   phyla.	   This	  
knowledge	  is	  needed	  in	  order	  to	  understand	  the	  mechanisms	  of	  how	  mercury-­‐
removing	  communities	  develop	  and	  their	  dynamics	  in	  engineered	  systems.	  
	  
The	  aim	  of	   the	  present	  study	  was	   to	  obtain	  effective	  mercury-­‐reducing	  mixed	  
cultures	   and	   correlate	   their	   long-­‐term	   performance	   with	   their	   microbial	  
community	   dynamics	   and	  merA	   gene	   content.	   Four	   microbial	   cultures	   were	  
enriched	   with	   different	   carbon	   sources	   that	   are	   commonly	   employed	   for	  
supplementing	  wastewater	  treatment	  processes	  (including	  glucose	  and	  acetate,	  
but	   also	   ethanol)	   and	   were	   characterized	   through	   culture-­‐dependent	   and	   -­‐
independent	  microbial	  techniques.	  The	  study	  was	  carried	  out	  throughout	  >	  500	  
days	   in	  order	  to	  assess	  the	  long-­‐term	  population	  dynamics	  and	  stability	  of	  the	  
mercury	   removal	   performance.	   Complementary	   molecular	   tools	   (denaturing	  
gradient	   gel	   electrophoresis	   [DGGE]	   and	   fluorescence	   in	   situ	   hybridization	  
[FISH])	  were	  used	  to	  monitor	  the	  population	  structure	  profile	  and	  composition	  





the	   enrichments	   was	   determined	   through	   quantitative	   polymerase	   chain	  
reaction	   (qPCR),	   which	   could	   then	   be	   correlated	   with	   their	   mercury	   removal	  
efficiency.	   Finally,	   mercury-­‐resistant	   pure	   cultures	   were	   isolated	   in	   order	   to	  
identify	   and	   compare	   merA-­‐containing	   species	   obtained	   with	   the	   different	  
carbon	  sources.	  	  
Materials	  and	  Methods	  	  
Enrichment	  of	  mercury-­‐reducing	  cultures	  with	  different	  carbon	  sources	  
Sludge	  from	  a	  mercury	  contaminated	  site	   in	  the	  Tagus	  River	  (Lisbon,	  Portugal)	  
was	   used	   to	   inoculate	   four	   shaken	   flasks,	   which	   were	   fed	   with	   a	   minimal	  
medium	  supplemented	  with	  3.84	  g	  COD	  L-­‐1	  of	  glucose,	  ethanol	  or	  acetate	  as	  the	  
sole	   carbon	   source	   (see	  Oehmen	  et	   al.,	   2009	   for	   the	  media	   composition)	   and	  
spiked	  with	  mercury.	  The	  enrichments	  were	  carried	  out	  at	  30	  °C.	  Once	  every	  14	  
d,	  half	  of	  the	  mixed	  liquor	  was	  replaced	  by	  fresh	  medium,	  and	  a	  new	  mercury	  
spike	   was	   made.	   Thus,	   the	   hydraulic	   retention	   time	   (HRT)	   and	   the	   sludge	  
retention	   time	   (SRT)	   were	   28	   days.	   The	   glucose	   and	   acetate-­‐1	   cultures	   were	  
operated	   initially	   with	   10	  mg	   Hg	   L-­‐1	   (added	   as	   HgCl2)	   for	   140	   days,	   and	   then	  
reduced	  to	  1	  mg	  Hg	  L-­‐1,	  because	  the	  acetate-­‐1	  culture	  was	  unable	  to	  sustain	  this	  
level	   of	   mercury	   removal.	   The	   ethanol	   and	   acetate-­‐2	   cultures	   were	   always	  
supplied	  with	  1	  mg	  Hg	   L-­‐1.	   The	   cultures	  were	  operated	  between	  505	  and	  645	  
days.	   Performance	   monitoring	   was	   carried	   out	   by	   atomic	   absorption	  
measurements	   of	   total	   mercury	   (including	   Hg0,	   Hg2+	   and	   soluble	   mercury	  
complexes)	  in	  the	  culture	  supernatant	  and	  volatile	  suspended	  solids	  (VSS)	  were	  
determined	   according	   to	   standard	   methods	   (APHA,	   2005).	   For	   more	  







Extraction	  of	  DNA	  from	  microbial	  cultures	  
	  
Biomass	  samples	  were	  collected	  from	  each	  mixed	  culture	  throughout	  the	  study.	  
DNA	  was	  extracted	  using	  glass	  beads	  and	  guanidine	  thiocyanate	  (adapted	  from	  
Pitcher	  et	  al.	  1989),	  which	  is	  summarised	  as	  follows:	  0.4	  g	  of	  sludge	  pellet	  was	  
homogenized	   by	   vortex	   with	   0.5	  mL	   of	   lysis	   buffer	   (50	  mM	   Tris-­‐HCl,	   50	  mM	  
EDTA,	   250	  mM	  NaCl,	   0.3	  %	   SDS,	   pH	   8.0)	   and	   0.2	  mL	   of	   glass	   beads	   (400-­‐600	  
microns,	   Sigma,	  USA).	  Cells	  were	   lysed	  by	  3	   cycles	  of	  5	  min	   incubation	  on	   ice	  
followed	  by	  5	  min	  vortexing.	  This	  was	  followed	  by	  sequential	   incubations	  with	  
RNAse	   (0.025	   mg	   mL-­‐1,	   1h	   at	   37	   °C)	   and	   0.5	   mL	   of	   GES	   (5M	   guanidine	  
isothiocyanate,	   100	   mM	   EDTA,	   0.5	   %	   sarkosyl,	   pH	   8.0,	   1h	   at	   65	   °C).	   After	  
centrifugation,	   the	   pellet	   was	   treated	   with	   potassium	   acetate	   to	   a	   final	  
concentration	   of	   0.5	   M.	   Samples	   were	   transferred	   to	   ice	   for	   10	   min,	   then	  
centrifuged	   and	   the	   aqueous	   phase	   was	   extracted	   with	   chloroform/isoamyl	  
alcohol.	   DNA	   was	   precipitated	   with	   cold	   isopropyl	   alcohol,	   pelleted	   by	  
centrifugation	  and	  washed	  with	  75	  %	  ethanol.	  DNA	  pellet	  was	  resuspended	   in	  
0.1	  mL	  TE	  (10	  mM	  Tris-­‐HCl,	  1	  mM	  EDTA,	  pH	  8.0).	  This	  method	  was	  selected	  for	  
DNA	  extraction	  of	  the	  mixed	  cultures	  since	  it	  showed	  best	  results	  with	  respect	  
to	  diversity	   coverage	  of	  activated	  sludge	  samples	  as	   compared	   to	  commercial	  
kits	  (data	  not	  shown).	  
	  
16S	  rRNA	  gene	  amplification	  by	  nested-­‐PCR	  
	  	  
In	  the	  first	  PCR	  reaction,	  a	  practically	   full-­‐length	  16S	  rRNA	  gene	  was	  amplified	  
using	   primers	   27f	   and	   1492r_uni	   (Lane,	   1991).	   The	   reaction	   contained	   1U	   of	  
Taq	  DNA	  polymerase,	  0.2	  mM	  of	  each	  deoxynucleoside	  triphosphate,	  10x	  PCR	  
Buffer,	  2	  mM	  of	  MgCl2,	  0.5	  pmol	  of	  each	  primer	  and	  1μL	  of	  template	  DNA	  in	  a	  





5	  min,	  20	  cycles	  at	  94	  °C	  for	  30	  sec,	  50	  °C	  for	  30	  sec,	  72	  °C	  for	  1	  min,	  and	  1	  cycle	  
at	  72	  °C	  for	  5	  min.	  For	  the	  second	  PCR	  reaction	  the	  primers	  968f_GC	  (Muyzer	  et	  
al.,	  1995)	  and	  1492r_bac	  (Lane,	  1991)	  were	  used.	  One	  microliter	  of	  the	  first	  PCR	  
reaction	   was	   used	   as	   template,	   with	   1U	   of	   Taq	  DNA	   polymerase	   (Invitrogen,	  
USA),	  0.2	  mM	  of	  each	  deoxynucleoside	  triphosphate,	  10x	  PCR	  Buffer,	  2.5	  mM	  
MgCl2	  and	  0.5	  pmol	  each	  primer	   in	  a	  total	  volume	  of	  25	  μL.	  The	  thermocycler	  
program	  comprised	  1	  cycle	  at	  94	  °C	  for	  5	  min,	  30	  cycles	  at	  94	  °C	  for	  30	  sec,	  48	  
°C	  for	  30	  sec,	  72	  °C	  for	  2	  min,	  and	  1	  cycle	  at	  72	  °C	  for	  5	  min.	  
	  
DGGE	  of	  PCR-­‐amplified	  16S	  rRNA	  genes	  
	  
DGGE	   was	   performed	   with	   the	   Dcode	   Universal	   Mutation	   Detection	   System	  
(BioRad,	  Hercules,	  CA,	  USA).	  Equal	  amounts	  of	  PCR	  products	  were	  loaded	  onto	  
8	  %	  (w/v)	  polyacrylamide	  gels	  (40	  %	  acrylamide/bis	  solution,	  37.5:1.	  Bio-­‐Rad)	  in	  
0.5X	   TAE	   (20	   mM	   Tris	   acetate,	   pH	   7.8,	   10	   mM	   sodium	   acetate,	   0.5	   mM	  
disodium	   EDTA).	   Polyacrylamide	   gels	   with	   a	   denaturant-­‐gradient	   of	   30-­‐60	   %	  
(100	  %	  denaturant	  contains	  7	  M	  urea	  and	  40	  %	  formamide)	  were	  run	  at	  80	  V	  
and	  60	  °C	  for	  16h.	  Electrophoresed	  gels	  were	  stained	  with	  SYBR	  Gold	  (1:10,000	  
dilution,	   Invitrogen)	   for	  30	  min	  and	  the	  obtained	  profiles	  were	  analyzed	  using	  
the	  Bionumerics	  5.0	  software	  (Applied	  Maths,	  Belgium).	  Fingerprint	  patterns	  of	  
the	  samples	  were	  analyzed	  using	  Pearson	  correlations,	  which	  provide	  pairwise	  
percent	  similarity	  values	  for	  all	   fingerprint	  densitometric	  curves.	  Dendrograms	  
relating	   DGGE	   profile	   similarities	   were	   automatically	   calculated	   by	   the	  
unweighted	   pair	   group	  method	   with	   arithmetic	   mean	   (UPGMA)	   algorithm	   of	  
the	  Bionumerics	  software.	  The	  cophenetic	  correlation	  of	   the	  dendrogram	  was	  






The	   relative	   change	   of	   each	  microbial	   population	   with	   respect	   to	   a	   common	  
reference,	  taken	  in	  this	  study	  as	  the	  inoculum,	  was	  determined	  from	  the	  matrix	  
of	   similarities	   for	   the	   densiometric	   curves	   of	   the	   DGGE	   profiles,	   as	   per	  




Sludge	  samples	   from	  each	  culture	  were	   fixed	  with	  paraformaldehyde	  solution	  
at	   4	   °C	   according	   to	   Amann	   (1995).	   The	   following	   specific	   oligonucleotide	  
probes	  were	  employed:	  ALF969	  for	  Alphaproteobacteria	  (Oehmen	  et	  al.,	  2006),	  
BET42a	   for	   Betaproteobacteria	   (Manz	   et	   al.,	   1992), GAM42a	   for	  
Gammaproteobacteria	  (Manz	  et	  al.,	  1992),	  CF319a	  for	  Cytophaga-­‐Flavobacteria	  
(Manz	   et	   al.,	   1996),	   and	   HGC69a	   for	   High	   GC	   content	   Gram-­‐positive	   bacteria	  
(Actinobacteria)	  (Roller	  et	  al.,	  1994).	  Each	  specific	  probe	  was	  applied	  with	  a	  Cy-­‐
3	   label,	   together	   with	   FITC-­‐labelled	   EUBMIX	   probe	   for	   all	   Bacteria	   (EUB338	  
[Amann	  et	  al.,	  1990]	  and	  EUB338-­‐II	  and	   III	   [Daims	  et	  al.,	  1999]).	  FISH	  samples	  
were	   observed	   using	   a	   Leica	   DRMA2	   epifluorescence	   microscope	   (Leica,	  
Wetzlar,	  Germany).	  	  
	  
Quantitative	  PCR	  analysis	  of	  the	  merA	  gene	  copy	  number	  
	  
The	   quantification	   of	   merA	   gene	   copies	   per	   ng	   DNA	   by	   real-­‐time	   PCR	   was	  
performed	  with	  an	  iQ5	  thermocycler	  and	  real-­‐time	  detection	  system	  (Bio-­‐Rad).	  
The	   primers	   used	   in	   this	   study	  were	  merA1	   and	  merA5	   (Liebert	   et	   al.,	   1997),	  
designed	   from	   consensus	   regions	   of	  merA	   sequences	   belonging	   to	   the	   Beta-­‐	  
and	  Gammaproteobacteria.	  The	  25	  μL	  reaction	  mixture	  contained	  12.5	  μL	  of	  iQ	  
SYBR	  Green	  supermix	   (Bio-­‐Rad),	  1.5	  μL	  of	  each	  primer	   (0.5	  pmol)	  and	  1	  μL	  of	  





1000	  (Thermo	  Scientific,	  Waltham,	  MA,	  USA).	  The	  thermocycler	  program	  was:	  
denaturation	  at	  95	  °C	  for	  5	  min,	  followed	  by	  45	  cycles	  at	  95	  °C	  for	  30	  sec,	  64	  °C	  
for	  30	  sec	  and	  1	  cycle	  at	  72	  °C	  for	  3	  min.	  At	  the	  end	  of	  each	  PCR	  run,	  melting	  
curve	  analysis	  was	  performed	  from	  60	  to	  95	  °C	  (0.1	  ºC	  s-­‐1)	  to	  detect	  nonspecific	  
PCR	  product	  and	  primer-­‐dimer	  co-­‐amplification.	  PCR	  products	  were	  visualized	  
in	   ethidium	   bromide-­‐stained	   1.2	   %	   agarose	   gels	   to	   verify	   the	   size	   of	   the	  
amplicons.	  
	  
DNA	   standard	   curves	   were	   constructed	   using	   the	   corresponding	   merA	   PCR	  
products	   of	   Acidithiobacillus	   ferrooxidans,	   DSMZ	   14882.	   Briefly,	   after	   merA	  
gene	  amplification,	  the	  resulting	  DNA	  product	  was	  cleaned	  with	  UltraClean	  PCR	  
Clean-­‐Up	   kit	   (MoBio	   Laboratories,	   Carlsbad,	   CA,	   USA)	   and	   quantified	   through	  
spectrophotometric	   analysis	   (NanoDrop 1000).	   The	   copy	   number	   was	  
calculated	   based	   on	   the	   measured	   DNA	   concentration	   and	   the	   molecular	  
weight	   of	   the	   reference	  merA	   amplicon.	   Cleaned	   PCR	   products	   were	   serially	  
diluted	  in	  TE	  (109-­‐100)	  and	  used	  as	  template.	  	  	  
	  
Baseline	   and	   threshold	   calculations	   were	   performed	   with	   the	   iQ5	   software	  
version	  2.1,	   using	   the	   fluorescence	   signals	   acquired	  at	   94	   °C,	   at	  which	  primer	  
dimers	   completely	   denatured	   and	   did	   not	   affect	   quantification.	   All	   real-­‐time	  
PCR	  quantifications	  were	  done	  in	  triplicate	  for	  both	  the	  standards	  and	  samples.	  
The	  results	  were	  normalized	  in	  respect	  to	  the	  template	  DNA	  concentration	  and	  
given	  as	  number	  of	  copies	  ng	  DNA-­‐1.	  
	  
Isolation	  of	  mercury	  resistant	  bacteria	  and	  DNA	  extraction	  	  
	  
Aliquots	  (100	  μL)	  of	  diluted	  (0.85	  %	  NaCl)	  biomass	  samples	  were	  spread	  on	  agar	  





1	  mL	  HgCl2	  solution	  (1	  g	  Hg	  L−1).	  The	  plates	  were	  incubated	  at	  27	  °C	  for	  3–4	  d.	  
Individual	   colonies	   were	   selected,	   re-­‐inoculated	   onto	   new	   plates	   with	   the	  
respective	  media	  and	  incubated	  at	  27	  °C	  for	  isolation	  in	  pure	  culture.	  
	  
Isolates	  were	  grown	  in	  Luria-­‐Bertani	  broth	  (Scharlau,	  Spain)	  supplemented	  with	  
1	  mg	   L−1	   of	   HgCl2	   at	   27	   °C	   on	   a	   rotary	   shaker.	   DNA	  was	   extracted	   using	   the	  
UltraClean	  Microbial	  DNA	  Isolation	  kit	  (Mo	  Bio	  Laboratories)	  and	  quantified	  in	  a	  
NanoDrop	  1000	  (Thermo	  Scientific).	  
	  
Phylogenetic	  analysis	  of	  merA	  and	  16S	  rRNA	  genes	  of	  the	  isolates	  
	  
The	  merA	   gene	   was	   amplified	   by	   polymerase	   chain	   reaction	   (PCR)	   using	   the	  
primers	   merA1	   and	   merA5,	   which	   were	   designed	   from	   consensus	   regions	   of	  
merA	   sequences	  belonging	  to	  the	  Beta-­‐	  and	  Gammaproteobacteria	   (Liebert	  et	  
al.,	  1997).	  The	  reaction	  contained	  1	  U	  of	  Taq	  DNA	  polymerase	  (Invitrogen),	  0.2	  
mM	  of	   each	   deoxynucleoside	   triphosphate,	   10x	   PCR	  buffer,	   2	  mM	  MgCl2,	   0.5	  
pmol	   of	   each	  primer	   and	  1	  μL	   template	  DNA	   in	   a	   total	   volume	  of	   25	  μL.	   The	  
thermocycler	  program	  consisted	  of	  1	  cycle	  at	  95	  °C	  for	  5	  min,	  30	  cycles	  at	  95	  °C	  
for	   1	  min,	   64	   °C	   for	   2	  min,	   72	   °C	   for	   3	  min,	   and	   1	   cycle	   at	   72	   °C	   for	   10	  min	  
(Liebert	  et	  al.,	  1997).	  16S	  rRNA	  genes	  were	  amplified	  using	  the	  primers	  27f	  and	  
1492r_bac	   (Lane,	   1991).	   The	   reaction	   contained	   1U	   of	   Taq	   DNA	   polymerase	  
(Invitrogen),	  0.2	  mM	  of	  each	  deoxynucleoside	  triphosphate,	  10x	  PCR	  buffer,	  2	  
mM	  MgCl2,	  0.5	  pmol	  of	  each	  primer	  and	  1	  μL	  template	  DNA	  in	  a	  total	  volume	  of	  
25	  μL.	  The	  thermocycler	  program	  was	  1	  cycle	  at	  94	  °C	  for	  5	  min,	  30	  cycles	  at	  94	  








Restriction	  fragment	  length	  polymorphism	  (RFLP)	  of	  the	  PCR	  products	  
	  
Amplified	  products	  of	  16S	  rRNA	  and	  merA	  genes	  of	  the	  isolates	  were	  digested	  
with	   two	   restriction	  endonucleases	  HaeIII	   and	  AluI	   (Takara,	  Otsu,	   Japan).	   Five	  
microliters	  of	  the	  amplified	  reaction	  solution	  was	  added	  to	  a	  mixture	  containing	  
1	  U	  of	  enzyme,	  2	  μL	  of	  10x	  restriction	  buffer	  and	  12.9	  μL	  sterile	  MilliQ	  water.	  
The	  mixtures	  were	   incubated	  overnight	  at	  37	  °C	  for	  digestion.	  After	  digestion,	  
the	   enzymes	  HaeIII	   and	  AluI	  were	   inactivated	   for	   15	  min	   at	   70	   °C	   and	   60	   °C,	  
respectively.	   Restriction	   fragments	   were	   separated	   by	   agarose	   gel	  
electrophoresis	   and	   identical	   digestion	   profiles	   were	   grouped	   in	   the	   same	  
operational	  taxonomic	  unit	   (OTU).	  Selected	  representatives	  of	  each	  OTU	  were	  
purified	   with	   an	   UltraClean	   PCR	   Clean-­‐Up	   kit	   (Mo	   Bio	   Laboratories)	   and	  




The	  CLUSTAL	  W	  algorithm	  was	  used	  to	  make	  sequence	  alignments	  with	  default	  
gap	  penalties.	  Phylogenetic	   trees	   for	   the	  16S	  rRNA	  gene	  and	  merA	  gene	  were	  
constructed	   by	   the	   neighborjoining	   method.	   Statistical	   significance	   was	  
evaluated	   by	   bootstrap	   analysis	   with	   1,000	   repeats.	   These	   methods	   are	  
included	  in	  MEGA	  4.1	  software	  (http://www.megasoftware.net).	  
The	   sequences	   used	   for	   tree	   construction	   were	   deposited	   in	   GenBank/NCBI	  
(http://www.ncbi.nlm.nih.gov/)	  with	  accession	  numbers	  HQ650218–HQ650231	  






Results	  and	  discussion	  
Mercury	  removal	  performance	  of	  the	  mixed	  cultures	  	  
	  
The	  cultures	  were	  operated	  for	  between	  505	  and	  645	  d	  using	  a	  14	  d	  cycle	  (i.e.,	  
fresh	  medium	  was	  supplied	  every	  14	  d),	  designed	  to	  allow	  sufficient	  time	  for	  a)	  
mercury	  removal	  and	  b)	  biomass	  growth.	  It	  has	  been	  previously	  observed	  that	  
biomass	  growth	  is	  limited	  at	  high	  Hg	  concentrations	  due	  to	  the	  inhibitory	  effect	  
of	   Hg	   on	   the	   biomass,	   thus	   detoxification	   and	   growth	   do	   not	   occur	  
simultaneously	   but	   rather	   sequentially	   (Fortunato	   et	   a.,	   2005;	  Oehmen	  et	   al.,	  
2009;	   von	   Canstein	   et	   al.,	   1999).	   Therefore,	   microbial	   survival	   pressure	   is	  
imposed	  by	  the	  presence	  of	  mercury	  during	  the	  first	  days	  after	  the	  Hg2+	  spike,	  
while	   the	   community	   structure	   is	   mostly	   influenced	   by	   the	   carbon	   source	  
available	  for	  growth	  thereafter.	  
	  
During	  the	  first	  140	  d,	  the	  glucose	  and	  acetate-­‐1	  cultures	  were	  operated	  with	  a	  
high	  mercury	   load	   (10	  mg	  Hg	   L−1).	   During	   the	   two	   first	   cycles	   of	   operation	   of	  
these	   two	   cultures,	   low	   mercury	   concentrations	   were	   found	   in	   the	   effluent	  
(Figure	   5.1).	   Since	   these	   cultures	   were	   inoculated	   from	   sediment,	   which	  
contains	   a	   high	   amount	   of	   inert	   solids	   in	   addition	   to	   microorganisms,	  
adsorption	  may	  have	  been	  the	  principal	  removal	  mechanism	  during	  this	  period.	  
Indeed,	   a	   previous	   study	   showed	   that	   Hg	   adsorption	   to	   solids	   is	   a	   relevant	  
removal	   mechanism	   in	   mixed	   microbial	   cultures	   (Oehmen	   et	   al.,	   2009).	   The	  
high	   level	   of	   mercury	   removal	   observed	   initially	   in	   Figure	   5.1	   quickly	  
deteriorated	   into	   a	   very	   poor	   removal	   rate,	   perhaps	   due	   to	   the	   saturation	   of	  
the	  available	  Hg	  adsorption	  sites.	  On	  day	  139,	  the	  effluent	  Hg	  concentration	  at	  
the	  end	  of	  the	  14	  d	  cycle	  was	  substantially	  higher	  in	  the	  acetate-­‐1	  culture	  (6349	  





reduced	  or	  even	  no	  period	  of	  time	  during	  the	  cycle	  for	  biomass	  growth	  in	  the	  
acetate-­‐1	  culture.	  After	  140	  d	  of	  operation,	  the	  concentration	  of	  mercury	  in	  the	  
feed	  was	  reduced	  from	  10	  to	  1	  mg	  Hg	  L−1.	  This	  resulted	  in	  a	  notable	  decrease	  in	  
effluent	   Hg	   concentrations	   for	   both	   cultures	   (Figure	   5.1),	   particularly	   for	   the	  
glucose-­‐fed	   culture	   within	   one	   sludge	   age	   (28	   d)	   after	   the	   change	   in	   feed.	  
Indeed,	  in	  the	  glucose-­‐fed	  culture,	  the	  Hg	  concentration	  was	  negligible	  one	  day	  












Figure	  5.1.	  Effluent	  Hg	  concentration	  in	  the	  four	  cultures	  at	  the	  end	  of	  the	  14-­‐day	  cycle.	  
	  
	  
The	  ethanol	  and	  acetate-­‐2	  cultures	  were	  fed	  with	  a	  1	  mg	  Hg	  L−1	   load	  from	  the	  
beginning	   of	   the	   study;	   however,	   the	   high	   Hg	   removal	   efficiency	   observed	  
initially	   in	   these	   cultures	   (Figure	   5.1)	   was	   also	   likely	   due	   to	   adsorption.	   The	  
lower	   Hg	   removal	   observed	   in	   the	   ethanol	   culture	   until	   around	   day	   300	  may	  
have	  been	  due	  to	  the	  need	  for	  the	  populations	  to	  adapt	  to	  two	  potential	  toxic	  
compounds:	  mercury	   and	  ethanol.	   Indeed,	   the	   low	  ethanol	   consumption	   rate	  





shown).	   In	   order	   to	   minimize	   the	   potential	   inhibitory	   effect	   of	   ethanol,	   the	  
accumulated	  ethanol	  was	  washed	  out	  of	  the	  system	  on	  day	  300	  (by	  adding	  an	  
ethanol-­‐free	   feed	   during	   one	   cycle),	   which	   facilitated	   microorganism	   growth	  
and	  resulted	  in	  improved	  mercury	  removal	  efficiency.	  
	  
Overall,	  the	  performance	  of	  the	  glucose-­‐fed	  culture	  was	  superior	  to	  the	  others,	  
although	   the	   ethanol-­‐fed	   culture	   also	   displayed	   good	   Hg	   removal	   efficiency	  
after	   day	   350.	   The	   two	   acetate	   cultures	   showed	   a	   lower	   and	   unstable	  
performance.	   The	  average	  mercury	   concentration	   in	   the	   final	   effluent	   (during	  
the	  period	  where	  1	  mg	  Hg	  L−1	  was	  supplied	  to	  all	  cultures)	  was	  4,	  14,	  66	  and	  36	  
μg	   Hg	   L−1	   for	   the	   glucose,	   ethanol,	   acetate-­‐1	   and	   acetate-­‐2	   cultures,	  
respectively.	  Only	  the	  glucose-­‐fed	  culture	  had	  effluent	  that	  was	  consistently	  far	  
below	  the	  50	  μg	  Hg	  L−1	  discharge	   limit.	  The	  average	  biomass	  concentration	   in	  
the	  glucose	   culture	   (1.77	  g	  VSS	   L−1)	  was	  also	  higher	   than	   the	  other	  3	   cultures	  
(0.66,	  0.84	  and	  0.89	  g	  VSS	  L−1	  for	  the	  ethanol,	  acetate-­‐1	  and	  acetate-­‐2	  cultures,	  
respectively).	   The	   high	   mercury	   removal	   efficiency	   observed	   in	   the	   glucose	  
culture	  may	  have	  led	  to	  the	  increased	  biomass	  growth	  observed	  in	  this	  culture,	  
since	   Hg2+	   detoxification	   and	   biomass	   growth	   occur	   in	   distinct,	   sequential	  
phases.	  
	  
DGGE	  analysis	  of	  the	  long-­‐term	  population	  dynamics	  
	  
The	  microbial	   community	   shifts	  occurring	   in	   the	   cultures	  were	  analyzed	  using	  
PCR-­‐DGGE	  of	  the	  16S	  rRNA	  gene	  as	  a	  fingerprinting	  technique.	  Analysis	  of	  the	  
profiles	  acquired	  throughout	  the	  acclimatization	  showed	  that	  two	  main	  clusters	  
diverged	  from	  the	  initial	   inoculum.	  One	  cluster	  (cluster	   I,	  Figure	  5.2)	  consisted	  
of	  the	  glucose-­‐fed	  and	  ethanol-­‐fed	  cultures,	  which	  only	  shared	  <	  5%	  similarity	  





5.2).	  This	  shows	  that	  the	  microbial	  population	  structure	  enriched	  with	  acetate	  
diverged	   from	   those	   developed	   in	   the	   glucose	   and	   ethanol	   enrichments.	  
Furthermore,	   the	   two	  acetate	  cultures	  showed	  different	  DGGE	  profiles,	  which	  
probably	  reflects	  their	  different	  histories,	  since	  acetate-­‐1	  was	  initially	  fed	  with	  
10	  mg	  Hg	  L−1	  until	  day	  140.	  
	  
The	   reason	   for	   the	   divergence	   of	   the	   acetate	   cultures	   from	   the	   glucose	   and	  
ethanol	   cultures	   could	   be	   due	   to	   the	   fact	   that	   acetate	   forms	   complexes	  with	  
ionic	  mercury	   (Gardfeldt	   et	   al.,	   2003),	  making	   the	   toxic	  pressure	   lower	   in	   the	  
acetate	  cultures	  due	  to	  a	  lower	  bio-­‐available	  Hg	  fraction.	  Indeed,	  at	  the	  working	  
pH	   and	   ionic	   strength	   of	   this	   study,	   stable	   mercuric	   acetate	   complexes	   are	  
abiotically	  produced,	  particularly	  the	  tetra-­‐acetate	  form,	  which	  possibly	  hinders	  
the	   transport	   of	   Hg2+	   across	   the	   cell	   membrane.	   This	   would	   also	   explain	   the	  
lower	   removal	   efficiency	   by	   the	   acetate	   cultures	   as	   compared	   to	   the	   others.	  
Moreover,	  mercuric	  acetate	  complexes	  can	  slowly	  be	  converted	  abiotically	  into	  
methylmercury	  (Gardfeldt	  et	  al.,	  2003),	  which	   is	  the	  most	  toxic	  mercury	  form.	  
For	   these	   reasons,	  acetate	   seems	   least	   suited	   for	   the	  enrichment	  of	  mercury-­‐
reducing	  bacteria	  than	  the	  other	  studied	  carbon	  sources.	  
	  
The	  microbial	  population	   structure	  of	   the	  glucose-­‐fed	   culture	   stabilized	   faster	  
than	   the	   other	   enrichments,	   as	   shown	   by	   comparison	   of	   the	   profile	   changes	  
with	   respect	   to	   the	   inoculum	   (Figure	   5.3).	   The	   glucose	   culture	   showed	  
negligible	   variation	   after	   day	   104,	   whereas	   the	   ethanol-­‐	   and	   acetate-­‐fed	  
cultures	  had	  more	  dynamic	  populations.	  The	  high	  initial	  Hg	  concentration	  fed	  to	  
the	   acetate-­‐1	   culture	   up	   to	   day	   140	   was	   possibly	   responsible	   for	   the	   large	  
divergence	  from	  the	  inoculum,	  as	  shown	  by	  the	  high	  percent	  change	  observed	  
in	  the	  microbial	  population	  immediately	  following	  this	  period	  (Figure	  5.3).	  The	  










Figure	   5.2.	   DGGE	   profiles	   and	   UPGMA	   dendrogram	   showing	   Pearson	   correlations	   of	  
DGGE	  fingerprint	  patterns,	  displaying	   the	  similarity	  of	   the	   four	  microbial	  communities	  
throughout	  acclimatization	  to	  mercury	  fed	  with	  glucose	  (Glu),	  ethanol	  (Eth)	  or	  acetate	  
(Ace-­‐1	  and	  Ace-­‐2).	  	  
Cophenetic	   correlation=0.78.	   Clusters	   I	   (comprising	  most	   of	   the	   glucose	   and	   ethanol	  















Figure	   5.3.	   Percent	   change	   as	   compared	   to	   the	   inoculum	   determined	   from	   DGGE	  





The	  changes	  in	  the	  proportion	  of	  the	  most	  predominant	  bacterial	  groups	  during	  
the	   acclimatization	   study	   were	   monitored	   through	   FISH.	   This	   analysis	   was	  
carried	   out	   using	   probes	   targeting	   general	   phylogenetic	   groups	   that	   are	  
commonly	   found	   in	   wastewater	   treatment	   systems	   and	   environmental	  
communities,	   such	   as	   the	   Alpha,	   Beta	   and	   Gamma	   sub-­‐groups	   of	   the	  
Proteobacteria	  phylum,	  Cytophaga-­‐Flavobacteria	  and	  High	  G+C	  content	  Gram-­‐
positive	  bacteria	   (Actinobacteria).	   The	  glucose-­‐	  and	  ethanol-­‐fed	   cultures	  were	  
clearly	  dominated	  by	  members	  of	  the	  Gammaproteobacteria	  during	  the	  whole	  
study	   (Table	   5.1).	  No	  major	   differences	  were	   observed	   in	   the	   glucose	   culture	  
throughout	   the	   study,	   which	   matches	   the	   low	   variability	   observed	   through	  
DGGE	   analysis	   of	   this	   culture.	   The	   high	   %	   changes	   (as	   compared	   to	   the	  
inoculum)	  obtained	  for	  the	  ethanol	  culture	  after	  day	  300	  (Figure	  5.3)	  may	  have	  





and	   Actinobacteria,	   since	   the	   abundance	   of	   Gammaproteobacteria	   stayed	  
relatively	  stable.	  
	  
Table	  5.1.	  Semi-­‐quantitative	  FISH	  results	  for	  the	  four	  cultures	  at	  key	  days	  of	  operation.	  
Culture	  
/days	  of	  operation	  
FISH	  probe	  
ALF969	   BET42a	   GAM42a	   CF319a	   HGC69a	  
Inoculum	   +	   ++	   ++	   (+)	   +	  
Glucose	   	   	   	   	   	  
170	   -­‐	   -­‐	   +++	   -­‐	   -­‐	  
296	   -­‐	   -­‐	   +++	   -­‐	   (+)	  
479	   (+)	   +	   +++	   -­‐	   -­‐	  
Ethanol	   	   	   	   	   	  
192	   -­‐	   (+)	   +++	   -­‐	   (+)	  
221	   -­‐	   +	   +++	   (+)	   (+)	  
332	   -­‐	   -­‐	   +++	   -­‐	   -­‐	  
387	   -­‐	   -­‐	   +++	   (+)	   +	  
Acetate-­‐1	   	   	   	   	   	  
216	   (+)	   -­‐	   ++	   -­‐	   +	  
354	   -­‐	   +++	   (+)	   -­‐	   -­‐	  
497	   +	   ++	   +	   -­‐	   -­‐	  
505	   (+)	   +++	   +	   -­‐	   -­‐	  
Acetate-­‐2	   	   	   	   	   	  
303	   +	   ++	   -­‐	   (+)	   (+)	  
358	   +++	   -­‐	   -­‐	   -­‐	   (+)	  
415	   ++	   -­‐	   -­‐	   -­‐	   ++	  
-­‐	  not	  detected;	  (+)	  <5%;	  +	  10-­‐20%;	  	  	  ++	  20-­‐30%;	  	  	  +++	  >30%	  
ALF969:	   Alphaproteobacteria;	   BET42a:	   Betaproteobacteria;	   GAM42a:	  
Gammaproteobacteria;	  CF319a:	  Cytophaga-­‐Flavobacteria;	  HGC69a:	  Actinobacteria	  
	  
The	   FISH	   results	   also	   showed	   different	   population	   structures	   for	   the	   two	  
acetate	  cultures,	  as	  evidenced	  by	  the	  different	  DGGE	  band	  profiles,	  where	  the	  
acetate-­‐1	  culture	  showed	  higher	  dynamics	  with	  both	  techniques	  (Figure	  5.3	  and	  
Table	   5.1).	   The	   acetate-­‐1	   culture	  was	   dominated	   by	  Betaproteobacteria	   after	  
day	   354,	   although	   this	   group	   was	   not	   initially	   detected	   in	   this	   biomass.	   In	  
contrast,	  the	  acetate-­‐2	  culture	  was	  dominated	  by	  Alphaproteobacteria	  and	  had	  





conditions	  the	  cultures	  were	  subjected	  to	  at	  the	  beginning	  of	  the	  study,	  where	  
10	  mg	  Hg	  L−1	  was	  initially	  supplied	  to	  the	  acetate-­‐1	  culture	  and	  not	  to	  acetate	  2.	  
Actinobacteria	   were	   sporadically	   observed	   in	   all	   cultures,	   always	   in	   low	  
numbers,	  while	  a	   few	  Cytophaga-­‐Flavobacteria	  were	   found	   in	   the	  ethanol-­‐fed	  
culture	  during	  approximately	  2	  SRT	   (days	  385–	  445)	  and	  also	   in	   the	  acetate-­‐2	  
culture	  on	  day	  303.	  
	  
Quantitative-­‐PCR	  of	  the	  merA	  gene	  
	  
The	  number	  of	  copies	  of	   the	  merA	  gene	  was	  monitored	  through	  quantitative-­‐
PCR	  during	  acclimatization.	  In	  the	  inoculum,	  it	  was	  found	  to	  be	  below	  the	  limit	  
of	   quantification	   of	   the	   method	   (10±1),	   but	   it	   increased	   substantially	   in	   all	  
cultures	   within	   5	   sludge	   ages	   (SRT=	   28	   d),	   and	   attained	   very	   high	   numbers	  
towards	   the	  end	  of	   the	  study,	  particularly	   in	   the	  glucose	  and	  ethanol	  cultures	  
(Figure	  5.4).	  Overall,	  the	  glucose	  culture	  exhibited	  the	  highest	  number	  of	  merA	  
gene	   copies,	   which	   is	   in	   good	   agreement	   with	   the	   better	   mercury	   removal	  
performance	   of	   this	   culture	   throughout	   the	   study	   (Figure	   5.1).	   The	   acetate-­‐1	  
culture	  always	  showed	  a	  relatively	  low	  number	  of	  merA	  copies	  as	  compared	  to	  
the	   other	   cultures,	   which	   is	   consistent	   with	   the	   lower	   mercury	   removal	  
efficiency	   achieved	   by	   this	   system.	   The	   sudden	   decrease	   in	   the	   number	   of	  
copies	   of	   merA	   in	   this	   culture	   around	   day	   450	   could	   result	   from	  
underestimation	  due	  to	  primer	  specificity	  to	  Beta-­‐	  and	  Gammaproteobacteria,	  









Figure	   5.4.	   Copy	   number	   of	   the	   merA	   gene	   determined	   by	   qPCR	   in	   the	   glucose-­‐,	  
ethanol-­‐	  and	  acetate-­‐fed	  cultures	  throughout	  acclimatization.	  
	  
Nevertheless,	   other	   primers	   covering	   Alphaproteobacteria	   and	   Gram-­‐positive	  
bacteria	   are	   degenerated	   (Chadhain	   et	   al.,	   2006;	   Oregaard	   and	   Sorensen,	  
2007),	   and	   thus	   should	   not	   be	   applied	   for	   qPCR	   (Polz	   and	   Cavanaugh,	   1998;	  
Ramond	  et	  al.,	  2009).	  Furthermore,	  this	  decrease	  coincides	  with	  a	  decrease	   in	  
mercury	   removal	   performance	   (Figure	   5.1),	   suggesting	   that	   the	   microbial	  
community	   was	   not	   favorable	   for	   biological	   mercury	   reduction	   at	   this	   stage.	  
Similarly,	  the	  improvement	  in	  mercury	  removal	  performance	  of	  the	  ethanol-­‐fed	  
culture	  after	  day	  300	  (Figure	  5.1)	  was	  also	  consistent	  with	  a	  substantial	  increase	  
in	   the	  merA	   gene	  copy	  number,	  which	   increased	   from	  16	  copies	  ng	  DNA−1	  on	  
day	  221	  to	  15,365	  copies	  ng	  DNA−1	  on	  day	  332	  (Figure	  5.4).	  
	  
The	  merA	   gene	   copy	   number	   was	   also	   assessed	   in	   activated	   sludge	   samples	  
from	   three	   different	   WWTPs	   receiving	   domestic	   and	   industrial	   wastewater,	  
where	  it	  was	  found	  to	  be	  detectable	  in	  only	  one	  plant,	  and	  at	  a	  very	  low	  level	  
(39±8).	  This	  is	  similar	  to	  the	  low	  abundance	  observed	  in	  the	  inoculum,	  despite	  





al.,	   2005).	   These	   low	   values	   support	   the	   need	   for	   bioaugmentation	   or	  
acclimatization	   (using	   an	   appropriate	   carbon	   source)	  when	   aiming	   at	   carrying	  
out	  biological	  mercury	  removal.	  
	  
The	   increased	   number	   of	  merA	   gene	   copies	   per	   ng	  DNA	   observed	   soon	   after	  
inoculation	   (3,320	   ±	   1,820,	   1,398	   ±	   284	   and	   780	   ±	   311	  merA	   gene	   copies	   ng	  
DNA−1	   in	  the	  glucose,	  ethanol	  and	  acetate-­‐1	  cultures,	  on	  days	  44,	  123	  and	  90,	  
respectively,	   Figure	   5.4)	  was	   an	   expectable	   response	   to	   exposure	   to	  mercury	  
stress	   conditions	   (Nazaret	   et	   al.,	   2003;	   Ramond	   et	   al.,	   2008;	   Rasmussen	   and	  
Sorensen,	  2001).	  During	  acclimatization,	   an	   increased	  number	  of	  merA	   copies	  
was	   observed	   in	   all	   cultures,	   suggesting	   that	   it	   is	   an	   important	   factor	   in	   the	  
acclimatization	  process.	   The	   increase	   in	  merA	   copies	  was	  possibly	   induced	  by	  
horizontal	   gene	   transfer	   during	   exposure	   to	  mercury,	   but	   also	   by	   subsequent	  
growth	   of	   the	   transconjugants	   during	   the	   mercury-­‐free	   culture	   operation	  
phase,	  which	  usually	  accounted	  for	  >	  12	  d	  out	  of	  a	  14	  d	  cycle.	  This	  increase	  in	  
merA	  occurred	  independently	  of	  the	  change	  in	  microbial	  community,	  where	  the	  
number	   of	   gene	   copies	   continued	   to	   increase	   even	   after	   the	   population	   had	  
stabilized.	  
	  
Characterization	  of	  the	  isolates	  
	  
While	  FISH	  and	  DGGE	  enable	  monitoring	  of	  the	  microbial	  populations	  enriched	  
in	  each	  culture	  and	  their	  evolution	  throughout	  the	  study,	  these	  techniques	  do	  
not	  allow	  the	  mercury-­‐resistant	  bacteria	  in	  the	  cultures	  to	  be	  identified.	  
	  
Therefore,	  after	  a	   stable	  performance	  and	  population	   structure	  was	  observed	  
in	  the	  cultures	  (Figure	  5.1	  and	  5.3),	  pure	  cultures	  were	  isolated	  on	  agar	  plates	  





d	   of	   the	   study,	   resulting	   in	   101	   isolates.	   The	   isolates	   were	   grouped	   into	   13	  
different	   operational	   taxonomic	   units	   (OTUs)	   by	   combined	   analysis	   of	   RFLP	  
patterns	   obtained	   with	   their	  merA	   and	   16S	   rRNA	   gene	   amplicons	   using	   two	  
restriction	   enzymes	   (data	   not	   shown).	   Representatives	   of	   each	   16S	   rRNA	   or	  
merA	  OTU	  were	  sequenced	  and	  their	  phylogenetic	  affiliation	  was	   investigated	  
through	   similarity	   analysis	   with	   16S	   rRNA	   and	   merA	   genes	   sequences	  
(GenBank/NCBI)	   of	   bacteria	   previously	   reported	   to	   possess	   the	   merA	   gene	  
(Figure	  5.5	  A	  and	  5.5	  B,	  respectively).	  This	  approach	  aimed	  to	  identify	  mercury-­‐
resistant	   (merA	  positive)	  organisms	  enriched	   in	  each	  culture.	  Additionally,	   the	  
diversity	   of	   the	   16S	   rRNA	   and	  merA	   genes	   obtained	   from	   the	   isolates	   was	  
compared	   to	   study	   the	   transfer	  mechanism	   of	   the	   resistance	   determinant	   in	  
the	  cultures	  developed	  in	  this	  work.	  
	  
The	  16S	  rRNA	  OTU	  with	  the	  highest	  number	  of	  isolates	  (36)	  was	  very	  similar	  to	  
three	  other	  minor	  OTUs	  (adding	  up	  to	  47	  isolates)	  and	  were	  closely	  related	  to	  
Enterobacter	   and	   Klebsiella	   species	   (Figure	   5.5	   A).	   These	   members	   of	   the	  
Gammaproteobacteria	   include	   numerous	   faecal	   contamination-­‐related	  
bacteria,	   which	   have	   been	   reported	   to	   have	   the	  merA	   gene	   (Ramond	   et	   al.,	  
2009).	   Another	   16S	   rRNA	  OUT	   cluster	  with	   34	   isolates	   (mainly	   from	  one	  OTU	  
with	  33	  isolates),	  was	  closely	  affiliated	  with	  Alcaligenes	  and	  Bordetella	  species,	  
i.e.,	  Betaproteobacteria.	   A	   smaller	   OTU	   cluster,	   representing	   13	   isolates,	   was	  
related	   to	   Stenotrophomonas	   maltophilia	   and	   other	   members	   of	   the	  
Xanthomonadaceae,	   also	   Gammaproteobacteria.	   Finally,	   6	   isolates	   were	  
affiliated	   to	   Pannonibacter,	   belonging	   to	   the	   Alphaproteobacteria,	   and	   one	  
isolate	   was	   related	   to	   the	   Actinobacteria	   	   (Gram-­‐positive)	   Nocardiopsis	   and	  
Streptomyces.	   In	   a	   study	   comparing	   the	   isolates	   obtained	   from	   soil	   after	  




















Figure	   5.5.	  Neighbor-­‐joining	   trees	   showing	   the	  phylogenetic	   relationship	  of	   16S	   rRNA	  
gene	   and	   (B)	  merA	   gene	   sequences	   obtained	   from	   GenBank	   at	   NCBI	   and	   from	   this	  
study.	  	  
Black	  triangles	  indicate	  OUT	  representatives	  of	  the	  isolates	  obtained	  in	  this	  study.	  The	  
corresponding	   GenBank	   accession	   numbers	   are	   given	   between	   brackets,	   followed	   by	  
the	  number	  (in	  bold)	  of	  isolates	  in	  that	  OTU.	  Other	  symbols	  correspond	  to	  the	  cultures	  
from	  which	  that	  OTU	  was	  obtained	  (u	  glucose;	  o	  ethanol;	  ●acetate-­‐1	  and	  ▲	  acetate-­‐





Gammaproteobacteria	   	   (including	  Xanthomonas)	   also	  became	  dominant,	  with	  
only	  one	  isolate	  belonging	  to	  the	  high	  G+C	  Gram-­‐positive	  bacteria	  group.	  
	  
Interestingly,	   all	   isolates	   obtained	   from	   the	   glucose-­‐	   and	   ethanol-­‐fed	   cultures	  
belonged	   to	   the	   Gammaproteobacteria,	   whereas	   members	   of	   the	   Alpha-­‐,	  
Betaproteobacteria	   and	   Actinobacteria	   were	   also	   obtained	   from	   acetate-­‐fed	  
cultures	   (see	   symbols	   in	   Fig.	   5.5	   A).	   Despite	   the	   limitations	   associated	   with	  
cultivation,	   these	   results	   corroborate	   those	   observed	   with	   FISH,	   where	   the	  
acetate	  cultures	  showed	  higher	  diversity	  than	  the	  glucose	  and	  ethanol	  cultures	  
throughout	  the	  study.	  	  
	  
The	  merA	  OTUs	  could	  be	  grouped	  into	  three	  clusters.	  A	  cluster	  with	  47	  isolates	  
was	   closely	   related	   to	   the	   merA	   gene	   of	   transposon	   Tn5073	   in	   Klebsiella	  
pneumoniae	   	   (Figure	   5.5	   B).	   These	   isolates	  were	   the	   same	   as	   those	   affiliated	  
with	  Klebsiella	   and	   other	  Enterobacteriaceae	   through	   16S	   rRNA	   gene	   analysis	  
and	  were	  only	   found	   in	  the	  glucose-­‐	  and	  ethanol-­‐fed	  cultures.	  A	  second	  merA	  
OTU	  cluster	  included	  13	  isolates	  and	  was	  related	  to	  the	  merA	  found	  in	  plasmids	  
of	  Enterobactercloacae	  and	   other	  members	   of	   the	  Enterobacteriaceae	   family.	  
These	   isolates	   were	   all	   phylogenetically	   affiliated	   to	   the	   Xanthomonadaceae	  
Stronotrophomonas	   	   (Figure	   5.5	   A)	   and	   were	   present	   in	   all	   cultures.	   Finally,	  
another	   OTU	   of	   34	   isolates	   matched	   the	  merA	   in	   a	   transposon	   observed	   in	  
Xanthomonas	   (Gammaproteobacteria),	  while	   through	   16S	   rRNA	   gene	   analysis	  
they	   belonged	   to	   the	   Betaproteobacteria.	   These	   isolates	   were	   only	   found	   in	  
acetate-­‐fed	   cultures.	   All	   three	   merA	   OTU	   clusters	   shared	   relatively	   high	  
similarity	   (>	   75%),	   even	   among	   bacteria	   of	   different	   genera,	   families	   and	  
groups,	  which	  is	  not	  surprising	  regarding	  the	  high	  mobility	  of	  this	  gene	  (Osborn	  
et	  al.,	  1997).	  One	  hypothesis	  is	  that	  the	  merA	  gene	  was	  originally	  found	  in	  the	  





Xanthomonadaceae)	   and	   then	   horizontally	   transferred	   to	   other	   organisms,	  
including	  members	  of	  the	  Betaproteobacteria.	  	  
	  
It	  was	  not	  possible	  to	  amplify	  the	  merA	  gene	  of	  the	  three	  isolates	  belonging	  to	  
Alphaproteobacteria	   and	   Actinobacteria,	   despite	   their	   growth	   in	   mercury-­‐
containing	   media,	   which	   suggested	   that	   they	   possess	   a	   mercury-­‐resistant	  
determinant.	   This	   was	   likely	   due	   to	   the	   specificity	   of	   the	   merA	   primers	  
employed	   (Liebert	  et	  al.,	  1997),	  which	  were	  developed	   to	   target	  mostly	  Beta-­‐	  
and	   Gammaproteobacteria.	   Nevertheless,	   the	   low	   number	   of	   isolates	   found	  
outside	  these	  groups	  (7	  out	  of	  101	  isolates)	  suggested	  that	  the	  selected	  primers	  
covered	  the	  majority	  of	  bacteria	  in	  the	  cultures.	  
Conclusions	  
In	   this	   study,	   a	   clear	   shift	   in	   the	  microbial	   profiles	   of	   engineered	   cultures	   for	  
biological	  Hg2+	  reduction	  was	  observed	  shortly	  after	  mercury	  contamination	  (2–
4	  SRT),	  with	  a	  clear	  divergence	  of	  the	  two	  acetate	  cultures	  with	  respect	  to	  the	  
glucose-­‐	   and	   ethanol-­‐fed	   cultures,	   which	   clustered	   in	   higher	   similarity.	   The	  
glucose	  culture	  displayed	  a	  very	  stable	  microbial	  community,	  with	  the	  highest	  
abundance	  of	  merA	   gene	   copies	  and	   the	  best	  Hg	   removal	  performance.	  After	  
an	  initial	  period	  of	  unstable	  mercury	  removal	  due	  to	  ethanol	  accumulation,	  the	  
ethanol	   culture	   also	   achieved	   good	   performance	   and	   increasing	   merA	   copy	  
numbers.	  The	  acetate	  cultures	  showed	  more	  dynamic	  microbial	  profiles,	  as	  well	  
as	   lower	   mercury	   removal	   efficiency,	   which	   may	   have	   been	   due	   to	   lower	  
selection	  pressure	  on	  the	  culture	  caused	  by	  the	  formation	  of	  mercuric	  acetate	  
complexes.	  The	  diversity	   in	   the	  merA	   sequences	   from	  the	   isolates	  obtained	   in	  
this	  study	  was	  lower	  than	  their	  corresponding	  16S	  rRNA	  diversity.	  This	  suggests	  





acclimatization	   of	   the	   cultures.	   This	   was	   further	   supported	   by	   the	   very	   high	  
increase	   in	  merA	   gene	   copy	   number	   by	   qPCR	   during	   acclimatization,	   which	  
largely	   occurred	   after	   the	   microbial	   populations	   had	   stabilized,	   regardless	   of	  
the	  community	  composition.	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The	   detection	   of	   micropollutants	   in	   water	   sources	   is	   raising	   global	   concerns	  
regarding	   their	   potential	   risks	   to	   the	   environment	   and	   human	   health.	   WWTPs	  
represent	   the	   first	   treatment	   opportunity	   for	   removing	   these	   compounds	   and	  
preventing	  significant	  environmental	  exposure.	  In	  biological	  systems	  the	  microbial	  
fraction	   is	   known	   to	   play	   an	   important	   role	   in	   the	   elimination	   of	   pollutants.	  
However,	   little	   is	   known	   about	   the	  microbial	   populations	   in	   treatment	   systems	  
and	   their	   responses	   to	   these	   compounds.	   The	   assessment	   of	   variations	   in	  
microbial	   community	   structure	   and	   functionality	   are	   of	   basic	   importance	   for	  
understanding	   the	   micropollutant	   degradation	   potential	   of	   a	   system,	   and	   to	  
optimise	  the	  elimination	  of	  these	  compounds	  during	  the	  treatment	  process.	  
	  
In	  the	  first	  part	  of	  this	  thesis,	  the	  ability	  of	  activated	  sludge	  from	  three	  different	  
WWTPs	  to	  degrade	  two	  of	  the	  most	  highly	  detectable	  NSAIDs	   in	  the	   influents	  of	  
WWTPs	   worldwide	   was	   investigated	   and	   characterised	   through	   the	   use	   of	   a	  
mathematical	   model.	   Modelling	   of	   activated	   sludge	   processes	   is	   valuable	   to	  
further	  improve	  process	  optimisation	  and	  control	  in	  treatment	  systems	  aiming	  to	  
increase	   micropollutant	   removal	   and	   minimise	   their	   occurrence	   on	   receiving	  
waters.	  The	  model	  developed	  in	  this	  study	  effectively	  characterised	  the	  influence	  
of	  different	  loading	  rates	  and	  mixtures	  of	  compounds	  on	  the	  degradation	  of	  both	  
ibuprofen	  and	  ketoprofen	  by	  activated	  sludge.	  The	  degradation	  performance	  was	  
found	  to	  be	  a	  function	  of	  biomass	  composition	  and	  substrate	  loading	  rate.	  Higher	  
loading	   rates	   induced	   higher	   removal	   rates.	   Additionally,	   mixtures	   of	   both	  





each	  NSAID	  was	  fed	  individually.	  Furthermore,	  a	  lag	  phase	  was	  observed	  in	  all	  the	  
cases.	  The	  overall	  results	  contrast	  with	  the	  ones	  previously	  obtained	  by	  Collado	  et	  
al.	   (2012),	   where	   a	   lag	   phase	   was	   not	   observed	   and	   where	   higher	   degradation	  
rates	   were	   obtained	   at	   lower	   ibuprofen	   concentrations.	   The	   lag	   phase	   could	  
possibly	  be	   related	   to	   the	  acclimation	  and	  growth	  of	  degrading	  microorganisms,	  
as	  previously	  demonstrated	  by	  Chong	  et	  al.	   (2009).	  This	  hypothesis	  could	  hardly	  
be	   explored	   in	   activated	   sludge	   due	   to	   the	   impossibility	   of	   measuring	   the	  
microbial	   degraders.	   For	   this	   reason,	   microorganisms	   were	   isolated	   that	   could	  
easily	  allow	  to	  monitor	  the	  growth/function	  performance.	  Twelve	  new	  ibuprofen	  
and	   ketoprofen	   degraders	   were	   isolated	   and	   identified	   from	   the	   sludge	   that	  
showed	   the	  best	  NSAID	   removal	   performance.	   The	   in	   situ	   relevance	   and	   role	  of	  
these	   isolates	   in	   treatment	   systems	   is	   still	   unknown	   and	   requires	   further	   study.	  
Nevertheless,	   their	   identities	   are	   of	   great	   use	   in	   future	   studies	   aiming	   to	  
characterise	   the	  microbial	   populations	   involved	   in	  PhAC	  degradation	   in	  WWTPs.	  
One	  of	   the	   isolates,	   an	   ibuprofen	  degrader,	  was	   studied	   in	   similar	   experimental	  
conditions	   used	   in	   the	   tests	   with	   activated	   sludge	   to	   demonstrate	   the	   link	  
between	  biomass	  growth	  rate	  and	  ibuprofen	  degradation	  rate.	  The	  degradation	  of	  
ibuprofen	   by	   the	   isolate	   began	   immediately	   after	   its	   addition	   to	   the	   medium	  
without	  a	   lag	  phase	  showing	  a	  different	  behaviour	  as	  compared	  to	  the	  activated	  
sludge.	  This	  degradation	  profile	  was	  incorporated	  in	  a	  new	  model.	  This	  isolate	  was	  
not	   able	   to	   use	   ibuprofen	   as	   the	   sole	   carbon	   source,	   although	   degradation	  was	  
observed	   in	   the	   presence	   of	   other	   carbon	   sources.	   The	   ibuprofen	   degradation	  
performance	   was	   simultaneously	   dependent	   on	   the	   growth	   rate	   as	   well	   as	   the	  
ibuprofen	  concentration,	  with	  higher	  degradation	  rates	  at	  higher	  biomass	  growth	  
rates.	  Higher	  biomass	  growth	  rates	  were	  achieved	  with	  increasing	  concentrations	  
of	  yeast	  extract	  and	  tryptone.	  Other	  studies	  have	  also	  associated	  the	  degradation	  
efficiency	   with	   the	   presence	   of	   another	   primary	   substrate	   that	   can	   sustain	   cell	  





consideration	  when	   aiming	   at	   stimulating	   the	   degradation	   of	  micropollutants	   in	  
WWTPs.	  
	  
The	   differences	   in	   degradation	   performance	  observed	  between	  mixed	  microbial	  
cultures	   and	   pure	   cultures	   under	   similar	   environmental	   conditions	   highlight	   the	  
importance	   of	   testing	   the	   degradation	   performance	   for	   each	   specific	   microbial	  
community.	   Besides,	   these	   results	   emphasised	   that	   mathematical	   models	   may	  
require	   adaptation	   to	   describe	   different	   systems.	   The	   applicability	   of	   the	  
developed	  models	   in	  this	  study	  to	  predict	  and	  describe	  the	  degradation	  of	  other	  
NSAIDs	  or	  PhACs	   should	  be	   further	   investigated.	   Future	   studies	   should	   also	   test	  
technological	   and	   operational	   characteristics	   of	   the	   treatment	   systems,	   such	   as	  
temperature,	   redox	   potential,	   sludge	   and	   hydraulic	   retention	   time	   on	   the	  
degradation	  of	  performance	  of	  these	  NSAIDs.	  	  
	  
Interestingly,	   the	   ibuprofen	   bacterial	   isolate	   for	   which	   a	   model	   was	   developed	  
was	   found	   to	   be	   a	   new	   species.	   A	   polyphasic	   taxonomic	   approach,	  where	   both	  
phenotypic	   and	   genotypic	  methods	   were	   employed,	   suggested	   this	   isolate	   as	   a	  
new	   species	   of	   the	   genus	   Patulibacter,	   for	   which	   the	   name	   Patulibacter	  
medicamentivorans	  sp.	  nov.	  was	  proposed.	  The	  new	  species	  described	  here	  is	  the	  
first	  gram-­‐positive	  bacteria	  with	  a	  demonstrated	  ability	  to	  degrade	  ibuprofen.	  The	  
identification	   of	   this	   degrading	   microorganism	   is	   of	   great	   importance	   since	   it	  
enables	   to	   further	  monitor	   its	   presence	   and	   function	   in	   treatment	   systems.	   For	  
example,	   specific	   FISH	   probes	   can	   be	   designed	   to	   detect	   this	   microorganism	  
allowing	  its	  detection	  and	  quantification	  in	  natural	  systems	  and/or	  in	  engineered	  
systems	   aiming	   to	   enrich	   microbial	   communities	   for	   bioaugmentation	   or	  
bioremediation	   purposes	   and	   correlate	   it	   with	   the	   removal	   performance.	   	   The	  





mechanisms	   of	   ibuprofen	   degradation	   by	   identifying	   key	   enzymes	   involved	   in	  
process	  using	  a	  proteomic	  approach.	  
	  
In	  this	  thesis,	  the	  value	  of	  the	  combination	  of	  genomic	  and	  proteomic	  approaches	  
was	   demonstrated,	   which	   revealed	   novel	   information	   regarding	   the	   cellular	  
responses	   to	   this	   important	   NSAID.	   Ibuprofen	   degradation	   by	   Patulibacter	  
medicamentivorans	   was	   characterised	   by	   a	   metabolic	   labelling	   quantitative	  
proteomics.	   This	  methodology	  enabled	   the	   identification	  and	  quantification	  of	  a	  
number	  of	  up-­‐regulated	  proteins	  in	  the	  presence	  of	  low	  levels	  of	   ibuprofen,	  that	  
constitute	  potential	  candidates	  involved	  in	  the	  metabolic	  degradation	  pathway	  of	  
ibuprofen.	  Furthermore,	  all	  the	  proteins	  were	  reliably	  identified	  from	  the	  genome	  
of	   Patulibacter	   medicamentivorans,	   which	   was	   specifically	   sequenced	   for	   this	  
purpose.	  Some	  of	   the	  proteins	   identified	   in	   this	  study,	   including	  those	  that	  have	  
been	   previously	   described	   to	   be	   involved	   in	   the	   uptake	   and	   degradation	   of	  
aromatic	  hydrocarbons,	  were	  up-­‐regulated	  in	  the	  presence	  of	  ibuprofen:	  Acyl-­‐CoA	  
synthetase	   (J2XUN5),	   involved	   in	   the	   first	   step	   of	   CoA-­‐dependent	   degradation	  
pathway,	   catalysing	   the	   formation	   of	   an	   acyl-­‐CoA;	   Rieske	   (2Fe-­‐2S)	   iron-­‐sulphur	  
domain	   protein	   (D3F3V3),	   involved	   in	   the	   oxidation	   of	   aromatic	   ring	   structure;	  
enoyl-­‐CoA	  hydratase/isomerase	  (D3F114),	  known	  for	  catalysing	  the	  hydroxylation	  
of	   double	   bonds	   after	   opening	   of	   the	   aromatic	   ring;	   and	   an	   ABC-­‐2	   type	  
transporter	   (D3FB12),	   daunurobicin	   resistance	   ABC	   transporter	   ATPase	   (D3FBI3)	  
and	   an	   extracellular	   solute-­‐binding	   protein	   type	   1	   family	   (D3FBH9),	   known	   for	  
participating	  in	  the	  uptake	  of	  aromatic	  hydrocarbons.	  Additionally,	  the	  genome	  of	  
Patulibacter	  medicamentivorans	  revealed	  the	  presence	  of	  similar	  genes	  known	  to	  
be	   involved	   in	   the	   degradation	   of	   other	   aromatic	   hydrocarbons,	   benzoate	   and	  
phenylacetic	  acid,	  which	  reveals	  the	  versatility	  of	  this	  microorganism	  towards	  the	  






The	  genes	  previously	  reported	  as	  involved	  in	  ibuprofen	  degradation	  (Kagle	  et	  al.,	  
2009)	  were	  not	  found	  in	  the	  proteome	  of	  Patulibacter	  medicamentivorans,	  except	  
for	  a	  protein	  sharing	  33	  %	  identity	  with	  IpfF	  from	  Sphingomonas	  sp.	  Ibu-­‐2.	  This	  is	  
not	   surprising	   in	   view	  of	   the	  phylogenetic	  distance	  between	   the	   two	  organisms,	  
and	  supports	  the	  hypothesis	  of	  a	  novel	  metabolic	  pathway.	  The	  verification	  of	  the	  
role	  of	  the	  identified	  proteins	  requires	  further	  analysis	  such	  as	  expression	  studies	  
and	  protein	  characterisation.	  The	  identification	  of	  metabolites	  will	  further	  provide	  
more	  definitive	  links	  to	  physiological	  functions.	  
	  
The	   proteins	   identified	   in	   this	   study	   can	   be	   further	   used	   as	   biomarkers	   to	  
characterise	  the	  ability	  of	  a	  microorganism	  or	  a	  community	  of	  microorganisms	  to	  
degrade	  ibuprofen	  or	  other	  structural	  similar	  compounds.	  Biomarkers	  are	  of	  great	  
value	  for	  biotechnological	  applications,	  as	  they	  enable	  to	  monitor	  the	  degradation	  
potential	   of	   a	   microbial	   community	   and	   its	   dynamics	   throughout	  
operational/environmental	   variations	   in	   engineered	   and	   natural	   systems.	   For	  
example,	   qPCR	   primers	   targeting	   functional	   genes	   that	   encode	   for	   the	   specific	  
proteins	  identified	  in	  this	  study	  can	  be	  designed	  and	  applied	  for	  this	  purpose.	  
	  
The	   application	   of	   genetic/proteomic	   knowledge	   to	   the	   investigation	   of	  
micropollutant-­‐degrading	  communities	  was	  explored	   in	  this	  thesis,	   to	  establish	  a	  
link	   between	   mercury	   degradation	   performance	   and	   microbial	   community	  
dynamics.	   This	   work	   was	   focused	   on	   the	   enrichment	   of	   mercury-­‐reducing	  
microbial	   cultures	   fed	   with	   different	   carbons	   sources	   (glucose,	   ethanol	   and	  
acetate).	  	  
	  
The	   results	   showed	   that	   higher	   mercury	   reduction	   rates	   were	   obtained	   in	   the	  
glucose-­‐fed	  culture	  and	  lower	  in	  the	  acetate-­‐fed	  culture,	  suggesting	  that	  different	  





rRNA	   gene	   profiles	   obtained	   by	   DGGE.	   Additionally,	   FISH	   results	   matched	   the	  
variability	   observed	   with	   DGGE	   analysis,	   in	   which	   glucose-­‐	   and	   ethanol-­‐	   fed	  
cultures	  were	   dominated	   by	  Gammaproteobacteria	  while	   acetate	   cultures	  were	  
dominated	  by	  Alphaproteobacteria.	  	  
	  
The	  previous	  knowledge	  on	  the	  biological	  mercury	  reduction	  mechanism	  allowed	  
assessing	  the	  functional	  changes	  of	  the	  communities	  through	  quantification	  of	  the	  
merA	   gene	   copy	   numbers	   by	   qPCR.	   These	   results	   correlated	   with	   the	  
corresponding	   mercury	   removal	   efficiency	   of	   each	   culture.	   Moreover,	   the	  
taxonomic	   and	   functional	   diversity	   of	   the	   mercury-­‐resistant	   organisms	   was	  
investigated	  through	   isolation	  and	  sequencing	  of	   the	  16S	  rRNA	  and	  merA	  genes,	  
respectively.	  Higher	  diversity	  of	  the	  merA	  gene	  was	  observed	  when	  compared	  to	  
the	  16S	  rRNA	  gene,	  suggesting	  that	  horizontal	  gene	  transfer	  played	  an	  important	  
role	  in	  the	  acclimatisation	  process.	  This	  was	  also	  supported	  by	  the	  increase	  in	  the	  
merA	   copy	  number	  during	  acclimatisation,	  which	  occurred	  after	   the	  populations	  
performance	  had	  stabilised.	  Overall,	   it	  was	  demonstrated	  that	  glucose	  positively	  
affected	   the	  microbial	   selection	   resulting	   in	   a	   very	   stable	  microbial	   community,	  
with	   the	  highest	  abundance	  of	  merA	  gene	  copies	  and	  the	  best	  mercury	   removal	  
performance.	  	  
	  
Future	  studies	  should	  address	  other	  carbon	  sources	  such	  as	  sludge	  hydrolysate	  or	  
molasses	  due	  to	  economic	  advantages.	  A	  similar	  approach	  could	  be	  carried	  out	  to	  
verify	   the	   effect	   of	   these	   carbons	   sources	   on	   the	   microbial	   communities.	  
Nevertheless,	   the	   extrapolation	   of	   such	   studies	   should	   be	   done	   carefully	   and	  
should	   also	   account	   for	   the	   possible	   impacts	   on	   other	   important	   microbial	  






The	   overall	   results	   contribute	   to	   the	   understanding	   of	   the	   micropollutant	  
degrading	  microbial	  community	  structure	  and	  function	  in	  WWTPs.	  Biodegradation	  
of	   micropollutants	   in	   WWTPs	   is	   possible.	   However,	   in	   order	   to	   maximize	   the	  
potential	   benefits	   of	   microbial	   community	   in	   degrading	   such	   pollutants,	   it	   is	  
important	   to	   have	   fundamental	   understanding	   of	   the	   microbial	   degradation	  
capacity	   under	   different	   operational	   conditions,	   its	   biochemical	   systems	   and	   its	  
molecular	  biology.	  	  
	  
The	   biological	   removal	   of	   micropollutants	   in	   water	   and	   wastewater	   treatment	  
systems	   remains	   a	   great	   challenge	   that	   requires	   continuous	   study	   due	   to	   the	  
constant	  detection	  of	  new	  emerging	  micropollutants.	  The	  work	  presented	  in	  this	  
thesis	  represents	  a	  step	  forward	  in	  the	  understanding,	  monitoring	  and	  promoting	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Figure	   7.1.	   Polar	   lipid	   profile	   of	   strain	   I11T	  after	   separation	   by	   two-­‐dimensional	  
thin-­‐layer	  chromatography.	  DPG,	  diphosphatidylglycerol;	  PG,	  phosphatidylglycerol	  
















Figure	  7.2.	  Ibuprofen	  degradation	  by	  the	  bacterial	  isolate	  Patulibacter	  sp.	  I11.	  The	  
progression	   of	   degradation	   of	   ibuprofen	   by	   the	   Patulibacter	   sp.	   I11-­‐strain	   is	  












Figure	   7.3.	   A)	   Distribution	   of	   the	   quantitated	   proteome	   of	   the	   forward	   and	  
reverse	  labelling	  experiment	  (only	  considering	  unique	  proteins).	  73	  proteins	  were	  
exclusive	  to	  the	  forward	  labelling	  experiment,	  79	  exclusive	  to	  the	  reverse	  labelling	  
experiment	  and	  99	  proteins	  were	  common	  to	  both.	  B)	  Distribution	  of	  proteins	  at	  
three	   different	   levels	   of	   GO-­‐annotation:	   Biological	   process,	   Cellular	   component	  
and	  Molecular	  function.	  Each	  pie	  slice	  is	  labelled	  with	  the	  GO	  subcategory	  name,	  














Figure	   7.4.	   Distribution	   of	   the	   upregulated	   (i.e.	   log2	   ratio	   >=	   0.9)	   part	   of	   the	  
proteome	   of	   the	   forward	   and	   reverse	   labelling	   experiment	   (only	   considering	  
unique	   proteins)	   as	   well	   as	   distributions	   of	   proteins	   at	   three	   different	   levels	   of	  
GO-­‐annotation:	   Biological	   process,	   Cellular	   component	   and	   Molecular	   function.	  
Each	   pie	   slice	   is	   labelled	   with	   the	   GO	   subcategory	   name,	   number	   of	   GO	  
annotations	  within	  the	  category	  as	  well	  as	  the	  percentage	  fraction	  of	  annotations.	  
B)	  Distribution	  of	  the	  down-­‐regulated	  (i.e.	  log2	  ratio	  <=	  -­‐0.9)	  part	  of	  the	  proteome	  
of	   the	   forward	   and	   reverse	   labelling	   experiment	   (only	   considering	   unique	  











Table	  7.1.	  	  List	  of	  primers	  used	  in	  this	  study.	  	  
Target	  gene	   Primer’s	  name	   Sequence	  (5’-­‐3’)	   Size	  (bp)	  
PAI11_21070*	   IpfA2F	   CGACTACGTGGTCAAGTCGATCG	   170	  
	   IpfA2R	   AGAACGTCCACCCGTGGTACG	   	  
	   	   	   	  
PAI11_21080*	   IpfB1F	   CGGCAGATGTCGGTGATCTTCG	   135	  
	   IpfB1R	   ATCCAGCAGCTCGACGTTGGT	   	  
	   	   	   	  
PAI11_02050*	   IpfD2F	   CTTCGAGCCGTTCGGCGAGA	   170	  
	   IpfD2R	   CCTTCTCGCAGAACCCGAGGT	   	  
	   	   	   	  
PAI11_25140*	   IpfE1F	   TGACCAACGTCGTCGTCGACT	   157	  
	   IpfE1R	   CGGGCCTTCCAGAAGTAGTTGTG	   	  
	   	   	   	  
PAI11_13130*	   IpfF2F	   GACAACGTCATGGCCGGCTAC	   150	  
	   IpfF2R	   GCCGGTCACGATCATGTCCTTG	   	  
	   	   	   	  
D3F114	   P1F2	   GCATCGAGATCCCCTTCCGGTA	   149	  
	   P1R2	   GCCGCGGTTCTACGTCCAGA	   	  
	   	   	   	  
J2XUN5	   P2F1	   CCTGAACAGCGACCGCTACCT	   150	  
	   P2R1	   AAGGCGTCGTCGACCAGCAA	   	  
	   	   	   	  
D3F3V3	   P3F1	   TTCGCCCGCTGGATCGCTT	   151	  
	   P3R1	   GACGGATACAGGTACTGGCCGAT	   	  
	   	   	   	  
D3FBI3	   P4F2	   GCAGCAGCGTCGTCATGATCC	   142	  
	   P4R2	   CGGGGGCTGGTCAAGTCCTT	   	  
	   	   	   	  
D3FBI2	   P5F1	   ACGGTGAAGCCGATCGCGTT	   144	  
	   P5R1	   CTTCTCGTTCGGGACCGACGT	   	  
	   	   	   	  
D3FBH9	   P6F1	   CAAGTCGGTGATCAAGGAGTTCGA	   153	  
	   P6R1	   	  TAGTCGGTCAGGACGACGATGTC	   	  
	   	   	   	  
PAI11_13300	   I11_16SF2	   CACTGGTTAATAGCCAATCGGAGTGA	   156	  
	   I11_16SR2	   GACTTTCACAGCAGACTTACTGAACC	   	  
	   	   	   	  
	  
*	   Orthologous	   genes	   in	   Patulibacter	   sp.	   strain	   I11	   to	   ipfABDEF	   proposed	   to	   be	  








Table	   7.2.	   Ab	   initio	   predictions	   of	   functions	   of	   the	   putative	   uncharacterized	  
proteins,	   based	   upon	   the	   full-­‐length	   sequence	   retrieved	   from	   the	   annotated	  





Table	  7.3.	  The	  Sphingomonas	  Ibu-­‐2	  ipf	  genes,	  the	  Acinetobacter	  sp.	  (strain	  ADP1)	  
cat	   and	  ben	   genes	   and	   the	   E.coli	   K12	  paa	   genes	  with	   respective	   align	   products	  













	   Cell	  envelope	   Non-­‐enzyme	   -­‐-­‐-­‐	   Stress	  response	  
D3FA23	   	  
Central	  intermediary	  
metabolism	  
Enzyme	   Lyase	   -­‐-­‐-­‐	  
Q47N65	   	   Transport	  and	  binding	   Non-­‐enzyme	   -­‐-­‐-­‐	   Immune	  response	  
D3F293	   	  
Cell	  envelope	  
	  
Enzyme	   -­‐-­‐-­‐	   Immune	  response	  
D3FFG0	   	  
Cell	  envelope	  
	  
Enzyme	   -­‐-­‐-­‐	   Structural	  protein	  
B0CFJ3	   	   Cell	  envelope	  
Non-­‐enzyme	  
	  
-­‐-­‐-­‐	   Immune	  response	  













hydroxylase	  component	   5E-­‐91	  
40	  
	   A1E031	  






4E-­‐34	   46	   A1E030	  
IpfD	  




Ibu-­‐2	   Thiolase	   3E-­‐21	   36	   A1E029	  












synthetase	  and	  ligase	  
	  
10E-­‐
61	   33	   A1E027	  
benA	  









9E-­‐52	   33	   P07769	  
benB	  

























6E-­‐40	   34	   P07771	  
benD	  







protein]	  reductase	   8E-­‐24	   30	   P07772	  
benE	  





	   -­‐	   -­‐	   P07775	  
benK	  





	   -­‐	   -­‐	   O30513	  
benK	  









5E-­‐04	   24	   O30513	  
benP	  





	   -­‐	   -­‐	   -­‐	  
benM	  









4E-­‐39	   38	   O68014	  
catA	  







dioxygenase	  beta	  subunit	  
	  
8E-­‐29	   33	   P07773	  
catM	  









9E-­‐34	   34	   P07774	  
catB	  









4E-­‐30	   30	   Q43931	  
catC	  









2E-­‐23	   42	   Q43932	  
catI	  






Putative	  CoA	  transferase	  
A	  subunit	  
	  
2E-­‐03	   39	   Q43973	  
catJ	  








coenzyme	  A	  transferase	  
	  
8E-­‐02	   37	   Q59091	  
catF	  








7E-­‐74	   43	   Q43935	  
paaA	  
	   	   -­‐	   E.coli	  K12	   -­‐	   -­‐	   -­‐	   P76077	  
paaB	  
	   	  
PAI11_33410	  





0.30	   43	   P76078	  
paaC	  
	   	  
PAI11_05850	  
	   E.coli	  K12	   ABC	  transporter	  related	   0.64	   25	   P76079	  
paaE	  






reductases)	  family	  1	  
	  





ANCBI	  accession	  number	  of	  Patulibacter	  sp.	  strain	  I11	  align	  products.	  





	   	  
PAI11_02240	  
	   E.coli	  K12	   Enoyl-­‐CoA	  hydratase	   5E-­‐42	   47	   P76082	  
paaG	  
	   	  
PAI11_25220	  
	   E.coli	  K12	   Enoyl-­‐CoA	  hydratase	   3E-­‐39	   45	   P77467	  
paaH	  
	   	  
PAI11_02250	  




2E-­‐37	   35	   P76083	  
paaI	  
	   	  
PAI11_01080	  
	   E.coli	  K12	  
Uncharacterized	  protein,	  
possibly	  involved	  in	  
aromatic	  compounds	  
catabolism	  
1E-­‐6	   30	   P76084	  
paaJ	  
	   	  
PAI11_02260	  
	  
E.coli	  K12	   3-­‐ketoacyl-­‐CoA	  thiolase	   8E-­‐
112	  
54	   P0C7L2	  
paaK	  
	   	  
PAI11_05290	  
	   E.coli	  K12	   AMP-­‐binding	  protein	   1E-­‐8	   25	   P76085	  
paaL	  









40	   P0ABH9	  






3E-­‐24	   30	   P77455	  
paaZ	  







3E-­‐24	   30	   P77455	  
paaX	  









1E-­‐5	   25	   P76086	  
paaY	   	   PAI11_34980	  	   E.coli	  K12	   Acetyltransferase	   7E-­‐6	   33	   P77181	  
173
	  
